Exercise-based cardiac rehabilitation for adults with heart failure by Long, Linda et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Manuscript version: Published Version 
The version presented in WRAP is the published version (Version of Record). 
 
Persistent WRAP URL: 
http://wrap.warwick.ac.uk/113056                            
 
How to cite: 
The repository item page linked to above, will contain details on accessing citation guidance 
from the publisher. 
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  
 
Copyright © and all moral rights to the version of the paper presented here belong to the 
individual author(s) and/or other copyright owners. To the extent reasonable and 
practicable the material made available in WRAP has been checked for eligibility before 
being made available. 
 
Copies of full items can be used for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge. Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
Please refer to the repository item page, publisher’s statement section, for further 
information. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
Cochrane Database of Systematic Reviews
Exercise-based cardiac rehabilitation for adults with heart
failure (Review)
Long L, Mordi IR, Bridges C, Sagar VA, Davies EJ, Coats AJS, Dalal H, Rees K, Singh SJ, Taylor RS
Long L, Mordi IR, Bridges C, Sagar VA, Davies EJ, Coats AJS, Dalal H, Rees K, Singh SJ, Taylor RS.
Exercise-based cardiac rehabilitation for adults with heart failure.
Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD003331.
DOI: 10.1002/14651858.CD003331.pub5.
www.cochranelibrary.com
Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
11BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
17RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Figure 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Figure 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Figure 6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Figure 7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Figure 8. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
28DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
29AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
43CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
131DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 All exercise interventions versus usual care, Outcome 1 All-cause mortality up to 12 months’
follow-up. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
Analysis 1.2. Comparison 1 All exercise interventions versus usual care, Outcome 2 All-cause mortality more than 12
months’ follow-up. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
Analysis 1.3. Comparison 1 All exercise interventions versus usual care, Outcome 3 Hospital admission up to 12 months’
follow-up. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
Analysis 1.4. Comparison 1 All exercise interventions versus usual care, Outcome 4 Hospital admission more than 12
months’ follow-up. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
Analysis 1.5. Comparison 1 All exercise interventions versus usual care, Outcome 5 Hospital admission heart failure
only. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
Analysis 1.6. Comparison 1 All exercise interventions versus usual care, Outcome 6 Health-related quality of life - MLWHF
up to 12 months’ follow-up. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Analysis 1.7. Comparison 1 All exercise interventions versus usual care, Outcome 7 Health-related quality of life - MLWHF
and other scales up to 12 months’ follow-up. . . . . . . . . . . . . . . . . . . . . . . . 139
Analysis 1.8. Comparison 1 All exercise interventions versus usual care, Outcome 8 Health-related quality of life - MLWHF
more than 12 months’ follow-up. . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
141ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
151APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
180WHAT’S NEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
180HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
180CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
181DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
181SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
181DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
182NOTES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
182INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iExercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Exercise-based cardiac rehabilitation for adults with heart
failure
Linda Long1 , Ify R Mordi2, Charlene Bridges3, Viral A Sagar4, Edward J Davies5, Andrew JS Coats6, Hasnain Dalal1,7, Karen Rees8,
Sally J Singh9, Rod S Taylor1,10
1Institute of Health Research, University of Exeter Medical School, Exeter, UK. 2Molecular and Clinical Medicine, University of
Dundee, Dundee, UK. 3Institute of Health Informatics Research, University College London, London, UK. 4King’s College Hospital,
London, UK. 5Department of Cardiology, Royal Devon&ExeterHealthcare Foundation Trust, Exeter, UK. 6University of East Anglia,
Norwich, UK. 7Department of Primary Care, University of Exeter Medical School, Truro Campus, Knowledge Spa, Royal Cornwall
Hospitals Trust, Truro, UK. 8Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK. 9Cardiac
and Pulmonary Rehabilitation, Glenfield Hospital, Leicester, UK. 10Institute of Health &Wellbeing, University of Glasgow, Glasgow,
UK
Contact address: Rod S Taylor, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK. rod.taylor@gla.ac.uk.
Editorial group: Cochrane Heart Group.
Publication status and date: New search for studies and content updated (no change to conclusions), published in Issue 1, 2019.
Citation: Long L, Mordi IR, Bridges C, Sagar VA, Davies EJ, Coats AJS, Dalal H, Rees K, Singh SJ, Taylor RS. Exercise-based
cardiac rehabilitation for adults with heart failure. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD003331. DOI:
10.1002/14651858.CD003331.pub5.
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Chronic heart failure (HF) is a growing global health challenge. People with HF experience substantial burden that includes low exercise
tolerance, poor health-related quality of life (HRQoL), increased risk of mortality and hospital admission, and high healthcare costs.
The previous (2014) Cochrane systematic review reported that exercise-based cardiac rehabilitation (CR) compared to no exercise
control shows improvement in HRQoL and hospital admission among people with HF, as well as possible reduction in mortality over
the longer term, and that these reductions appear to be consistent across patient and programme characteristics. Limitations noted by
the authors of this previous Cochrane Review include the following: (1) most trials were undertaken in patients with HF with reduced
(< 45%) ejection fraction (HFrEF), and women, older people, and those with preserved (≥ 45%) ejection fraction HF (HFpEF) were
under-represented; and (2) most trials were undertaken in the hospital/centre-based setting.
Objectives
To determine the effects of exercise-based cardiac rehabilitation on mortality, hospital admission, and health-related quality of life of
people with heart failure.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and three other databases on 29
January 2018. We also checked the bibliographies of systematic reviews and two trial registers.
Selection criteria
We included randomised controlled trials that compared exercise-based CR interventions with six months’ or longer follow-up versus
a no exercise control that could include usual medical care. The study population comprised adults (> 18 years) with evidence of HF -
either HFrEF or HFpEF.
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Data collection and analysis
Two review authors independently screened all identified references and rejected those that were clearly ineligible for inclusion in the
review. We obtained full papers of potentially relevant trials. Two review authors independently extracted data from the included trials,
assessed their risk of bias, and performed GRADE analyses.
Main results
We included 44 trials (5783 participants with HF) with a median of six months’ follow-up. For this latest update, we identified 11 new
trials (N = 1040), in addition to the previously identified 33 trials. Although the evidence base includes predominantly patients with
HFrEF with New York Heart Association classes II and III receiving centre-based exercise-based CR programmes, a growing body of
studies include patients with HFpEF and are undertaken in a home-based setting. All included studies included a no formal exercise
training intervention comparator. However, a wide range of comparators were seen across studies that included active intervention (i.e.
education, psychological intervention) or usual medical care alone. The overall risk of bias of included trials was low or unclear, and
we downgraded results using the GRADE tool for all but one outcome.
Cardiac rehabilitation may make little or no difference in all-cause mortality over the short term (≤ one year of follow-up) (27 trials,
28 comparisons (2596 participants): intervention 67/1302 (5.1%) vs control 75/1294 (5.8%); risk ratio (RR) 0.89, 95% confidence
interval (CI) 0.66 to 1.21; low-quality GRADE evidence) but may improve all-cause mortality in the long term (> 12 months follow up)
(6 trials/comparisons (2845 participants): intervention 244/1418 (17.2%) vs control 280/1427 (19.6%) events): RR 0.88, 95%CI 0.75
to 1.02; high-quality evidence). Researchers provided no data on deaths due to HF. CR probably reduces overall hospital admissions
in the short term (up to one year of follow-up) (21 trials, 21 comparisons (2182 participants): (intervention 180/1093 (16.5%) vs
control 258/1089 (23.7%); RR 0.70, 95% CI 0.60 to 0.83; moderate-quality evidence, number needed to treat: 14) and may reduce
HF-specific hospitalisation (14 trials, 15 comparisons (1114 participants): (intervention 40/562 (7.1%) vs control 61/552 (11.1%) RR
0.59, 95% CI 0.42 to 0.84; low-quality evidence, number needed to treat: 25). After CR, a clinically important improvement in short-
term disease-specific health-related quality of life may be evident (Minnesota Living With Heart Failure questionnaire - 17 trials, 18
comparisons (1995 participants): mean difference (MD) -7.11 points, 95% CI -10.49 to -3.73; low-quality evidence). Pooling across
all studies, regardless of the HRQoL measure used, shows there may be clinically important improvement with exercise (26 trials, 29
comparisons (3833 participants); standardised mean difference (SMD) -0.60, 95% CI -0.82 to -0.39; I² = 87%; Chi² = 215.03; low-
quality evidence). ExCR effects appeared to be consistent different models of ExCR delivery: centre vs. home-based, exercise dose,
exercise only vs. comprehensive programmes, and aerobic training alone vs aerobic plus resistance programmes.
Authors’ conclusions
This updated Cochrane Review provides additional randomised evidence (11 trials) to support the conclusions of the previous version
(2014) of this Cochane Review. Compared to no exercise control, CR appears to have no impact on mortality in the short term (< 12
months’ follow-up). Low- to moderate-quality evidence shows that CR probably reduces the risk of all-cause hospital admissions and
may reduce HF-specific hospital admissions in the short term (up to 12 months). CR may confer a clinically important improvement
in health-related quality of life, although we remain uncertain about this because the evidence is of low quality. Future ExCR trials
need to continue to consider the recruitment of traditionally less represented HF patient groups including older, female, and HFpEF
patients, and alternative CR delivery settings including home- and using technology-based programmes.
P L A I N L A N G U A G E S U M M A R Y
Exercise-based cardiac rehabilitation for heart failure
Background
People with heart failure (HF) experience fatigue and shortness of breath. This negatively affects their activities of daily living and
health-related quality of life. They are at increased risk of hospital admission and death.
Study characteristics
We searched the scientific literature for randomised controlled trials (experiments inwhich two ormore interventions, possibly including
a control intervention or no intervention, are compared by randomly allocating participants to study groups). We looked at the
effectiveness of exercise-based rehabilitation compared with no exercise in adults (over 18 years of age) with heart failure. We considered
HF due to reduced ejection fraction (HFrEF) (i.e. the chambers of the heart contract poorly, and, as a result, a smaller volume of
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blood is pumped around the body). We also considered HF due to preserved ejection fraction (HFpEF) (i.e. the chambers of the heart
contract normally but do not relax efficiently, resulting in a smaller volume of blood pumped around the body). Our search is current
to January 2018.
Key results
We found 44 studies that included 5783 people with HF, mainly HFrEF. The findings of this update are broadly consistent with those
of the previous (2014) version of this Cochrane Review. They show important benefits of exercise-based rehabilitation that include a
probable reduction in the risk of overall hospital admissions in the short term, as well as the potential for reduction in heart failure
admissions. The effect of exercise-based rehabilitation on health-related quality of life is uncertain due to very low-quality evidence.
Exercise-based rehabilitation maymake little or no difference in all-cause mortality in trials with follow-up less than 12 months. Further
evidence is needed to better show the effects of exercise rehabilitation among people with HFpEF and the impact of alternative models
of delivery, such as home-based programmes.
Quality of evidence
Generally, recent trials have been better reported and are at low to moderate risk of bias. Using the GRADE method, we assessed the
quality of evidence to range from high to very low across measured outcomes. Common reasons for downgrading outcomes include
that results were inconsistent and/or imprecise.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Exercise-based cardiac rehabilitation compared to usual care for heart failure
Patient or population: adults with heart failure
Setting: hospital-based, community-based, and home-based sett ings
Intervention: exercise-based cardiac rehabilitat ion
Comparison: usual care
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with usual care Risk with all exercise
interventions
All- cause mortality up
to 12 months’ follow-
up (all studies)
Range: 6 to 12 months
58 per 1000 52 per 1000
(38 to 70)
RR 0.89
(0.66 to 1.21)
2596
(27 RCTs, 28 compar-
isons)
⊕⊕©©
LOWa,b
Overall. exercise-based
CRmay make lit t le or no
dif ference in all-cause
mortality in the short
term (up to 12 months)
. Six studies had no
events in either the in-
tervent ion arm or the
control arm
Sensit iv-
ity analysis f rom stud-
ies at low risk of bias
show sim ilar treatment
ef fects (RR 0.9, 95%
CI 0.6 to 1.34; part ic-
ipants = 1651; studies
= 16; I² = 0%). From
these studies, exercise-
based cardiac rehabili-
tat ion probably makes
lit t le or no dif ference
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in all-cause mortality in
the short term. Studies
were downgraded due
to imprecision (small
number of events <300)
Overall, exercise-based
CR has a tendency to-
wards a slight reduc-
t ion in all-cause mortal-
ity in the medium term
(over 12 months) based
on the large HF-ACTION
study (RR 0.88, 95% CI
0.75 to 1.02; part ici-
pants = 2845; studies =
6; I² = 34%; high-quality
evidence as assessed
via GRADE)
HF- related mortality - - - - - Studies did not con-
sistent ly report deaths
due to HF nor sudden
deaths
Hospital admission up
to 12 months’ follow-
up (all studies)
Range: 6 to 12 months
237 per 1000 166 per 1000 (142 to
197)
RR 0.70
(0.60 to 0.83)
2182
(21 RCTs)
⊕⊕⊕©
MODERATEc
Overall exercise-based
CR probably improves
hospital admissions in
the short term (up to 12
months)
Sensit ivity analysis
f rom studies at low risk
of bias was higher (RR
0.74, 95% CI 0.59 to 0.
92; part icipants = 1161;
studies = 9; I² =0%)
Based on low risk of
bias studies, exercise-
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based CR may improve
hospital admissions in
the short term (up to 12
months). Studies were
downgraded due to im-
precision (small num-
ber of events < 300
and conf idence inter-
vals including potent ial
for no benef it and im-
portant benef it , as 95%
CI crosses RR of 0.75)
Overall, we are uncer-
tain whether exercise-
based CR improves
hospital admissions in
the medium term (over
12 months) (RR 0.7,
95%CI 0.47 to 1.05; par-
t icipants = 2691; stud-
ies = 6; I² = 66%; very
low-quality evidence as
assessed via GRADE)
(see footnotes c, d and
e for reasons for down-
grade)
Hospital
admission heart failure
only (all studies)
Range: 6 months to 6.2
years
111 per 1000 65 per 1000
(46 to 93)
RR 0.59
(0.42 to 0.84)
1114
(14 RCTs, 15 compar-
isons)
⊕⊕©©
LOWb,f
Overall, exercise-based
CR may improve hos-
pital admissions for
heart failure only in the
medium term (over 12
months)
Sensit ivity analysis
f rom studies at low risk
of bias was higher (RR
0.61, 95% CI 0.36 to 1.
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04; part icipants = 588;
studies = 6; I² = 10%)
Based on low risk of
bias studies, exercise-
based CR may make
lit t le or no dif ference
in hospital admissions
for heart failure only.
Studies were down-
graded due to impreci-
sion (small number of
events < 300 and conf i-
dence intervals includ-
ing potent ial for no ben-
ef it and important ben-
ef it , as 95% CI crosses
RR of 0.75)
Health- related quality
of life - MLWHFup to 12
months’ follow-up (all
studies)
Range: 6 to 12 months
Mean 18 to 56 MD 7.11 lower (10.49
lower to 3.73 lower)
- 1995
(17 RCTs, 18 compar-
isons)
⊕⊕©©
LOWf,g
Overall, exercise-based
CRmay improve health-
related quality of lif e in
the short term (up to 12
months)
Sensit ivity
analysis f rom studies at
low risk of bias was
lower (MD 3.38 lower,
95% CI 6.95 lower to 0.
19 higher; part icipants
= 1101; studies = 9; I² =
71%)
Based on low risk of
bias studies, exercise-
based cardiac rehabili-
tat ion may confer lit t le
or no benef it f or health-
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related quality of lif e
in the short term (up
to 12 months) Studies
were downgraded due
to imprecision (conf i-
dence intervals includ-
ing potent ial for no ben-
ef it and important clin-
ical benef it ) and incon-
sistency (I² = 71%)
Overall, we are un-
certain whether ex-
ercise-based CR im-
proves health-related
quality of lif e in the
medium term (longer
than 12 months) (MD 9.
49 lower, 95% CI 17.48
lower to 1.5 lower; par-
t icipants = 329; stud-
ies = 3; I² = 73%; very
low-quality evidence as
assessed via GRADE)
(see footnotes h, i, and
j for reasons for down-
grade)
Health- related quality
of life - MLWHF and
other scales up to 12
months’ follow-up (all
studies)
Range: 6 to 30 months
Mean 18 to 71 SMD 0.60 lower (0.82
lower to 0.39 lower)
- 3833
(26 RCTs, 29 compar-
isons)
⊕⊕©©
LOWf,k
Overall, exercise-based
CRmay improve health-
related quality of lif e in
the short term (up to 12
months)
Sensit ivity analy-
sis f rom studies at low
risk of bias was sim-
ilar (SMD 0.42 lower,
95% CI 0.65 lower to 0.
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19 lower; part icipants =
3181; studies = 16; I² =
84%)
Based on low risk of
bias studies, exercise-
based cardiac reha-
bilitat ion probably im-
proves health-related
quality of lif e in the
short term (up to 12
months). Studies were
downgraded due to in-
consistency (I² = 84%)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; CR: cardiac rehabilitat ion; HF: heart failure; MD: mean dif ference; MLWHF: Minnesota Living With Heart Failure quest ionnaire; OR: odds rat io; RCT:
randomised controlled trial; RR: risk rat io; SMD: standardised mean dif ference
GRADE Working Group grades of evidence.
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aSome concerns with random sequence generat ion and allocat ion concealment; bias likely - therefore quality of evidence
downgraded by one level.
bImprecise due to small numbers of events (< 300) (Ryan 2016); therefore quality of evidence downgraded by one level.
cSome concerns with random sequence generat ion, allocat ion concealment, and groups balanced at baseline; bias likely -
therefore quality of evidence downgraded by one level.
d Inconsistent direct ions of ef fect and substant ial stat ist ical heterogeneity (I² = 66%); therefore quality of evidence downgraded
by one level.
eImprecise due to conf idence intervals, including potent ial for no benef it and important benef it , as 95%CI crosses RR of 0.75;
therefore quality of evidence downgraded by one level.
f Some concerns with random sequence generat ion, allocat ion concealment, and blinding of outcome assessment; bias likely
- therefore quality of evidence downgraded by one level.9
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g Inconsistency with considerable stat ist ical heterogeneity (I² = 82%); therefore quality of evidence downgraded by one level.
hSome concerns with random sequence generat ion, allocat ion concealment, blinding of outcome assessment, intent ion-to-
treat analysis, and groups not receiving the same intervent ion; bias likely - therefore quality of evidence downgraded by two
levels.
i Inconsistency with substant ial stat ist ical heterogeneity (I² = 73%); therefore quality of evidence downgraded by one level.
j Imprecise due to small number of part icipants (< 400) (Ryan 2016); therefore quality of evidence downgraded by one level.
k Inconsistency with considerable stat ist ical heterogeneity (I² = 86%); therefore quality of evidence downgraded by one level.
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B A C K G R O U N D
Description of the condition
Chronic heart failure (HF) is a growing global health challenge
(Braunwald 2015; Ziaeian 2016), with increasing prevalence as
reported in Braunwald 2015 and an annual economic burden pre-
dicted to grow to more than USD108 billion per annum as the
population ages (Cook 2014). Unplanned hospital admissions are
a key driver of the cost of HF (Cook 2014).
Patients with HF experience substantial burden that includes exer-
cise intolerance, poor health-related quality of life (HRQoL),mor-
tality, increased hospital admissions, and higher healthcare costs
(Braunwald 2015; Ziaeian 2016). With important gains in mor-
tality achieved over the past decade through pharmacological and
device therapy in patients with HF with reduced ejection fraction
(HFrEF) (Braunwald 2015), the focus is increasingly shifting to-
wards HRQoL (Calvert 2007).
Heart failure has two main subcategories: HF with impaired left
ventricular contraction, which results in a reduced ejection frac-
tion (< 45% to 50%), known as HF with reduced ejection frac-
tion (HFrEF) (ACCF/AHA 2013); and HF with preserved ejec-
tion fraction (HFpEF), with an ejection fraction greater than 45%
to 50% (Dunley 2017; Lam 2011). Whilst epidemiological data
show that approximately half of all patients with HF have HFpEF
(Dunley 2017), only more recent trials of drug and medical de-
vice therapies have recruited this patient subgroup. Although drug
therapy and device therapy have helped to improve outcomes in
HFrEF, the prognosis in HFpEF largely remains unchanged. No
large-scale randomised trials have demonstrated treatment bene-
fits that alter the natural course of HFpEF, or that lower mortality
(Holland 2011; Komajda 2017).
Description of the intervention
The British Association for Cardiovascular Prevention and Reha-
bilitation (BACPR) defines cardiac rehabilitation (CR) as: “the
coordinated sum of activities required to influence favourably the
underlying cause of cardiovascular disease, as well as to provide
the best possible physical, mental and social conditions, so that
the patients may, by their own efforts, preserve or resume optimal
functioning in their community and, through improved health
behaviour, slow or reverse progression of disease” (BACPR 2017).
This definition emphasises that whilst the central component of
CR is exercise training (Piepoli 1998; Piepoli 2015), CR pro-
grammes should be comprehensive and should provide risk factor
and lifestyle education on risk factormanagement plus counselling
and psychological support (Corra 2005).
Based on current evidence on clinical outcomes and costs, national
and international guidelines on the management of HF, includ-
ing those of the American College of Cardiology/American Heart
Association, the European Society of Cardiology, and the Na-
tional Institute forHealth and Care Excellence (NICE) in the UK,
consistently recommend CR as an effective and safe intervention
(ACCF/AHA2013; ESC2016;NICE 2018).However, surveys in
the United States and Europe have shown that the current uptake
of CR for HF remains suboptimal, with less than 20% of HF pa-
tients receiving rehabilitation (Bjarnason-Wehrens 2010; Golwala
2015). To improve access to and uptake of CR for HF, there have
been calls for alternative models to centre-based CR, including
home-based and technology-based provisions (Dalal 2015).
How the intervention might work
Exercise-based CR might benefit patients with HF through a va-
riety of mechanisms. First, for people with an ischaemic cause
of HF, exercise training improves myocardial perfusion by alle-
viating endothelial dysfunction, thereby dilating coronary ves-
sels, and by stimulating new vessel formation by way of intermit-
tent ischaemia (ExTraMatch 2004). Indeed, Belardinelli and col-
leagues have demonstrated that aerobic training improvesmyocar-
dial contractility and diastolic filling (Belardinelli 1998). In addi-
tion, a meta-analysis by Haykowsky and associates shows the ben-
efits of exercise training for cardiac remodelling, as measured by
ejection fraction, end-diastolic volume, and end-systolic volume
(Haykowsky 2007). Regardless of the cause, HF is characterised
by important neurohormonal and musculoskeletal abnormalities.
Exercise training may reduce adrenergic tone and increase vagal
tone, as suggested by an assessment of variability in heart rate.
Skeletal muscle dysfunction and wasting may also respond to ex-
ercise training (ExTraMatch 2004). Regular physical activity in
people with HF has been shown to stimulate vasodilation in the
skeletal muscle vasculature (Hambrecht 1998).
Why it is important to do this review
This is an update of a Cochrane review published in 2014. The
first Cochrane systematic review of exercise-based CR for HF in
2004 concluded that exercise training improved short-term (up to
one-year follow-up) exercise capacity compared with no exercise
control (Rees 2004). However, only one of the 29 included ran-
domised controlled trials (RCTs) was formally powered for hospi-
talisation and mortality. Few trials at that time assessed HRQoL.
Accepting the evidence for improvement in short-term exercise
capacity, the updated 2010 Cochrane Review focussed on trials
providing follow-up of six months or longer that reported clinical
events (mortality, hospitalisation) or HRQoL (Davies 2010). The
2010 review of 19 randomised trials (3647 participants) showed
no difference between exercise and control in either short-term or
long-term all-cause mortality, a reduction in HF-related hospitali-
sations (risk ratio (RR) 0.72, 95% confidence interval (CI) 0.52 to
0.99), and improvement in patient-reported HRQoL (standard-
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ised mean difference (SMD) 20.63, 95% CI 20.37 to 20.80) with
exercise therapy. Most of the trials included in the 2010 review
included men with New York Heart Association (NYHA) class II
to III disease. None of these trials included people with HFpEF,
and programmeswere delivered only in a centre-based setting. The
2014 review of 33 RCTs (4740 participants) presented findings
consistent with the previous (2010) version and concluded that
exercise-based CR reduced the risk of hospital admission due to
HF and led to improvements in HRQoL compared with no ex-
ercise. To continue to promote international access and uptake of
CR for HF, the current evidence base must be updated to reflect
recent trials that are increasingly testing alternative models to cen-
tre-based CR, such as home- and technology-based programmes
(Dalal 2015).
By gathering additional RCT evidence provided since the 2014
Cochrane review, and by performing a GRADE analysis, authors
of this review update sought to reassess the effectiveness of exer-
cise-based CR in terms of mortality, hospital admissions, morbid-
ity, and HRQoL of people with HF compared with no exercise
training, regardless of setting.
O B J E C T I V E S
To determine the effects of exercise-based cardiac rehabilitation
on mortality, hospital admission, and health-related quality of life
of people with heart failure.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs of a parallel-group or cross-over design that
provided follow-up for at least six months post randomisation.
We chose this follow-up as it is likely to reflect changes in event
outcomes as well as the focus of policy makers.
Types of participants
We included adults aged 18 years or older with HF. We excluded
trials that focussed on participants who had received exercise-based
CR, as previous participant exposure to the intervention may con-
found the interpretation of trials. However, if the trial population
consisted primarily of new CR patients who predominantly had
HF, we included the trial.
Types of interventions
We included exercise-based interventions given alone or as a com-
ponent of comprehensive CR (defined as programmes with com-
ponents such as health education and psychological interventions,
in addition to exercise interventions). The control group must
not have received exercise training but may have received active
intervention (i.e. education, psychological intervention) or usual
medical care alone.
Types of outcome measures
Tobe included, the studymust have intended to assess one ormore
of the following outcomes. When reported, we extracted outcome
results at two time points: up to and including 12 months’ follow-
up (short-term), and longer than 12 months’ follow-up (long-
term). The longest follow-up was included in each time point
analysis to assess treatment effects.
Primary outcomes
• All-cause mortality
• HF mortality
• Number of participants who experienced an all-cause
hospital admission
• Number of participants who experienced an HF-related
hospital admission
These event outcomes reflect both potential efficacy and harm.
Secondary outcomes
• HRQoL assessed by a validated outcome measure (e.g. 36-
item Short Form (SF-36), Minnesota Living With Heart Failure
(MLWHF) questionnaire)
• Costs and cost-effectiveness
Search methods for identification of studies
To update searches from the previous Cochrane Review, we
searched the Cochrane Central Register of Controlled Trials
(CENTRAL), in the Cochrane Library, from January 2013 to 29
January 2018. We also searchedMEDLINE, Embase, the Cumu-
lative Index to Nursing and Allied Health Literature (CINAHL),
and PsycINFO (January 2013 to 30 January 2018), without lan-
guage restrictions. We checkedWeb of Science and bibliographies
of systematic reviews. We examined trial registers (World Health
Organization (WHO) International Clinical Trials Registry Plat-
form (ICTRP) and Clinicaltrials.gov) twice, on 14 March 2018,
and again on 4 October 2018.
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Electronic searches
For this update, we reran searches of the following databases on
29 January 2018 (search strategies presented in Appendix 1).
• CENTRAL, in the Cochrane Library (2017, Issue 12 of
12).
• Epub Ahead of Print, In-Process & Other Non-Indexed
Citations, MEDLINE Daily, and MEDLINE (Ovid, 1946 to 29
January 2018).
• Embase (Ovid, 1980 to 2018 week 5).
• CINAHL (EBSCO, 1937 to 29 January 2018).
• PsycINFO (Ovid, 1806 to January week 4 2018).
• Web of Science: Science Citation Index - Expanded (SCI-
EXPANDED), Social Sciences CItation Index (SSCI), Arts and
Humanities Citation Index (A&HCI), Conference Proceedings
Citation Index - Science (CPCI-S), Conference Proceedings
Citation Index - Social Science and Humanities (CPCI-SSH)
(Thomson Reuters, 1900 to 29 January 2018).
We used the Cochrane sensitivity-maximising RCT filter for
MEDLINE, and we applied to our Embase search terms recom-
mended in the Cochrane Handbook for Systematic Reviews of In-
terventions (Lefebvre 2011). We applied adaptations of this filter
to CINAHL, PsycINFO, and Web of Science. We imposed no
restrictions on language of publication.
We also conducted a search of two trial registers.
• World Health Organization International Clinical Trials
Registry Platform (WHO ICTRP; www.who.int/ictrp/en).
• ClinicalTrials.gov (clinicaltrials.gov).
For the original review and the first update (Davies 2010; Rees
2004), we searched CENTRAL, in the Cochrane Library (2001,
Issue 1; 2007, Issue 1);MEDLINE; Embase; and CINAHL (1984
to January 2008) (see Appendix 2 and Appendix 3). The search
strategy developed in 2008 for the second review update included
broader terms, as this search was part of a review strategy that
sought to identify evidence for cardiac rehabilitation that included
an update of this review and exercise-based rehabilitation for coro-
nary heart disease (Heran 2011), as well as home- versus centre-
based cardiac rehabilitation (Taylor 2010). For the last update
(Taylor 2014), we updated the search from the previous version
(Davies 2010), and we included CENTRAL, in the Cochrane Li-
brary (2013, Issue 1);MEDLINE (Ovid, 30 January 2013week 4);
MEDLINE In-Process (Ovid, 5 February 2013); Embase (Ovid,
January 2013 week 5); CINAHL (EBSCOhost, 5 February 2013);
and PsycINFO (Ovid, 30 January 2013 week 5). We made a small
addition to the January 2013 search strategy to reflect more recent
use of the terms ’HFPEF’ and ’HFREF’.
Searching other resources
We handsearched the reference lists of all eligible trials and con-
ducted forward citation searching of all primary studies and re-
view articles for additional references not identified by electronic
searches. We contacted experts in the field for unpublished and
ongoing trials, and we contacted trial authors for additional infor-
mation when necessary. We also examined any relevant retraction
statements and errata for included studies.
Data collection and analysis
Selection of studies
Two review authors (LL and IM) independently screened refer-
ences identified by the search strategy by reviewing titles and ab-
stracts and discarded clearly irrelevant studies. To be selected, ab-
stracts had to clearly identify the study design, an appropriate pop-
ulation, and relevant components of the intervention, as described
above. We obtained the full-text reports of all potentially relevant
trials, and two review authors (LL and IM) independently assessed
them for eligibility based on the defined inclusion criteria. We
resolved disagreements by discussion with a third review author
(RST). RST undertook data study selection in previous review
versions. We recorded the selection process in sufficient detail to
complete a PRISMA flow diagram (Figure 1).
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Figure 1. Study flow diagram.
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Data extraction and management
We extracted relevant data regarding inclusion criteria (study de-
sign; participants; interventions including type of exercise, fre-
quency, duration, intensity, and modality; comparisons; and out-
comes) and risk of bias (randomisation, blinding, attrition, and
control). Two review authors (LL and IM) independently extracted
data using a standardised data extraction form that had been pi-
loted on at least one of the studies included in the review. We
resolved disagreements by discussion with a third review author
(RST). We contacted study authors when necessary to seek clarifi-
cation on issues of reporting or to obtain further outcome details.
We have detailed excluded studies and reasons for their exclusion
in the Characteristics of excluded studies table.
We extracted the following study characteristics.
• Methods: study design, total duration of study, number of
study centres and locations, study setting, withdrawals, and
study dates.
• Participants: N, mean age, age range, gender, severity of
condition, diagnostic criteria, inclusion criteria, and exclusion
criteria.
• Interventions: intervention, comparison, and co-
interventions.
• Outcomes: primary and secondary outcomes and time
points reported.
• Notes: trial funding and notable conflicts of interest of trial
authors, when reported.
One review author (RST) transferred data into Review Manager
5.3 (RevMan 2014), and another review author (LL) double-
checked that data were entered correctly by checking study char-
acteristics for accuracy against the study report.
Assessment of risk of bias in included studies
Factors considered included the quality of random sequence gen-
eration and allocation concealment, selective outcome reporting,
incomplete outcome data, blinding of outcome assessors, and in-
complete outcome data (Higgins 2011). Two review authors (LL
and IM) assessed the risk of bias of eligible trials, and a third review
author (RST) verified the decision. RST undertook risk of bias
assessments in previous review versions. We conducted a sensitiv-
ity analysis and stratified results by risk of bias at the study level
(presence of low risk of bias for either allocation concealment or
sequence generation).
We assessed three additional quality criteria: whether study groups
were balanced at baseline (small trials although randomised may
be subject to chance imbalances), whether intervention and con-
trol groups received comparable care (apart from the exercise com-
ponent of the intervention, as this may confound between-group
comparisons), and analysis by intention-to-treat (as stated in each
trial). Two of these criteria (groups balanced at baseline and groups
receiving comparable treatment), agreed upon in advance by the
review authors, have not been validated but have been used to
assess quality in several of our previous Cochrane Reviews on CR
(Taylor 2010; Taylor 2014). We assessed these additional quality
criteria as follows.
Groups balanced at baseline
• Low risk of bias: characteristics of participants in the
intervention and control groups at baseline are reported to be
comparable or can be judged to be comparable (e.g. baseline data
reported in Table 1) in terms of likely main prognostic factors
• Unclear risk of bias: whether characteristics of participants
in the intervention and control groups are balanced at baseline is
not reported, and reported information is inadequate for
assessment (e.g. no Table 1)
• High risk of bias: evidence shows substantive imbalance in
the baseline characteristics of intervention and control groups
with regard to likely major prognostic factors
Groups receiving comparable treatment (except exercise)
• Low risk of bias: all co-interventions were delivered equally
across intervention and control groups
• Unclear risk of bias: information was insufficient to assess
whether co-interventions were delivered equally across groups
• High risk of bias: co-interventions were not delivered equally
across intervention and control groups
Intention-to-treat analysis
• Low risk of bias: the trial reports that study authors
conducted intention-to-treat analyses, and it includes all the
principles of such an analysis (e.g. keeping participants in the
intervention groups to which they were randomised, regardless
of the intervention they actually received; measuring outcome
data on all or most participants (i.e. > 80% of those
randomised); imputing all missing data in the analysis via
appropriate methods (e.g. multiple imputation)
• Uncertain risk of bias: it is unclear whether investigators
performed an intention-to-treat analysis
• High risk of bias: the trial does not include an intention-to-
treat analysis, or researchers reported substantive loss of outcome
data (e.g. > 20%) and performed analyses according to
imputation methods known to create bias, such as last
observation carried forward
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We graded each potential source of bias as high, low, or unclear,
and we provided a quote from the study report together with
a justification for our judgement in the ’Risk of bias’ table. We
summarised the ’Risk of bias’ judgements across different studies
for each of the domains listed. When information on risk of bias
was related to unpublished data or correspondence with a study
author, we noted this in the ’Risk of bias’ table.
When considering treatment effects, we took into account the risk
of bias for studies that contributed to those outcomes.
Measures of treatment effect
We processed data in accordance with the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We expressed
dichotomous outcomes as risk ratios (RRs) and 95% confidence
intervals (CIs) for each study. For continuous variables, we com-
pared net changes (i.e. exercise group minus control group to ob-
tain differences) and calculated the mean difference (MD) or the
standardised mean difference (SMD) and 95% CI for each study.
We calculated SMDs when all studies assessed the same outcome
but measured it in a variety of ways (e.g. different HRQoL mea-
sures). For each trial, we sought the mean change (and standard
deviation (SD)) in outcomes between baseline and follow-up for
both exercise and control groups, and, when not available, we in-
stead used the absolute mean (and SD) outcome at follow-up for
both groups. When trials reported more than one HRQoL out-
come subscale or more than one HRQoL measure, we prioritised
inclusion of data in the meta-analysis in the following manner: (1)
the overall or total HRQoL score; and (2) if not available, the first
HRQoL subscale reported.We tabulated all reportedHRQoLout-
comes for all measures and all subscales at all follow-up times in-
cluded for each.When necessary, we reversed the scores ofHRQoL
measures so that a negative between-group difference consistently
reflected improvement in HRQoL in favour of exercise-based CR.
We considered treatment effects for HRQoL in terms of clinically
meaningful differences (e.g. we considered a 5-point difference
on the MLWHF questionnaire as clinically meaningful) (Rector
1992).
Unit of analysis issues
For trials with more than one relevant intervention arm included
in the same analysis, we divided the number randomised in the
control group by the number of intervention arms to obtain the
denominator for data analysis. In accordance with Section 16.4
of the Cochrane Handbook for Systematic Reviews of Intervention (
Higgins 2011), if we had included data from cross-over trials, we
would have included both periods of any cross-over trials identi-
fied, assuming that (1) there had been a washout period considered
long enough to reduce carry-over, (2) no irreversible events such as
mortality had occurred, and (3) appropriate statistical approaches
had been used. If we had included cluster trials, we would have
considered whether the reported data analysis had appropriately
taken account of the aggregate nature of the data.
Dealing with missing data
We contacted investigators or study sponsors to verify key study
characteristics and to obtain missing numerical outcome data
when possible (e.g. when we identified a study as abstract only).
When this was not possible, and when missing data were not
thought to introduce serious bias, we explored the impact of in-
cluding such studies on the overall assessment of results by per-
forming a sensitivity analysis.
Assessment of heterogeneity
We explored heterogeneity among included studies qualitatively
(by comparing the characteristics of included studies) and quanti-
tatively (using the Chi² test for heterogeneity and the I² statistic).
Assessment of reporting biases
We used funnels plots and Egger tests to assess potential small-
study effects and publication bias for those outcomes with an
adequate number of trials (more than 10) (i.e. all-cause mortality,
hospital admissions, and HRQoL) (Egger 1997; Higgins 2011).
Data synthesis
We processed data in accordance with the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011), and we under-
took meta-analyses when these were meaningful (i.e. when treat-
ments, participants, and the underlying clinical questionwere sim-
ilar enough for pooling to make sense). We pooled data from each
study using a fixed-effect model, except when we identified sub-
stantial statistical heterogeneity (I² statistic > 50%), in which case
we applied a random-effects model, which provided a more con-
servative statistical comparison of the difference between interven-
tion and control, because a confidence interval around a random-
effects estimate is wider than a confidence interval around a fixed-
effect estimate. We completed data synthesis and analysis using
Review Manager 5.3 software (RevMan 2014).
’Summary of findings’ table
Two review authors (LL and IM) independently employed
the Grading of Recommendations Assessment, Development
and Evaluation (GRADE) approach to interpret study results
(Schünemann 2011). We used the five GRADE considerations
(study limitations, consistency of effect, imprecision, indirectness,
and publication bias) to assess the quality of a body of evidence
as it related to studies that contributed data to the meta-analyses
and narrative summaries for pre-specified outcomes. We resolved
any discrepancies in judgement through discussion. One review
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author (LL) used GRADEproGDT software (GRADEpro GDT
2015) to import data from Review Manager to create a ’Sum-
mary of Findings’ table that included the following pre-specified
outcomes: all-cause mortality; all-cause hospital admissions; heart
failure hospital admissions; and HRQoL.
Subgroup analysis and investigation of heterogeneity
We explored potential heterogeneity in exercise-based rehabilita-
tion via two approaches: (1) within-trial subgroup analyses (sup-
ported by subgroup × intervention/control interaction terms), and
(2) between-trial analyses via meta-regression. We used meta-re-
gression to examine the association between effects of exercise on
all-cause mortality, all-cause hospitalisation, and HRQoL (ML-
WHF or other measures) up to 12 months, as these three out-
comes were reported by the greatest number of trials. The meta-
regression included the following specific study co-variates.
• Mean per cent left ventricular ejection fraction (LVEF).
• Dose of aerobic exercise (calculated as overall number of
weeks of training × mean number of sessions per week × mean
duration of sessions in minutes).
• Type of exercise (aerobic training alone or aerobic plus
resistance training).
• Mean age.
• Sex (per cent male).
• Setting (hospital only, home only, both hospital and home).
• Type of rehabilitation (exercise only vs comprehensive).
• Overall risk of bias (’low’, i.e. absence of bias in allocation
concealment and/or sequence generation).
• Single centre versus multi-centre.
• Publication date.
We added year of publication as an additional study level factor
(pre- vs post-2000) to assess the potential effect of a change in the
standard of usual care over time, that is, to reflect when beta block-
ers, angiotensin-receptor blockers, and angiotensin-converting en-
zyme inhibitors became established therapies for HF (Shekelle
2003). Given the relatively small ratio of trials to co-variates, we
limited meta-regression to univariate analysis (Higgins 2011). We
used the permute option in STATA to allow for multiple testing
in meta-regression. Due to the risks of multiple testing, we used a
conservative cut-off of P < 0.01.
Sensitivity analysis
We compared the results of meta-analysis including all studies ver-
sus meta-analysis including only those studies judged to have over-
all low risk of bias (low risk of allocation concealment or sequence
generation).
R E S U L T S
Description of studies
We have presented the details of studies included in this review
in the Characteristics of included studies table, and reasons for
exclusion in the Characteristics of excluded studies table. We
have detailed the status of ongoing trials in the Characteristics of
ongoing studies table, and we have provided information on stud-
ies awaiting classification in the Characteristics of studies awaiting
classification table.
Results of the search
The electronic search for this update yielded a total of 20,416 titles
and abstracts. We identified 11 additional studies through addi-
tional searches. After de-duplication, we found that 12,944 stud-
ies were eligible for screening. Following screening, we formally
evaluated 92 studies for inclusion or exclusion by retrieving the
full-text publications. We newly included a total of 11 RCTs (29
publications) in the review, bringing the total of included stud-
ies to 44 (75 publications). Backwards and forwards searching of
the reference lists of eligible publications did not reveal additional
publications for inclusion.We identified three ongoing trial proto-
cols (NCT01914315;NCT02196038;NCT03041376).Wehave
summarised the study selection process in the PRISMA flow dia-
gram (Figure 1).
Included studies
The 2004 and 2010 versions of this Cochrane review contributed
eight (Rees 2004),11 (Davies 2010), and 14 trials to this latest up-
date (Taylor 2014). We excluded from the 2010 review several tri-
als included in the 2004 review, as their follow-up was less than six
months, or investigators reported only exercise capacity outcomes.
For this update, we identified 11 additional trials - 13 compar-
isons in patients with HF (Antonicelli 2016; Chen 2018; Cowie
2014;Dalal 2018;Dehkordi AH2015;Du 2018;Giallauria 2008;
Kaltsatou 2014; Lang 2018;Mehani 2013; Reeves 2017).We have
summarised the study selection process in the PRISMA flow dia-
gram shown in Figure 1.
The 44 included trials (75 publications) randomised 5783 partic-
ipants predominantly with HFrEF and NYHA classes II and III
heart failure. Six trials included an (undefined) proportion of peo-
ple with HFpEF (Antonicelli 2016; Davidson 2010; Gary 2010;
Nilsson 2008; Reeves 2017; Wall 2010). Most trials were small,
single-centre studies, and one large trial contributed ~40% (2331
participants) of all included participants (HF ACTION 2009).
The mean age of participants across the included studies ranged
from51 to81 years. Studies recruited predominantlymen (median
79%), although evidence shows that recent trials recruited more
women. Only 10 trials reported on ethnicity. Seven trials reported
follow-up in excess of 12 months (Austin 2005; Belardinelli 1999;
Belardinelli 2012; Cowie 2014; HF ACTION 2009; Jónsdóttir
2006a; Mueller 2007). Four trials included more than one exer-
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cise intervention arm, and each contributed two separate compar-
ative arms for the purpose of themeta-analysis (Cowie 2014; Gary
2010; Kaltsatou 2014; Klocek 2005).
All trials evaluated an aerobic intervention, and 14 studies (15
comparisons) also included resistance training (Austin 2005;
Chen 2018; DANREHAB 2008; Dracup 2007; Jolly 2009;
Jónsdóttir 2006a; Kaltsatou 2014; Koukouvou 2004; McKelvie
2002; Norman 2012; Pozehl 2008; Reeves 2017; Witham 2005;
Witham 2012). Researchers most commonly delivered exercise
training in an exclusively centre-based setting or in a centre-based
setting in combination with some home exercise sessions. Ten
studies (13 comparisons) were conducted in a largely home-based
setting (Cowie 2014; Dalal 2018; Dracup 2007; Du 2018; Gary
2010; Jolly 2009; Kaltsatou 2014; Lang 2018; Passino 2006; Wall
2010). The dose of exercise training ranged widely across studies,
with session duration of 10 to 120 minutes, one to seven sessions
per week, intensity of 40% to 80% maximal heart rate to 50% to
85% maximal oxygen uptake (VO max) to Borg rating 11 to
18, over a period of eight to 120 weeks. In addition to exercise
training, 14 trials included other (’comprehensive rehabilitation’)
elements that consisted of educational and psychological interven-
tions (Chen 2018; Cowie 2014; Dalal 2018; DANREHAB 2008;
Davidson 2010; Gary 2010; Jolly 2009; Jónsdóttir 2006a; Lang
2018; Mueller 2007; Myers 2000; Nilsson 2008; Pozehl 2008;
Witham 2012).
All included studies included a no formal exercise training inter-
vention comparator. However, a wide range of comparators were
seen across studies that included active intervention (i.e. educa-
tion, psychological intervention) or usual medical care alone.
All but 18 studies reported their funding sources (Belardinelli
1999; Bocalini 2008; Chen 2018; Davidson 2010; Giallauria
2008; Giannuzzi 2003; Gielen 2003; Gottlieb 1999; Hambrecht
1995; Jónsdóttir 2006a; Klocek 2005; Koukouvou 2004;
McKelvie 2002; Mehani 2013; Nilsson 2008; Norman 2012;
Passino 2006; Witham 2005). Two studies were funded by the
pharmaceutical industry (HF ACTION 2009; Keteyian 1996).
We have provided details of the studies included in this review in
the Characteristics of included studies table.
Excluded studies
We excluded 63 studies identified in the search for this update
for reasons listed in the Characteristics of excluded studies table.
The most common reason for exclusion was follow-up less than
six months.
In total, we excluded 124 studies (63 studies from this update
and 61 studies from the previous review) for the following rea-
sons: 18 (14.5%) studies were not RCTs; one (0.8%) study was
a duplicate; three (2.4%) studies were not conducted in adults
with heart failure; 35 (28.2%) studies did not report relevant out-
comes; 12 (9.7%) studies provided an inappropriate intervention;
four (3.2%) studies provided an inappropriate comparator; eight
(6.45%) studies generated no usable data; and 43 (34.7%) stud-
ies reported follow-up less than six months. See Characteristics of
excluded studies and Figure 1.
Ongoing studies and studies awaiting classification
Three clinical trials were still ongoing when we completed this
update (NCT01914315; NCT02196038; NCT03041376).
Seven studies were completed and are awaiting classification
(ACTR12608000263392; ISRCTN86879094; NCT01033591;
NCT01785121; NCT02078947;
NCT02696486; NCT02903225). Two studies included patients
with HFrEF and HFpEF (NCT01785121; NCT03041376). See
Characteristics of ongoing studies and Characteristics of studies
awaiting classification.
Risk of bias in included studies
The overall risk of bias in included trials was generally low or
unclear, and the level of reporting improved in more recent trials
(Figure 2 and Figure 3). Study authors reported particularly poorly
the details of generation and concealment of random allocation
sequence and blinding.
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Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Allocation
We judged Austin 2005, Cowie 2014, Dalal 2018, DANREHAB
2008, Davidson 2010, Dehkordi AH2015, Du 2018, Hambrecht
2000, HF ACTION 2009, Jolly 2009, Kaltsatou 2014, Lang
2018, McKelvie 2002, Reeves 2017, Witham 2005, Witham
2012, and Yeh 2011 to be at low risk of bias for allocation con-
cealment and/or sequence generation.
All studies randomly allocated participants to study conditions.
We deemed that 27 studies had unclear risk of bias and 16 studies
had low risk of bias in the method used to generate randomisation
sequence. Mehani 2013 had high risk of bias in the method used
to generate randomisation sequence.
A total of 34 studies had unclear risk of bias and 10 studies had low
risk of bias in the methods used to conceal participant allocation.
Blinding
Given the nature of an exercise intervention, it is not possible
to blind participants and carers. However, we judged only three
studies to be at high risk of bias for blinding of outcome assessment
(Austin 2005; Jolly 2009; Norman 2012).
Incomplete outcome data
When reported, losses to follow-up and rates of dropout were rel-
atively high, ranging from 5% to 40% across studies. We judged
37 studies to be at low risk of bias, as they described the numbers
of and reasons for dropouts, which were balanced across groups.
We judged four studies to be at high risk of bias (Bocalini 2008;
Cowie 2014; Du 2018; Willenheimer 2001). Bocalini provided
data at follow-up for only 42 of 53 (79%) participants. Du had
a high dropout rate in the intervention group (24%) compared
to the control group (14%) and provided no explanation for dif-
ferences between the two groups. Cowie provided follow-up data
for only 46 of 60 participants (77%). Willenheimer reported out-
come data for only 43 of 54 participants (80%) randomised at
10 months’ follow-up. We undertook no imputation or sensitivity
analysis to assess effects of loss to follow-up in that study, and its
authors stated that participants available at 10 months’ follow-up
are representative.
Selective reporting
We judged the risk of selective reporting to be unclear in seven
studies (Antonicelli 2016; Dehkordi AH 2015; Giallauria 2008;
Kaltsatou 2014; McKelvie 2002; Mehani 2013; Passino 2006).
We considered the risk of bias to be high in one additional study
because researchers did not report the outcome ’number of hospi-
talisations’ and we obtained the data from the study’s lead investi-
gator (Cowie 2014).
Other potential sources of bias
With the exception of three studies (Cowie 2014; Dalal 2018;
Lang 2018), all included studies did not provide objective evi-
dence of imbalance in baseline characteristics. Most studies per-
formed an intention-to-treat analysis, comparing exercise and con-
trol group outcomes according to the initial randomallocation. Be-
cause some studies did not report co-intervention details for both
exercise and control groups, they may be prone to performance
bias (Belardinelli 1999;Giannuzzi 2003;Gielen 2003;Hambrecht
1995; Hambrecht 2000; Keteyian 1996; Klecha 2007; Klocek
2005; McKelvie 2002; Nilsson 2008; Pozehl 2008).
Effects of interventions
See: Summary of findings for the main comparison Exercise-
based cardiac rehabilitation compared to usual care for heart failure
All-cause mortality
A total of 27 studies (28 comparisons; 2596 participants) reported
all-cause mortality at up to 12 months’ follow-up. Several tri-
als reported no deaths in either the exercise or the control arm
(Dehkordi AH 2015; Gielen 2003; Kaltsatou 2014; Klecha 2007;
Lang 2018; Reeves 2017). Results show no difference in pooled
mortality at up to 12months’ follow-up between groups (interven-
tion 67/1302 (5.1%) vs control 75/1294 (5.8%) events: risk ratio
(RR) 0.89, 95% confidence interval (CI) 0.66 to 1.21; P = 0.47;
I² = 0%; Chi² = 15.85; P = 0.96; fixed-effect analysis) (Analysis
1.1).We assessed the evidence to be of low quality via the GRADE
method because of concerns about risk of bias (random sequence
generation and allocation concealment) and concerns about im-
precision (small number of events at < 300) (Ryan 2016).
Austin 2005, Belardinelli 1999, HF ACTION 2009, Jónsdóttir
2006a, and Mueller 2007 reported mortality at 60, 26, 30, 28,
and 74 months, respectively. Although not reported in their orig-
inal publication, we obtained mortality data at 10 years from
Belardinelli 2012 by contacting the study authors. We found high-
quality evidence towards a slight reduction in all-cause mortality
when pooled across the longest follow-up point of the six trials
(six comparisons; 2845 participants) with more than 12 months’
follow-up (intervention 244/1418 (17.2%) vs control 280/1427
(19.6%) events): RR 0.88, 95% CI 0.75 to 1.02; P = 0.09; I² =
34%; Chi² = 7.54; P = 0.18; fixed-effect analysis) (Analysis 1.2).
HF ACTION 2009 dominated this effect estimate. We assessed
the evidence to be of high quality using GRADE.
HF mortality
Studies did not consistently report deaths due to HF.
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All-cause hospital admissions
Exercise-based rehabilitation probably reduces the number of peo-
ple experiencing all-cause hospital admissions at up to 12 months’
follow-up (21 trials; 21 comparisons; 2182 participants) (interven-
tion 180/1093 (16.5%) vs control 258/1089 (23.7%) events: RR
0.70, 95% CI 0.60 to 0.83; P = 0.0001; I² = 19%; Chi² = 24.56;
P = 0.21; fixed-effect analysis) (Analysis 1.3). Using GRADE, we
assessed the evidence to be of moderate quality because of con-
cerns about risk of bias (random sequence generation, allocation
concealment, and groups balanced at baseline).
We are uncertain whether exercise-based rehabilitation reduced
all-cause hospital admissions in trials with more than 12 months’
follow-up (six trials; seven comparisons; 2691 participants) (inter-
vention 772/1348 (57.2%) vs control 825/1343 (61.4%) events:
RR 0.70, 95% CI 0.47 to 1.05; P = 0.08; I² = 66%; Chi² = 17.81;
P = 0.007) (Analysis 1.4). Using GRADE, we assessed the evi-
dence to be of very low quality because of concerns about risk of
bias (random sequence generation, allocation concealment, and
groups balanced at baseline), as well as high levels of statistical
heterogeneity and imprecision (confidence intervals including po-
tential for important harm or benefit).
HF hospital admissions
Exercise-based rehabilitation may reduce HF-specific hospital ad-
missions (14 trials; 15 comparisons; 1114 participants) (interven-
tion 40/562 (7.1%) vs control 61/552 (11.1%) events: RR 0.59,
95% CI 0.42 to 0.84; P = 0.003; I² = 11%; Chi² = 15.81; P =
0.32) (Analysis 1.5). Using GRADE, we assessed the evidence to
be of low quality because of concerns about risk of bias (random
sequence generation, allocation concealment, and blinding of out-
come assessment) and imprecision due to small numbers of events
(< 300) (Ryan 2016). None of the studies reported HF hospital
admissions at longer than 12 months’ follow-up.
Health-related quality of life
Of the 44 included trials, 29 (31 comparisons) reported a val-
idated HRQoL measure (Table 1). Most studies reported dis-
ease-specific quality of life using the MLWHF questionnaire; HF
ACTION 2009 used the Kansas City Cardiomyopathy Question-
naire (KCCQ). Investigators also assessed generic HRQoL using
the EuroQoL Group Quality of Life Questionnaire based on 5
dimensions (EQ-5D), the SF-36, the Psychological General Well-
being index (PGWB), the Patient’s Global Assessment of Quality
of Life (PGAQoL), and Spritzer’s Quality of Life Index (QLI).
Gottlieb 1999 reported HRQoL values at follow-up for the exer-
cise group but not for the control group. Of the 31 comparisons,
18 (55%) reported statistical superiority in one or more HRQoL
domains following exercise-based CR compared with control. No
trials reported a lower HRQoL domain score with CR than with
control.All included studies included HRQoL outcome at ≥ six
months follow up except Belardinelli 1999 and Reeves 2017 that
were reported at around three months follow up.
Lower MLWHF questionnaire scores indicate better patient
HRQoL. We found evidence of high levels of statistical hetero-
geneity in the exercise-control difference in MLWHF scores at
follow-up across studies. When pooled across the 17 trials (18
comparisons; 1995 participants) that reported the total MLWHF
score up to 12 months’ follow-up, results may show clinically im-
portant improvement with exercise (mean difference (MD) -7.11,
95% CI -10.49 to -3.73; P < 0.0001; I² = 82%; Chi² = 93.22; P <
0.00001; random-effects analysis) (Analysis 1.6). Using GRADE,
we assessed the evidence to be of low quality because of concerns
about risk of bias (random sequence generation, allocation con-
cealment, and blinding of outcome assessment) and inconsistency
with considerable heterogeneity.
Pooling across all studies, regardless of the HRQoL measure used,
shows there may be clinically important improvement with ex-
ercise at up to 12 months’ follow-up (26 trials; 29 comparisons;
3833 participants) (standardised mean difference (SMD) -0.60,
95% CI -0.82 to -0.39; P < 0.0001; I² = 87%; Chi² =215.03; P
< 0.0001; random-effects analysis) (Analysis 1.7). As advised in
the Cochrane Handbook for Systematic Reviews of Interventions, we
excluded McKelvie 2002 from this SMD analysis, as it reported
the difference in HRQoL between baseline and follow-up, while
all other included studies were based on final HRQoL outcome
scores.
Using GRADE, we assessed this evidence to be of low quality be-
cause of concerns about risk of bias (random sequence generation,
allocation concealment, and blinding of outcome assessment) and
inconsistency along with considerable heterogeneity. However, it
is notable that when considering evidence from studies at low risk
of bias for this outcome, we judged that exercise-based CR prob-
ably improved HRQoL. We are uncertain whether exercise-based
CR improves HRQoL because of the very low quality of the evi-
dence.
The three trials (three comparisons; 329participants) that reported
MLWHF score at follow-up greater than 12 months show im-
provement compared with control (MD -9.49, 95% CI -17.48 to
-1.50; P = 0.02; I² = 73%; Chi² = 7.33; P = 0.03; random-effects
analysis) (Analysis 1.8). Using GRADE, we assessed this evidence
to be of very low quality because of concerns about risk of bias
(random sequence generation, allocation concealment, blinding
of outcome assessment, intention-to-treat analysis, and groups not
receiving the same intervention), inconsistency with considerable
heterogeneity, and imprecision due to small numbers of partici-
pants (< 400) (Ryan 2016).
Costs and cost-effectiveness
Six included trials reported economic data, with two undertaking
a full cost-effectiveness analysis (Georgiou 2001; HF ACTION
2009), and four reporting costs (Cowie 2014; Dalal 2018; Lang
22Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2018; Witham 2012) (Table 2). Based on data reported in
Belardinelli 1999, Georgiou and colleagues estimated an addi-
tional mean healthcare cost in the exercise training group com-
pared with the control group of USD3227 per person (Georgiou
2001). Researchers calculated this cost by subtracting the averted
hospitalisation cost - USD1336/person - from the cost of exer-
cise training and wages lost due to exercise training - estimated
at USD4563/person. Based on exponential survival modelling to
15.5 years, the estimated increment in life expectancywith exercise
was 1.82 years/person compared with control, and the incremen-
tal cost-effectiveness ratio was USD1773/life-year saved. The HF
ACTION group estimated a mean gain in quality-adjusted life-
years (QALYs) of 0.03 at an additional mean cost of USD1161
per person at 2.5 years’ follow-up (HF ACTION 2009). Although
they did not report an incremental cost-effectiveness ratio, study
authors stated that there was an 89.9% probability that exercise
training was more cost-effective than usual care at a maximum
willingness to pay threshold of USD50,000. Witham and col-
leagues reported that mean costs in the exercise group were lower
(by £477.85 per person) than in the control group at six months’
follow-up (Witham 2012). This cost difference was primarily the
result of a reduction in the days of hospital admission in the exer-
cise group comparedwith the control group.None of the between-
group differences in costs or outcomes across these three studies
achieved statistical significance at P = 0.05 or less. Cowie 2014
reported that CR programmes incurred similar costs, whether de-
livered in the patient’s home (£196.53 per patient) or in a super-
vised hospital setting (£221.58 per patient).
Meta-regression
We examined predictors of all-cause mortality, all-cause hospitali-
sation, and HRQoL intervention effects (follow-up of 12 months
or less) using univariate meta-regression. The no evidence of sign-
ficant association (at P<0.05) between outcomes and study level
covariates with the expection of study risk of bias (Table 3). The
effect size for HRQoL and hospiatlisation for studies at high risk
of bias were larger than for studies at low risk of bias.
Within-trial subgroup analyses
Several study authors reported that they had undertaken subgroup
analyses. However, most of these analyses were not based on a
formal subgroup interaction test with the intervention effect but
instead on a cross-sectional association between particular partici-
pant characteristics and outcomes (e.g. association between partic-
ipant age at baseline andmortality (regardless of exercise or control
group allocation)) (Austin 2005; Belardinelli 1999; Belardinelli
2012; Davidson 2010; Klocek 2005). Two studies reported sub-
group analyses when the methods were unclear (Pozehl 2008; Yeh
2011). Only the large HF ACTION trial undertook pre-defined
formal interaction tests of differences in intervention effects be-
tween subgroups. HF ACTION study authors reported no evi-
dence of differences in intervention effects as assessed for either
the primary outcome (all-cause mortality or hospitalisation) or
HRQoL (Kansas City Cardiomyopathy Questionnaire (KCCQ)
overall score) across several participant-defined subgroups (Table
4). TheHFACTIONgroup also undertook a large post hoc obser-
vational analysis of people assigned to exercise training (Keteyian
2012). This analysis shows that the volume of exercise undertaken
by participants was associated with the risk for clinical events, and
moderate levels (3 to 7 metabolic equivalent (MET) hours per
week) of exercise were needed to derive clinical benefit.
Small-study bias
We found no evidence of funnel plot asymmetry for all-cause
mortality or hospitalisations, nor for all HRQoL scores (Egger test
P > 0.05) (Figure 4 Figure 5 Figure 6 and Figure 7). However, we
found evidence of asymmetry for MLWHF measures (Egger test
P < 0.0001) (Figure 8).
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Figure 4. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.1 All-cause
mortality up to 12 months’ follow-up.
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Figure 5. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.3 Hospital
admission up to 12 months’ follow-up.
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Figure 6. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.5 Hospital
admission heart failure only.
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Figure 7. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.6 Health-
related quality of life - MLWHF up to 12 months’ follow-up.
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Figure 8. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.7 Health-
related quality of life - MLWHF and other scales up to 12 months’ follow-up.
D I S C U S S I O N
Summary of main results
This review update shows that, based on low-quality evidence,
when compared with no exercise control, exercise-based cardiac
rehabilitation (CR) may have little or no effect on the risk of
short-term (up to 12 months’ follow-up) all-cause mortality. The
included studies did not provide data on heart failure (HF)-related
mortality. High-quality evidence shows a slight reduction in all-
cause mortality in trials on exercise-based CR with follow-up in
excess of 12 months. Low-quality evidence suggests a reduction
in hospital admissions related to HF. Because evidence is of very
low quality, we are uncertain about the effects of exercise-based
CR on health-related quality of life (HRQoL). It is important to
note that statistical heterogeneity was substantial among studies
assessing HRQoL. Although studies support the cost-effectiveness
of exercise-based CR compared to control, available evidence is
sparse.
Overall completeness and applicability of
evidence
The generalisability of the previous version of this review was
limited as most included studies recruited only low- to moderate-
risk younger men. However, with inclusion of more women, older
patients, and people with HF with preserved ejection fraction
(HFpEF) in recent trials, and with more trials of CR delivered
in a home-based setting, the findings of this updated review have
potentially greater external validity and applicability.
Quality of the evidence
The general lack of reporting of methods used in the included
trials makes it difficult to assess their methodological quality; we
therefore judged them to be at unclear risk of bias. Evidence of
a large treatment effect for HRQoL outcomes in studies judged
to be at overall high risk of bias compared with studies at low
risk of bias suggests that risk of bias may be a major driver of
the substantive statistical heterogeneity seen across trials for this
outcome. Improvement in the quality of reporting is apparent in
more recent trials.
Using the GRADE method, we assessed the quality of evidence
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to range from high to very low across outcomes. We downgraded
outcomes for hospital admissions (both all-cause over 12 months’
follow-up and HF-related admissions) for risk of both bias and
imprecision. In addition, we downgraded all-cause hospital ad-
missions over 12 months’ follow-up for inconsistency. We down-
graded all-cause re-admissions at up to 12 months only for risk of
bias. We downgraded all HRQoL outcomes for risk of bias and
inconsistency, with HRQoL measured by the Minnesota Living
With Heart Failure questionnaire (MLWHF) over 12 months’ fol-
low-up downgraded for imprecision, in addition to risk of bias
and inconsistency. We downgraded all-cause mortality up to 12
months for risk of bias and imprecision; we considered evidence
for all-cause mortality over 12 months to be of high quality and
did not downgrade it based on any GRADE criteria.
Potential biases in the review process
We believe this is the most comprehensive systematic review to
date of randomised controlled trial (RCT) evidence on the impact
of exercise-based CR for people with HF. However, our review has
some limitations. The overall risk of bias of included trials was
generally low or unclear, although evidence shows improvement
in the level of reporting in trials published over the last five to ten
years. However, details of generation and concealment of random
allocation sequence and blinding of outcome assessments were
particularly poorly reported and therefore were subject to bias.
Funnel plot asymmetry for HRQoL is indicative of small-study
bias and possible publication bias. Although a specific goal of
this updated review was to clarify the impact of exercise training
programmes on clinical events, many included trials were relatively
small and provided short-term follow-up (< 12 months), so that
the numbers of deaths and hospitalisations reported by most trials
were small. Indeed, for many studies, we located event data in the
trial descriptions of losses to follow-up and exclusions rather than
as reported outcomes per se. All included studies included a no
formal exercise training intervention comparator. However, a wide
range of comparators were seen across studies that included active
intervention (i.e. education, psychological intervention) or usual
medical care alone.
Agreements and disagreements with other
studies or reviews
The individual patient data (IPD) meta-analysis (Exercise Train-
ing Meta-Analysis of Trials for Chronic Heart Failure - ExTra-
MATCH) was origjnally published in 2004 (ExTraMatch 2004);
recently the ExTraMATCH II collaboration updated this IPD
meta-analysis based on RCTs included in the 2014 Cochrane re-
view (ExTraMATCH II; Taylor 2014). The ExTraMATCH II
events analysis included data obtained from 18 trials includ-
ing 3912 participants with HF with reduced ejection fraction
(HFrEF). Collaboration authors reported that, compared to con-
trol data, they found no statistically significant differences in
pooled time to event estimates in favour of ExCR, although con-
fidence intervals (CIs) were wide (all-cause mortality: hazard ra-
tio (HR) 0.83, 95% CI 0.67 to 1.04; HF-specific mortality: HR
0.84, 95% CI 0.49 to 1.46; all-cause hospitalisation: HR 0.90,
95% CI 0.76 to 1.06; and HF-specific hospitalisation: HR 0.98,
95% CI 0.72 to 1.35). Lack of statistically significant impact of
CR on all-cause mortality is consistent with the findings of this
updated Cochrane Review. However, the finding of no reduction
in all-cause or HF hospitalisations with CR contrasts with the
information provided in this update and in the 2014 version of
this Cochrane Review. A possible explanation for this difference
is that the ExTraMATCH II authors were not able to obtain par-
ticipant data from all trial authors, and that not all included tri-
als collected hospitalisation data as a time-to-event outcome. The
ExTraMATCH II authors also noted a limitation of their analy-
sis, which showed lack of consistency in how our included trials
with IPD defined and collected clinical event outcome data. As
noted in recent commentaries on clinical events, in HF trials, with
the exception of all-cause mortality, the collection and reporting
of other outcomes including cause-specific mortality and hospi-
talisation can be prone to confounding and bias (Zannad 2013).
In accord with this Cochrane Review update, ExTraMATCH II
foundno strong evidence of differential effects ofCRacross patient
characteristics (i.e. age, sex, ethnicity, New YorkHeart Association
(NYHA) functional class, ischaemic aetiology, ejection fraction,
exercise capacity) on mortality or hospitalisation outcomes.
Our findings are consistent with those of other systematic re-
views/meta-analyses of RCTs for CR for HF published since the
2014 version of this review. Zhang and colleagues collated trial-
level data from 2533 patients with HF enrolled in 28 published
RCTs (Zhang 2018). Based on the MLWHF questionnaire, study
authors reported a similar magnitude of pooled improvement in
HRQoL (mean -6.8, 95% CI -3.9 to -9.7; P < 0.0001). Similarly,
based on eight RCTs including 317 participants with HFpEF,
Chen and colleagues reported a pooled improvement in MLWHF
score of -6.8 (95% CI -9.7 to -3.8; P < 0.0001) (Chen 2018). Fi-
nally, in accord with our updated Cochrane Review, Vromen 2018
found in a meta-regression analysis that CR exercise programme
characteristics of frequency, intensity, and session duration were
not predictive of CR outcomes. However, exercise programmes
with higher overall energy expenditure did lead to better exercise
capacity outcomes.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Results of this update review show that CR results in clinical im-
provement inHRQoL and reduces risk of hospitalisation, and that
these benefits appear to be consistent across ExCR programme
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characteristics (including centre and home CR settings) and sup-
port the recommendations provided in current international clin-
ical guidelines that the offer of exercise-based CR should be made
taking account of patient’s preference for CR setting (ACCF/AHA
2013; ESC 2016; NICE 2018).
Implications for research
Despite clinical guidelines stating support of exercise-based CR
for management of HF, internationally the provision and uptake
of rehabilitation in HF remain poor (Bjarnason-Wehrens 2010;
Golwala 2015). Further robust randomised trials are needed to as-
sess the clinical effectiveness and economic value (costs and cost-ef-
fectiveness) of alternative models of exercise-based CR delivered as
conventional centre-based programmes, as well as home- and tech-
nology-based programmes. Future trials must consider the gen-
eralisability of trial populations (women, older people, and peo-
ple with HFpEF remain under-represented in trial populations);
application of interventions to enhance long-term maintenance
of exercise training and outcomes (Karmali 2014); and costs and
cost-effectiveness of exercise-based CR programmes.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Antonicelli 2016
Methods Parallel-group RCT
Participants N randomised: 343 (exercise 170, control 173)
Diagnosis (% of pts):
Aetiology: ischaemic 49%, hypertension 36%, valvular 15%
LVEF: total 48.4 ± 13.4%, exercise 47.9 ± 13.3%, control 49 ± 13.4%
NYHA: not reported
Case mix: not reported
Age (mean ± SD), years: total 76.9 ± 5.67, exercise 76.21 ± 5.21, control 77.6 ± 6.02
Percentage male: total 56.9%, exercise 60.6%, control 53.2%
Percentage white: not reported
Inclusion/exclusion criteria:
Inclusion: inpatients or outpatients > 70 years of age, CHF from any cause with reduced
or preserved ejection fraction (EF), NYHA functional class ≥ II, Mini Mental State
Examination score > 24
Exclusion: survival prognosis < 6 months, severe uncontrolled diabetes, acute heart de-
compensation in previous 2 months, severe chronic obstructive pulmonary disease, se-
vere liver failure with survival prognosis < 12 months; severe chronic kidney disease with
glomerular filtration rate < 15 mL/min/1.73 m², severe disabling systemic disease, severe
cognitive impairment, inability to perform ET
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic (cycling)
Frequency: 3 sessions/week (for 24 weeks)
Duration: 50 minutes (30 minutes on cycle ergometer)
Intensity: 20 minutes intense exercise on cycle ergometer per exercise session (60 rpm,
achieving 60% to 70% maximum predicted heart rate)
Modality: cycle ergometer
Settings: hospital and home
Other: supervised (face-to-face by physiotherapist in hospital and remotely by nurse via
telemonitoring at home)
Control group / Comparison:
Usual care (medication, education/advice on discharge from hospital); GP appointment
within 2 weeks of discharge and hospital cardiologist appointment at 12 months
Outcomes All-cause hospital admissions; HRQoL (MLWHF)
Country and setting Italy
Single centre
Follow-up 3 months and 6 months
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Antonicelli 2016 (Continued)
Notes Exercise group received heart failure education
Source of funding: strategic project grant of the Italian Ministry of Health, 2007:
“Modelli riabilitativi multi-disciplinari: i nuovi farmaci per il paziente anziano con scom-
penso cardiaco cronico?”. Part of the 2007 I.N.R.C.A. Strategic Program, RFPS-2007-
6-654027: “Assessment of biological parameter changes induced by the rehabilitation
program in elderly patients with congestive heart failure”. This work was also supported
by grants from TERPAGE project PORMarche FESR 2007-2013 Italy to RA and FO;
and Universita Politecnica delle Marche, Italy, to FO
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description of the randomisation process provided
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No protocol identified
Intention-to-treat analysis? Low risk Although the term ITT was not stated, it appears from the
CONSORT diagram that ITT analysis was undertaken
Incomplete outcome data? Low risk All withdrawals and dropouts were described
Exercise: 20/170 (11.8%) lost to follow-up
Control: 10/173 (5.8%) lost to follow-up
Groups balanced at baseline? Low risk “There were no differences between the two groups at baseline”
Groups received same intervention? Low risk All participants continued with usual medication and received
education/advice before discharge from the hospital
Austin 2005
Methods Parallel-group RCT
Participants N randomised: 200 (exercise 100, control 100)
Diagnosis (% of participants):
Aetiology: ischaemia 77%, hypertension 15.5%, DCM 5.5%, other 2%
NYHA: Class II 51.5%, Class III 48.5%
LVEF: 40% to 35%: 16.5%; < 35% to 30%: 45%; < 30%: 38.5%
Case mix: 100%, as above
Age, years: exercise 71.9 (SD 6.3), control 71.8 (SD 6.8)
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Austin 2005 (Continued)
Male: 43%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age > 60 years, NYHA Class II or III, LVSD < 40% as confirmed by echocar-
diography
Exclusion: diastolic dysfunction, significant co-morbidity preventing entry into the study
because of terminal disease or inability to exercise (e.g. severe musculoskeletal disorder,
unstable IHD, advanced valvular disease), resident outside the catchment area or in a
long-term care establishment
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic endurance training and low resistance training/high repet-
itive muscular strength work
Frequency: 2 sessions/week (for 8 weeks), 1 session/week (for 16 weeks) plus 3 sessions/
week at home
Duration: 2.5-hour class (for 8 weeks) and 1-hour class (for next 16 weeks)
Intensity: not reported
Modality: not reported
Settings: hospital and home
Other: none
Control group / Comparison:
Standard care group (including monitoring of clinical status, explanation of HF and its
treatment, self-monitoring, dietary advice, and contact details of clinical nurse specialist)
Outcomes HRQoL (MLWHF questionnaire and EuroQol/EQ-5D); healthcare utilisation (length
of stay in hospital, admissions arising from heart disease, prescribed HF medication);
mortality
Country and setting UK
Single centre
Follow-up 6 months and 5 years (after randomisation)
Notes Source of funding:Nevill Hall Coronary andResearchThrombosis Fund,NorthGwent
Cardiac After Care Charity, Gwent Healthcare Trust, University of Glamorgan
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A computer was used to generate a list of random numbers”
Allocation concealment (selection bias) Low risk “The numbers, placed in plain sealed envelopes by a university
colleague prior to patient recruitment, were allocated to the par-
ticipants by a hospital colleague unconnected with the study.
The allocation schedule was not broken until the trial was com-
pleted”
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Austin 2005 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Not for HRQoL; data on deaths, admissions from hospital
records department
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Although the term ITT was not stated, it appears from the
CONSORT diagram that ITT analysis was undertaken
Incomplete outcome data? Low risk CONSORT diagram was presented, showing participant flow.
No imputation or sensitivity analysis was done to assess the
impact of loss to follow-up
Groups balanced at baseline? Low risk “There are no significant differences in the baseline parameters
of the standard care and experimental groups”
Groups received same intervention? Low risk Yes, both groups received usual medical care; the only difference
between groups was the exercise intervention provided
Belardinelli 1999
Methods Parallel-group RCT
Participants N randomised: 99 (exercise 50, control 49)
Diagnosis (% of participants):
Aetiology: ischaemic cardiomyopathy 85%, idiopathic DCM 15%
NYHA: Class II 49%, Class III 34%, Class IV 17%
LVEF: exercise 28.4 (SD 6), control 27.9 (SD 5)
Case mix: see above
Age, years: exercise 56 (SD 7), control 53 (SD 9)
Male: 89%
White: not reported
Inclusion/exclusion criteria:
Inclusion: HF, LVEF < 40%, sinus rhythm, diagnosis of CHF based on clinical symptoms
and signs with or without radiological evidence of pulmonary congestion
Exclusion: unstable angina, recent acute MI, decompensated congestive HF, haemody-
namically significant valvular heart disease, significant chronic pulmonary illness, un-
controlled hypertension, renal insufficiency (serum creatinine > 2.5mg/dL), orthopaedic
or neurological limitations
Interventions Exercise:
Total duration: 14 months; 8 weeks supervised, then 12 months maintenance
Aerobic/resistance/mix: aerobic
Frequency: 2 to 3 sessions/week
Duration: 40 minutes/session
Intensity: 60% max VO
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Belardinelli 1999 (Continued)
Modality: cycling
Setting: hospital-based programme
Other: all sessions were supervised by a cardiologist
Control group / Comparison:
Standard medical care
Outcomes HRQoL (MLWHF questionnaire); mortality; morbidity; cost-effectiveness
Country and setting Italy
Single centre
Follow-up 14 months and 26 months (after randomisation)
Notes Source of funding: none reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Losses to follow-up were reported
Groups balanced at baseline? Low risk “The baseline characteristics of the study population are shown
in Table 1. The 2 groups were well balanced with respect to
most characteristics, including peak VO2, New York Heart As-
sociation functional class, and left ventricular ejection fraction.
There were no differences in type and doses of medications,
blood chemistry, and previous cardiac events”
Groups received same intervention? Unclear risk Not reported
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Belardinelli 2012
Methods Parallel-group RCT
Participants N randomised: 123 (exercise 63, control 60)
Diagnosis (% of participants):
Aetiology: ischaemic 80%, non-ischaemic 20%
NYHA: Class II 59%, Class III 41%
LVEF: 37 (SD 8)
Case mix: see above
Age, years: 59 (SD 14)
Male: 78%
White: not reported
Inclusion/exclusion criteria
Inclusion: clinical stability for 3months before enrolment, LVEF<40%, ability to exercise
Exclusion: haemodynamically significant valvular heart disease, uncontrolled DM and
hypertension, orthopaedic or neurological problems, renal insufficiency (creatinine > 2.
5 mg/dL)
Interventions Exercise:
Total duration: 10 years; 8 weeks’ supervised, then 12 months’ maintenance
Aerobic/resistance/mix: aerobic
Frequency: 2 to 3 sessions/week
Duration: 40 minutes/session
Intensity: 60% max VO for first 2 months, thereafter at 70% max VO
Modality: cycling
Settings: hospital and home
Other: trained participants were encouraged to exercise without supervision at home at
least a third time, performing aerobic activities at the same HR as the other 2 supervised
sessions
Exercise sessions held at the hospital were supervised by cardiologists. Study authors
emphasise that the supervised element was maintained over 10 years of follow-up
Control group / Comparison:
Standard medical care. Participants were instructed to continue with their usual home
daily physical activities, avoiding exercise training in a supervised environment. They
were free to perform aerobic activities such as walking, cycling (home or outside), and
swimming, avoiding a duration longer than 30 minutes. Study authors advised control
group participants to walk and perform usual physical activities
Outcomes HRQoL (MLWHF questionnaire); mortality; morbidity (including hospitalisation);
cost-effectiveness
Country and setting Italy
Single centre
Follow-up 10 years (every 12 months) (after randomisation)
Notes Every 6 months, participants exercised at the hospital, then returned to a coronary club,
where they exercised the rest of the year
Source of funding: no external funding
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Belardinelli 2012 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk “All analyses were performed with an intention-to-treat princi-
ple”
Incomplete outcome data? Low risk Losses to follow-up were reported
Dropout rate was 3% on average in the exercise group. 2/63 did
not complete the protocol - 1 because of a car accident and the
other for personal reasons. 3/60 in the control group decided to
withdraw from the study for reasons unrelated to their clinical
status
Groups balanced at baseline? Low risk “The baseline characteristics of the study population are shown
in Table 1. The 2 groups were well balanced with respect to most
characteristics, including peak VO2, New York Heart Associ-
ation functional class, left ventricular ejection fraction. There
were no difference in type and doses of medication, blood chem-
istry, and previous cardiac events”
Groups received same intervention? Low risk Both groups appeared to receive the same interventions apart
from the CR intervention
Bocalini 2008
Methods Parallel-group RCT
Participants N randomised: 53 (exercise 28, control 25)
Diagnosis (% of participants):
Aetiology: MI 45.2%, systemic hypertension 19%, dilated Chagas’ cardiomyopathy 11.
9%, DM 4.8%, other 19.1%
NYHA: Class II or III
LVEF: ≤ 45%
Case mix: 100%, as above
Age, years: exercise 61 (SD 12), control 60 (SD 11)
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Bocalini 2008 (Continued)
Male: 88%
White: not reported
Inclusion/exclusion criteria:
Inclusion: EF < 45%, symptoms of NYHA functional Class II or III, optimised pharma-
cological therapy established at least 4 weeks before inclusion in the study, compensated
HF state at least 2 months before
Exclusion: age < 50 years, NYHA functional Class IV, clinical instability in the preceding 2
months, non-optimised therapy, uncontrolled arrhythmias,MI within the last 2months,
surgery-associated cardiomyopathy, pulmonary disease or other co-morbid conditions
that limit physical exercise, accentuated severe cardiac symptoms (hypotension, complex
ventricular arrhythmia, progressive worsening of dyspnoea, and significant ischaemia
at low rates) during ergometric tests, regular participation in some exercise programme
within the last 6 months, frequency in the training protocol < 80%
Interventions Exercise: Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 90 minutes
Intensity: target HR (50% of work at maximum HR)
Modality: walking on a treadmill
Setting: not reported
Other: relaxation and stretching exercises before and after every session
Control group / Comparison:
Usual medical therapy - individual dietary guidance and pharmacological therapy
Outcomes HRQoL (shortened version ofWorldHealthOrganizationQuality of Life questionnaire)
; hospitalisation
Country and setting Brazil
Single centre
Follow-up 6 months (after randomisation)
Notes Initially randomised 53 participants; excluded data from participants who withdrew,
were lost to follow-up, etc.; hence analysed 42 participants
Although setting was not reported, the exercise programme was described as “supervised”
Source of funding: none reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
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Bocalini 2008 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? High risk “During the follow-up, medicine doses were not modified ex-
cept for those that presented impairment of symptoms and, con-
sequently, these patients were excluded from the analysis”
Incomplete outcome data? High risk Only 42/53 (79%) provided data at follow-up
Groups balanced at baseline? Low risk Table 1 of the publication shows that groups were well balanced
Groups received same intervention? Low risk “All patients continued with pharmacological therapy and indi-
vidual dietary guidance”
Chen 2018
Methods Parallel-group RCT
Participants N randomised: 62 (exercise 31, control 31)
Diagnosis (% of participants):
Aetiology: coronary artery disease 41.9%, cardiomyopathy 35.5%, rheumatic heart dis-
ease 9.7%, hypertension 6.5%, valvular 6.5%
NYHA: Class II to IV
LVEF: mean 43.5%, SD 13.8
Case mix: 100%, as above
Age, years: exercise 61 (SD 14), control 62 (SD 15)
Male: 59.7%
White: not reported
Inclusion/exclusion criteria:
Inclusion: heart failure diagnosis, NYHA class II to IV, > 18 years old
Exclusion: cognitive impairment, unable to be contacted by telephone or home visit,
included in other study, COPD, life expectancy < 1 year, other diagnosis limiting activity
Interventions Exercise:
Total duration: 26 weeks
Aerobic/resistance/mix: mix
Frequency: up to 3 sessions/week
Duration: 20 to 40 minutes/session
Intensity: as tolerated by participant
Modality: walking
Setting: hospital
Other: education, depression therapy, home visits
Control group / Comparison:
Standard of care (telephone call at 2weeks, 2 clinic reviews at 90 and 180 days), mortality,
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Chen 2018 (Continued)
hospitalisation
Outcomes HRQoL (MLWHF questionnaire and Short Physical Performance Battery - SPPB)
Country and setting China
Single centre
Follow-up 6 months
Notes Source of funding: none reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “A computer generated randomization list was created by a statis-
tician for patient randomization”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Data collectors (nurses) were blinded to randomisation; whether
they were blinded to outcomes is not clear
Selective reporting (reporting bias) Low risk All outcomeswere reported (no protocol publication is available)
Intention-to-treat analysis? Low risk Although the term ITT was not stated, it appears that groups
were analysed according to initial random allocation
Incomplete outcome data? Low risk Only 2 deaths were reported; no other losses to follow-up were
described
Groups balanced at baseline? Low risk “Baseline demographic and clinical characteristics were not sig-
nificantly different between the SC group and MDMP group
(Table 1)”
Groups received same intervention? Low risk “Medications recommended by the 2013 American College of
Cardiology Foundation/American Heart Association Guideline
for the Management of Heart Failure.50 were prescribed for
all the patients in this study at optimal dosage if there was no
contradiction”
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Methods Parallel-group RCT - 2 arms
Participants N randomised: 46; 15 hospital, 15 home, 16 control
Diagnosis (% of pts):
Aetiology: not reported
NYHA: Class II: exercise (home 60%, hospital 53.3%), control 56.3%
NYHA: Class III: exercise (home 40%, hospital 46.7%), control 43.7%
LVEF: not reported (severe LVSD: exercise (home 60%, hospital 53.3%), control 56.
3%)
Case mix: 100%, as above
Age, years: exercise (home 63.3, hospital 69.2), control 60.4
Percentage male: 91.3%(total), exercise (home 86.7%, hospital 86.7%), control 100%
Percentage white: not reported
Inclusion/exclusion criteria:
Inclusion: left ventricular systolic dysfunction on echocardiography, clinically stable for
at least 1 month, receiving optimised medication
Exclusion: significant ischaemic symptoms at lowworkloads, uncontrolled diabetes, acute
systemic illness/fever, recent embolism, active pericarditis or myocarditis, moderate to
severe aortic stenosis, regurgitant valvular heart disease requiring surgery, myocardial
infarction within past 3 weeks, new-onset atrial fibrillation, signs and symptoms of de-
compensation, other co-morbidities (life-threatening, uncontrolled, infectious, or exac-
erbated by exercise)
Interventions Exercise:
Total duration: 8 weeks
Aerobic/resistance/mix: aerobic
Frequency: 2 sessions/week
Duration: 60 minutes
Intensity: not specified
Modality: circuit training
Setting: hospital-based (intervention 1) and home-based (intervention 2)
Other: hospital group with a senior cardiac rehabilitation physiotherapist, a physiother-
apy technical instructor, and a senior cardiac nurse present at each class; home group
monitored by a senior cardiac rehabilitation physiotherapist by telephone, twice during
their 8-week intervention (estimated as two 20-minute calls, plus 10-minute documen-
tation, i.e. 1 hour per participant)
Control group / Comparison:
Usual care, which included specialist HF nursing input
Outcomes Hospitalisations; costs
Country and setting United Kingdom
Follow-up 5.2 years
Notes Source of funding: NHS Ayrshire and Aaran’s Coronary Heart Disease Managed Clin-
ical Network
Risk of bias
54Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cowie 2014 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Nodetails of randomisation sequence generation process
were provided
Allocation concealment (selection bias) Low risk Concealed envelopes were used
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk The researcher collating and analysing data was blind
to participants’ randomisation groups when measuring
long-term activity levels, but blinding was unclear for
outcomes
Selective reporting (reporting bias) High risk Number of hospitalisations was not reported (obtained
from study lead investigator)
Intention-to-treat analysis? Low risk Although the term ITT was not stated, it appears that
groups were analysed according to initial random allo-
cation
Incomplete outcome data? High risk 46/60 (77%) provided follow-up data
Groups balanced at baseline? Unclear risk Hospital group participants were almost 10 years older
than control participants and so were at high risk of bias,
whereas the home group and the control group were
similar and so were at low risk of bias
Groups received same intervention? Low risk Usual care was standard in all 3 groups
Dalal 2018
Methods Parallel-group RCT
Participants N randomised: 216; 107 exercise, 109 control
Diagnosis (% of pts):
Aetiology: ischaemic intervention 45%, control intervention 46%
Female: intervention 24%, control 19%
NYHA: Class II: intervention 59%, control 58%; Class III: intervention 19%, control
24%
LVEF: mean 34%
Case mix: 100%, as above
Age: intervention mean 69.7 (SD 10.9), control mean 69.9 (SD 11.0)
Percentage male: 78% (total); intervention 76, control 81%
Percentage white: 100%
Inclusion/exclusion criteria
Inclusion: men and women aged ≥ 18 years with a confirmed diagnosis of HFrEF
on echocardiography or angiography (left ventricular ejection fraction < 45% within
the preceding 5 years), no deterioration of HF symptoms in prior 2weeks resulting in
hospitalisation or alteration of HF medication
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Exclusion: cardiac rehabilitation (CR) within the past 12months; received an intracardiac
defibrillator (ICD); cardiac re-synchronisation therapy (CRT) or combined CRT/ICD
device in prior 6months; contraindications to exercise testing or exercise training; in a
long-term care establishment or unwilling or unable to travel to research assessments,
or to accommodate home visits; unable to understand study information or unable to
complete outcome questionnaires
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 2 to 3 times/week
Duration: 12 weeks
Intensity: not reported
Modality: not reported
Setting: home-based
Participants received the REACH-HF Manual (including a choice of 2 exercise pro-
grammes); a participant ‘Progress Tracker’ booklet to record symptoms, physical activity,
and other actions related to self-care; support for caregivers and facilitation by cardiac
nurses or physiotherapists, including assessing individual participant and caregiver needs
and concerns and tailoring the intervention content to address these; this element was
supported by a 3-day training course for facilitators on how to deliver the intervention
using a patient-centred style of communication
Control group / Comparison:
Usual care (“...intervention and control group patients received usual medical manage-
ment for HF according to current guidelines”)
Outcomes Primary outcome: MLWHF questionnaire
Secondary outcomes: death; hospitalisation; HeartQoL; EQ-5D-3L; costs
Country and setting United Kingdom
Multi-centre (4 sites)
Follow-up 4, 6, and 12 months
Notes Funding source: National Institute for Health Research (NIHR) under its Programme
Grants for Applied Research Programme (Grant Reference Number RP-PG-1210-
12004)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were randomly allocated in a 1:1 ratio, stratified by
investigator site and baseline plasma N-terminal proB-type na-
triuretic peptide (NT-pro-BNP) levels (≤2000 vs >2000pg/mL)
, using minimisation to facilitate balance between the groups.
Randomisation numbers were computer generated and assigned
in strict sequence at the point of randomisation”
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Allocation concealment (selection bias) Low risk “To maintain concealment, the Peninsula Clinical Trials Unit
used a password protected, web based randomisation system to
allocate participants after completion of consent and entry of
baseline assessment data”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome assessors and statistician were blinded
Selective reporting (reporting bias) Low risk All pre-specified outcomes were reported as in the published
protocol
Intention-to-treat analysis? Low risk “Primary analyses were based on ITT complete case analyses”
Incomplete outcome data? Low risk All participants were accounted for in a CONSORT flow dia-
gram
Groups balanced at baseline? High risk “Patient level characteristics at baseline were well balanced be-
tween the groups, apart frommore frequent cardiac comorbidity
(history ofmyocardial infarction and atrial fibrillation) and, con-
sequently, a higher Charlson comorbidity score in the control
group (table 1).Mean baselineMLHFQ scores for the REACH-
HF group were higher (poorer) than for the control group, but
secondary baseline outcomes were similar for the two groups”
Groups received same intervention? Low risk Both groups received usual care
DANREHAB 2008
Methods Parallel-group RCT
Participants N randomised: 91 (exercise 45, control 46)
Age, years: exercise median 66 (range 33 to 91), control median 65 (range 29 to 94)
Male: 90%
White: not reported
Inclusion/exclusion criteria:
Inclusion: symptoms of CHF and objective findings or effect of medication
Exclusion: mental disorders and social problems (such as dementia, alcoholism, or drug
addiction); transferred to other department or hospital at discharge; severe illness, in-
cluding NYHA Class IV; living at nursing home; did not speak Danish; refused consent
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: mix
Frequency: 3 sessions/wk
Duration: 90 minutes/session
Intensity: 50% max HR
Modality: not reported
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Setting: supervised centre-based plus home-based also encouraged to continue
Other: physical exercise was conducted as a mixture of endurance and strengthening
training using various upper and lower body modalities easily implemented as activi-
ties that participants could perform at home. CR included participant education, exer-
cise training, dietary counselling, smoking cessation, psychosocial support, risk factor
management, and clinical assessment. All components reflected theoretical and practical
approaches followed by individual follow-up and feedback. The lifestyle intervention
strategy was based on the stages of changemodel and the self-efficacy theory. The lifestyle
intervention was designed as a group intervention, but individual counselling was also
provided
Control group / Comparison:
Usual care participants were offered follow-up treatment prescribed by the discharging
physician as outpatient control or by the general practitioner. Pharmaceutical treatment
followed routine clinical practice based on current national guidelines. The discharging
nurse or physician determined whether participants were referred to smoking cessation
and dietary counselling parallel to outpatient treatment
Outcomes Primary outcomes: composite outcomemeasure included overall mortality,MI, or acute
first-time re-admission due to heart disease other than MI
Secondary outcomes: collected data based on an adapted standardised interview ques-
tionnaire and a postal questionnaire (e.g. SF-36, HADS); clinical examination; blood
tests
Country and setting Demark
Single centre
Follow-up 12 months
Notes HF subset of 770 participants were randomised; this study included other participants
withoutHF (coronary heart disease and individuals ar high risk but no diagnosed disease)
.Only data onHFpatients used in this review.Randomisationwas stratified by indication
Funding source: Copenhagen Hospital Corporation Research Council, Danish Heart
Foundation, Danish Pharmacy Foundation of 1991, Danish Research Council, Danish
Centre for Evaluation and Health Technology Assessment, Danish Ministry of the Inte-
rior and Health, Development Fund of Copenhagen County, Villadsen Family Founda-
tion, Eva and Henry Fraenkel’s Memorial Foundation, Builder LP Christensen’s Foun-
dation, Danish Animal Protection Foundation, Bristol-Myers Squibb, Merck Sharp and
Dohme, and AstraZeneca
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients who gave informed consent were randomized us-
ing a centralized randomization procedure administered by the
Copenhagen Trial Unit. The randomization was stratified ac-
cording to risk group (CHF, IHD, or HR) based on a random-
permuted multiblock within-stratum method”
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Allocation concealment (selection bias) Low risk As above
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Because of the nature of CR, the interventions were open to
the investigators and the patients. Investigator independent out-
come data from registries were chosen to ensure blinded assess-
ment and outcome analysis”
Selective reporting (reporting bias) Low risk All outcomes listed in the methods were reported in the results
Intention-to-treat analysis? Low risk ITT analysis was stated
Incomplete outcome data? Low risk 81% overall follow-up at 12 months
Groups balanced at baseline? Low risk “Patients were well matched at entry”
Groups received same intervention? Low risk Both groups received control care
Davidson 2010
Methods Parallel-group RCT
Participants N randomised: 105 (exercise 53, control 52)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: Class I: exercise 2%, control 0%; Class II: exercise 38%, control 33%; Class III:
exercise 60%, control 67%; Class IV: exercise 0%, control 0%
LVEF: not reported
Case mix: as above
Age, years: exercise 71.6 (SD not reported), control 73.9 (SD not reported)
Male: 67%
White: not reported
Inclusion/exclusion criteria:
Inclusion: patients of any age with diagnosis of HF of any aetiology and NYHA Class I
to IV. All participants were cleared by their physician to participate in the exercise group
Exclusion: participants with unstable angina pectoris were ineligible to participate
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 1 session/week
Duration: 30 to 50 minutes
Intensity: not reported
Modality: gymnasium: treadmills, stationary cycles, recumbent cycles
Home-based: hall walks, stairs, and sporting activities such as lawn bowls
Setting: supervised gymnasium, home-based programme tailored to participant’s needs
Other: also attended a nurse-co-ordinated CR clinic with emphasis on self-manage-
ment. A group-based educational session was conducted for study participants and their
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families. The exercise group attended the nurse-co-ordinated CR clinic, where compre-
hensive assessment was performed by the physiotherapist, the CR co-ordinator, and the
occupational therapist
Control group / Comparison:
Information session, then usual medical care
Outcomes HRQoL (MLWHF questionnaire); all-cause and cardiovascular-related hospital admis-
sion; mortality
Country and setting Australia
Single centre
Follow-up 12 months (after randomisation)
Notes The trial had to be stopped prematurely at 12 months following introduction of chronic
and complex care for people with CHF by the New South Wales Health Department.
“In view of trends in favour of the intervention group and emerging evidence from other
studies, it was considered unethical and untenable to continue randomization in view
of the policy mandate. When the trial was stopped there were 53 participants in the
intervention group and 52 participants in the usual care group”
Source of funding: none reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were randomized to either the intervention or con-
trol group by means of a computer-generated program”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The randomization technique was blinded to the investigators
until the close of the study”
Selective reporting (reporting bias) Low risk All outcomes were described and all methods were reported
Intention-to-treat analysis? Low risk Although this was not reported as an ITT analysis, groups did
appear to be analysed according to original randomised alloca-
tion
Incomplete outcome data? Low risk “No participants were lost to follow-up”
Groups balanced at baseline? Low risk “…there were few differences between intervention and usual
care groups, indicating success of randomization. The most im-
portant difference on clinical variable was that a significantly
greater proportion of people in the intervention group were tak-
ing spironolactone at baseline”
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Groups received same intervention? Low risk Both groups appeared to receive the same interventions apart
from the CR intervention
Dehkordi AH 2015
Methods Parallel-group RCT
Participants N randomised: 61 (exercise 30, control 31)
Diagnosis (% of pts):
Aetiology: ischaemic cardiomyopathy 67.2%, hypertension 26.2%, dilated cardiomyopa-
thy 4.9%
NYHA: Class I: exercise 0, control 0
Class II: exercise 20%, control 19.33%
Class III: exercise 83%, control 81%
LEVF: exercise 32 ± 4%; control 33 ± 5%
Case mix: as above
Age (mean ± SD), years: exercise 60 ± 4.25, control 58 ± 4.22
Percentage male: 67.2% (exercise 60%, control 74%)
Percentage white: not reported
Inclusion/exclusion criteria:
Inclusion: patients admitted to hospital with diagnosis of heart failure, with LVEF ≤
40%, and in sinus rhythm
Exclusion: difficulty with movement; no heart transplant 3 months after exercise pro-
gramme; no advanced heart failure; available throughout the study; coronary bypass
surgery during the study; other neurological, orthopaedic, peripheral vascular, or pul-
monary disease, making it impossible to complete exercise; unwilling to co-operate
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic only (walking)
Frequency: 3 sessions/week
Duration: 40 minutes
Intensity: in short term (up to 6 weeks), < 3MET (simple walking until heart rate reaches
60% of heart rate reserve); in longer term (≥ 6 weeks), heart rate 70% of heart rate
reserve
Modality: walking
Setting: hospital sport facility or gymnasium (supervised)
Control group / Comparison:
Usual care (medication and lifestyle advice)
Outcomes HRQoL (MacNew Questionnaire)
Country and setting Iran, hospital
Follow-up 6 months
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Notes Exercise group supervised by nurse or cardiologist; control group supervised by physician
Source of funding: Research and Technology Deputy of ShahrekordUniversity of Med-
ical Sciences
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The randomisation code was developed with a computer ran-
dom-number generator
Allocation concealment (selection bias) Unclear risk Method of allocation was not described
Blinding (performance bias and detection
bias)
All outcomes
Low risk HRQoL assessment was self-administered
Selective reporting (reporting bias) Unclear risk No protocol was identified
Intention-to-treat analysis? Low risk Although the term ITT was not stated, it appears from the
CONSORT diagram that ITT analysis was undertaken
Incomplete outcome data? Low risk No loss to follow-up was reported in either arm
Groups balanced at baseline? Low risk No differences were noted between groups
Groups received same intervention? Low risk Medications were unchanged in both groups
Dracup 2007
Methods Parallel-group RCT
Participants N randomised: 173 (exercise 86, control 87)
Diagnosis (% of participants):
Aetiology: ischaemic; idiopathic; valvular; DCM; other
NYHA: Class II to IV
LVEF: 26.4 (SD 6.8)
Case mix: 100%, as above
Age, years: 54 (SD 12.5)
Male: 71.7%
White: 60.1
Inclusion/exclusion criteria:
Inclusion: English-speaking, age 18 to 80 years, NYHA II to IV, and LVSD with LVEF
< 40% as documented by echocardiogram or radionuclide ventriculography within 6
months, and sinus rhythm
Exclusion:MIor recurrent anginawithin 3months, orthopaedic impediments to exercise,
severe obstructive pulmonary disease with forced expiratory volume < 1 L in 1 second
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as measured by spirometry, stenotic valvular disease as measured by echocardiogram,
history of uncontrolled ventricular tachyarrhythmias (documented by electrophysiology
study or 24-hourHoltermonitor), or absence of an implantable cardioverter-defibrillator
despite a history of sudden cardiac death
Interventions Exercise:
Total duration: unclear (6 months or 1 year)
Aerobic/resistance/mix: mix
Frequency: 4 sessions/week
Duration: 10 to 45 minutes
Intensity: 40% to 60% max HR
Modality: walking
Setting: home-based
Other: “After six weeks resistive training component involved both upper and lower
extremity strengthening. Resistance training was prescribed at 80% of one repetition
maximum, which is the maximal weight lifted one time, for 2 sets of 10 repetitions using
seated biceps curls to strengthen the arms & seated lateral raises to strengthen shoulders.
A second set of 10 repetitions at 80% of one repetition maximum was also prescribed…”
Control group / Comparison:
Maintained usual level of daily activities; no exercise component
Outcomes HRQoL (MLWHF questionnaire); mortality; hospitalisation
Country and setting USA
Single centre
Follow-up 6 months and 12 months (after randomisation)
Notes Home-based exercise programme
Subgroup analysis reported: Evangelista 2010
Source of funding: American Heart Association Western Division (NCR 133-09)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding reported for physical activity (accelerometer) outcome
but not reported for other outcomes
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
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Intention-to-treat analysis? Low risk Although not reported as ITT analysis, groups did appear to be
analysed according to original randomised allocation
Incomplete outcome data? Low risk “Twopatients (one from the experimental and one from the con-
trol group) were lost to follow-up within the first three months
of enrollment. One was incarcerated and the second left the ge-
ographic area with no forwarding information. The remaining
173 patients compose the final study”
Groups balanced at baseline? Low risk Current version: “There were no differences between the con-
trol and exercise groups at baseline with respect to sociode-
mographic variables (Table I) and most clinical characteristics.
However, patients in the exercise group had a significantly higher
likelihood of having a history of coronary heart disease and tak-
ing antiplatelet medication than in the control group”
Our version: “There were no significant differences in any of
baseline characteristics between the 2 groups, except for an-
giotensin-converting enzyme (ACE) inhibitor; adherers were
more likely to use ACE inhibitors than nonadherers (84% vs
60%; P = 0.039)”
Groups received same intervention? Low risk “Research nursesmade home visits weekly for the first two weeks
and then monthly to assess protocol adherence, correct use of
the pedometer, and tolerance to the exercise program. The home
visits also served as a form of attention control in the care- as-
usual group. All clinical questions were referred to the patient’s
cardiologist”
Du 2018
Methods Parallel-group RCT
Participants N randomised: 132 (exercise 67, control 65)
Diagnosis (% of participants):
Aetiology: ischaemic: total 60 (45%), exercise 33 (49%), control 27 (42%)
NYHA: Class II: total 92 (70%), exercise 49 (73%), control 43 (66%); Class III: total
40 (30%), exercise 18 (27%), control 22 (34%)
LVEF: total 32.6 (SD 12.5), exercise 32 (SD 11.6), control 33 (SD 13.5)
Case mix: 100%, as above
Age, years: total 60 (SD 15); exercise 62 (SD 15), comparator 58 (SD 15)
Male: total 104 (78.8%); exercise 56 (83.6%), control 48 (73.8%)
White: not reported
Inclusion/exclusion criteria:
Inclusion: symptomatic heart failure, NYHA II to III
Exclusion: unstable angina pectoris, unexplained syncope in previous 3 months, resting
heart rate > 120 beats/min, participating in any structured exercise programme, inability
to give informed consent, significant cognitive impairment
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Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic
Frequency: 1 session/week
Duration: 6 minutes/session
Intensity: tailored to individual
Modality: walking (home heart walk)
Setting: home-based
Other: usual care
Control group / Comparison:
Usual care consisting of bedside education, cardiology appointments
Outcomes HRQoL (SF-36 and MLWHF questionnaire)
Country and setting Australia
Multi-centre
Follow-up 3 months and 6 months
Notes Australain New Zealand Clinical Trial Registry 12609000437268. Participants in this
study were younger than the average age of the heart failure population
Source of funding: Australian Department of Health and Ageing, as part of the Sharing
Health Care Initiative
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were randomized at a 1:1 ratio through a central
phone randomization centre using computer generated random
numbers”
Allocation concealment (selection bias) Low risk “Participants were randomized at a 1:1 ratio through a central
phone randomization centre using computer generated random
numbers”
Blinding (performance bias and detection
bias)
All outcomes
Low risk A blinded assessor conducted outcome assessments at follow-up
(3 months and 6 months)
Selective reporting (reporting bias) Low risk No differences were noted between the protocol and the study
Intention-to-treat analysis? Low risk “Data were analysed according to the intention-to-treat princi-
ple”
Incomplete outcome data? High risk 16/67 were lost to follow-up in the exercise group
9/65 were lost to follow-up in the control group
All reasons for losses to follow-up were reported but no expla-
nation was given for differences between groups
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Groups balanced at baseline? Low risk Tables 1 and 2
Groups received same intervention? Low risk Both groups received usual care
Gary 2010
Methods Parallel-group RCT - 2 arms
Participants N randomised: total 65; intervention 1 (comp): 28 (CBT 10; CBT and exercise 18);
intervention 2 (ex alone): 37 (exercise alone 20; control 17)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: Class II 43.3%; Class III 56.7% (as a whole)
LVEF: ≥ 15%
Case mix: 100%, as above
Age, years: 65.8 (SD 13.5)
Male: 41.9%
White: not reported
Inclusion/exclusion criteria:
Inclusion: documented medical diagnosis of HF; LVEF ≥ 15% documented within the
last year by echocardiogram, cardiac catheterisation, ventriculography, or radionuclide
ventriculography; receiving therapy for HF according to guidelines published by the
American College of Cardiology/American Heart Association recommendations (an-
giotensin-converting enzyme inhibitors, diuretics, beta blockers, angiotensin receptor
blockers, hydralazine and nitrate combination, etc.); Hamilton Rating Scale for Depres-
sion (HAM-D) score ≥ 11; positive results on the Mini International Neuropsychiatric
Interview (Mini) for minor or major depression; DSM-IV diagnosis for depression for
14 days, or for 7 days if history of major depressive disorder in the last 6 months. Par-
ticipants also had to be English speaking; living independently (non-institutionalised)
within 100 miles of Atlanta, Georgia; able to respond to questions appropriately; able to
hear adequately to respond to verbal questions; not involved in any structured exercise
programme or walking 3 times/week for a minimum of 20 minutes; not participating
in any psychotherapy; and not hospitalised within the last 60 days
Exclusion: suicide ideation according to psychiatric assessment or Mini evaluation; ma-
jor psychiatric co-morbidity such as schizophrenia, personality disorder, or dementia;
planned surgery; not given a diagnosis of HF in the past 3 months; renal insufficiency
(serum creatinine > 2.5 mg/dL); uncontrolled hypertension; acute bereavement or loss
of significant other within the last month or currently involved in family crisis such as
divorce; any disorder interfering with independent ambulation; and terminal illness such
as cancer
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 30 to 45 minutes/session, maximum 1 hour
Intensity: Borg < 15 (’moderate’)
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Modality: walking
Setting: home-based
Other: exercise + CBT group also received 12 weeks of weekly 1-hour sessions of CBT
for 12 weeks. No other co-interventions were mentioned
Control group / Comparison:
Usual care
“Participants assigned to the UC [usual care] group received no information or coun-
selling from their health care provider other than that normally provided”
Outcomes HRQoL (MLWHF questionnaire); mortality
Country and setting USA
Single centre
Follow-up 24 weeks (after randomisation)
Notes Exercise group participants had 12 weekly face-to-face home visits by a research nurse to
monitor walking progress and to tailor the exercise prescription. “At the first home visit
for EX, the research nurse (1) educated the patient on the rationale for EX in HF; (2)
instructed on self-monitoring of symptoms [dyspnoea, heart rate (HR), fatigue] during
walking; (3) provided the patient with a Polar monitor and instruction on how to use
it; (4) provided patient with EX logs and instructions; (5) instructed on use of the 6- to
20-point Borg’s rate of perceived exertion (RPE) scale; (6) provided patient with blood
pressure cuff and weight scale, if not available; and (7) observed participant response to
walking out side home”
Source of funding: Southeast Affiliate of the American Heart Association Beginning
Grant-in-Aid, Atlanta Clinical and Translational Science Institute at Emory University
School of Medicine
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Data collectors were blinded to group assignment”
Selective reporting (reporting bias) Low risk Outcome were described in the Methods and were re-
ported in the Results
Intention-to-treat analysis? Low risk Although not stated, CONSORT diagram suggests that
groups were analysed according to initial randomised
allocation
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Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow-up
were reported. In exercise group, 1 patient died and 3
withdrew at 24 weeks. In usual care group, 2 participants
and 1 participant withdrew at 12 and 24 weeks, respec-
tively. In combined CBT/exercise group, 2 withdrew at
12 weeks. 1 was lost to follow-up and 1 withdrew at 24
weeks. In CBT group, 1 withdrew at 12 weeks and 24
weeks. 1 died and 1 was lost to follow-up at 24 weeks
Groups balanced at baseline? Low risk “There were no BL differences between groups on any
demographic or outcome variables”
Groups received same intervention? Low risk Groups appeared to receive the same care other than
exercise and CBT interventions
Giallauria 2008
Methods Parallel-group RCT
Participants N randomised: 61 (exercise 30, control 31)
Diagnosis (% of participants):
Aetiology: anteroseptal acute MI: total 55.7%, exercise 60%, control 55%
NYHA: exercise 2.7 ± 0.7, control 2.6 ± 0.5
LVEF: exercise 41.6 ± 11.3%, control 42.0 ± 7.6%
Case mix: 100%, as above
Age (mean ± SD), years: exercise 55.9 ± 3.1, control 55.1 ± 3.7
Male: total 72.1%, exercise 73.3%, control 71%
White: not reported
Inclusion/exclusion criteria:
Inclusion: consecutive patients immediately post STEMI
Exclusion: residual myocardial ischaemia, severe ventricular arrhythmias, atrioventricu-
lar block, valvular disease requiring surgery, pericarditis, severe renal dysfunction (i.e.
creatinine > 2.5 mg/dL)
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 40 minutes (30 minutes plus 5 minutes of warm-up and 5 minutes of cool-
down)
Intensity: tailored to individual (target 60% to 70% of VO peak achieved at initial
symptom-limited cardiopulmonary exercise test)
Modality: cycling
Setting: hospital (supervised)
Other: usual care co-interventions
Control group / Comparison:
Usual care (generic instructions re exercise and diet plus a visit at 6 months)
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Giallauria 2008 (Continued)
Outcomes Hospital admissions
Country and setting UK
Single centre
Follow-up 6 months
Notes Source of funding: study authors state there was no conflict of interest related to spon-
sorship
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear whether clinician prescribing hospitalisation following
dyspnoea was blinded
Selective reporting (reporting bias) Unclear risk No protocol available
Intention-to-treat analysis? Unclear risk Not stated whether intention-to-treat analysis was performed,
but looks as if groupswere analysed to original randomallocation
Incomplete outcome data? Low risk All participants were accounted for
Groups balanced at baseline? Low risk No differences between groups were noted (Table 1)
Groups received same intervention? Low risk Medications were uptitrated to maximal in both groups
Giannuzzi 2003
Methods Parallel-group RCT
Participants N randomised: 90; 45 each group
Diagnosis (% of participants):
Aetiology: HF secondary to idiopathic DCM; ischaemic heart disease; valvular disease
NYHA: Class II to III
LVEF: exercise 25% (SD 4), control 25% (SD 4)
Case mix: 100%
Age, years: exercise 60 (SD 7), control 61 (SD 7)
Male: not reported
White: not reported
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Giannuzzi 2003 (Continued)
Inclusion/exclusion criteria
Inclusion: HF secondary to idiopathic DCM, ischaemic heart disease, or valvular disease;
echocardiographic ejection fraction < 35%; clinical stability for at least 3 months under
optimised therapy; NYHA functional Class II to III; peak oxygen uptake (VO ) < 20
mL/kg/min; echocardiographic images of adequate quality for quantitative analysis
Exclusion: any systemic disease limiting exercise; hypertrophic cardiomyopathy; valvular
disease requiring surgery; angina pectoris; sustained ventricular arrhythmias; severe hy-
pertension; excess variability (> 10%) at baseline cardiopulmonary exercise test; inability
to participate in a prospective study for any logistical reason
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 to 5 sessions/week
Duration: 30 minutes
Intensity: 60% peak VO
Modality: exercise cycle, daily brisk walk, calisthenic. In addition, requested to take brisk
daily walk for > 30 minutes
Setting: supervised cycling sessions at rehabilitation centre; unsupervised sessions at home
Other: not reported
Control group / Comparison:
Educational support but no formal exercise protocol was provided
Outcomes Mortality; morbidity
Country and setting Italy
Multi-centre (15 CR units)
Follow-up 6 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
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Giannuzzi 2003 (Continued)
Intention-to-treat analysis? Low risk Although not stated, it is clear from the CONSORT diagram
that 2 groups were analysed according to ITT
Incomplete outcome data? Low risk 45/45 (100%) in exercise training group, 44/45 (98%) available
at 6 months’ follow-up
Groups balanced at baseline? Low risk “No significant differences were observed between the 2 groups
with respect to demographic and clinical data, including age,
weight, cause of heart failure, or New York Heart Association
functional class. Furthermore, there was no difference between
the 2 groups in the medications received during the 6-month
period of the study”
Groups received same intervention? Unclear risk Not clearly stated whether co-treatments (i.e. cardiovascular
medication) in the 2 groups were the same
Gielen 2003
Methods Parallel-group RCT
Participants N randomised: 20 (exercise 10, control 10)
Diagnosis (% of participants):
Aetiology: IHD, DCM
NYHA: Class II 90%, Class III 10%
LVEF: exercise mean 26.1% (SD 6), control mean 24.7% (SD 8)
Case mix: 100%, as above
Age, years: exercise 55 (SD 6), control 53 (SD 9)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age < 70 years with CHF (NYHA II to III) as a result of DCM or IHD as
assessed by cardiac catheterisation. All had clinical, radiological, and echocardiographic
signs of CHF and an LVEF of 40% as assessed by ventriculography and clinically stable
condition for > 3 months before enrolment
Exclusion: significant valvular heart disease, uncontrolled hypertension, peripheral vascu-
lar disease, pulmonary disease, musculoskeletal abnormalities precluding exercise train-
ing
Interventions Exercise:
Total duration: 2 weeks inpatient followed by 6 months outpatient
Aerobic/resistance/mix: aerobic
Frequency: 7 sessions/week
Duration: 20 minutes/session
Intensity: 70% symptom-limited VO max
Modality: cycle ergometers
Setting: supervised sessions at hospital and home-based unsupervised sessions
Other: expected to participate in 1 group training session (walking, calisthenics, and
non-competitive ball games) of 60 minutes each week. Participants were asked to exercise
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Gielen 2003 (Continued)
for 20 minutes/d at home
Control group / Comparison:
Continued sedentary lifestyle and remained on individually tailored cardiac medication
supervised by private physicians
Outcomes Mortality
Country and setting Switzerland
Single centre
Follow-up 26 weeks (after randomisation)
Notes Source of funding: none reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Although ITT analysis not reported, groups do appear to be
analysed according to original randomised allocation
Incomplete outcome data? Low risk No loss to follow-up
Groups balanced at baseline? Low risk “Patients in the training group and in the control group showed
a significantly reduced left ventricular ejection fraction (training
group: 26.1 ±3.1%, control group: 24.7± 2.4%; NS [not sig-
nificant]) and exercise capacity as determined by peak oxygen
uptake (training group: 20.3 ± 1.0 ml/kg min, control group:
17.9 ± 1.6 ml/kg min; P NS)”
Groups received same intervention? Unclear risk Details of co-interventions not reported
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Gottlieb 1999
Methods Parallel-group RCT
Participants N randomised: 33
Diagnosis (% of participants):
Aetiology: ischaemic or primary
NYHA: Class II or III
LVEF: exercise 22% (SD 8), control 25% (SD 10)
Case mix: 100%, as above
Age, years: exercise 67 (SD 7), control 64 (SD 10)
Male: exercise 15/16 (94%), control 11/14 (79%), total 87%
White: not reported
Inclusion/exclusion criteria:
Inclusion: NYHA Class II to III for at least 3 months and on stable medications for
the past 1 month. All participants were on maximal medical therapy with angiotensin-
converting enzyme inhibitors, diuretic, and digoxin. All participants had EF < 40% by
nuclear ventriculography. No participants had obstructive valvular disease, MI within 3
months, or limitation of exercise secondary to angina or new arrhythmias
Exclusion: not reported
Interventions Exercise:
Total duration: 3 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 30 minutes
Intensity: Borg 12 to 13
Modality: bike and treadmill
Setting: supervised sessions at medical centre by a nurse or an exercise physiologist
Other: care provided by a specialist HF physician
Control group / Comparison:
Usual medical care
Other: care provided by specialist HF physicians
Outcomes HRQoL (MLWHF questionnaire and MOS SF-36 questionnaire); mortality; morbidity
Country and setting USA
Single centre
Follow-up 6 months (after randomisation)
Notes MLWHF, MOS, SF-36 results not reported for the control group
Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
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Gottlieb 1999 (Continued)
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Yes, QUORUM flow diagram reported
Unclear how loss to follow-up, dropout, and cross-over were
dealt with
Groups balanced at baseline? Low risk “There were no differences at baseline between patients ran-
domised to the control group and those randomised to the ex-
ercise program”
Groups received same intervention? Low risk “Medical follow-up of both the control and intervention patient
groups was provided by specialized heart failure physicians”
Hambrecht 1995
Methods Parallel-group RCT
Participants N randomised: 22 (exercise 12, control 10)
Diagnosis (% of participants):
Aetiology: DCM 86%, ischaemic heart disease 14%
NYHA: Class II (55%), Class III (45%)
LVEF: exercise 26% (SD 9), control 27% (SD 10)
Case mix: 100%, as above
Age, years: exercise 50 (SD 12), control 52 (SD 8)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: EF < 40% as assessed by radionucleotide scintigraphy and reduced fractional
shortening < 30% as assessed by echocardiography; willingness to participate in the study
for the next 6months; permanent residence within 25 kmof the training facility; physical
work capacity at baseline > 25 watts without signs of myocardial ischaemia (i.e. angina
or ST segment depression); clinically stable > 3 months
Exclusion: exercise-induced myocardial ischaemia or ventricular tachyarrhythmias (>
Lown Class IVa), valvular heart disease, uncontrolled hypertension, peripheral vascular
disease, COPD, orthopaedic or other conditions precluding regular participation in ex-
ercise sessions
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Hambrecht 1995 (Continued)
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 4 to 6 sessions/week
Duration: 10 to 60 minutes/session, 1 hour at home
Intensity: 70% VO max
Modality: cycling, walking, ball games, and calisthenics
Setting: first 3 weeks supervised hospital-based training; thereafter, home-based
Other: none
Control group / Comparison:
After discharge, medical therapy was continued and participants were supervised by
private physician
Outcomes Morbidity and mortality
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Dropouts and clinical events were fully reported for both groups.
No imputation was undertaken
Groups balanced at baseline? Low risk “There were no significant differences in baseline variables be-
tween the training and control groups”
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Hambrecht 1995 (Continued)
Groups received same intervention? Unclear risk The exercise group had a 3-week hospital stay; the control group
stayed only 3 days. Control group followed up with private
physician. No comment was included on follow-up of the in-
tervention group
Hambrecht 1998
Methods Parallel-group RCT
Participants N randomised: 20 (exercise 10, control 10)
Diagnosis (% of participants):
Aetiology: IHD 35%, DCM 65%
NYHA: Class II 65%, Class III 35%
LVEF: exercise mean 24% (SD 13), control mean 23% (SD 10%)
Case mix: as above
Age, years: exercise 54 (SD 9), control 56 (8)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age < 70 years, with CHF as a result of DCM or IHD; LVEF < 40%
Exclusion: DM, hypertension, overt atherosclerotic PVD, hypercholesterolaemia, ven-
tricular tachycardia, COPD, primary valvular disease
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 2 to 6 sessions/d
Duration: 10 to 20 minutes/session
Intensity: 70% VO max
Modality: bike ergometer
Setting: supervised hospital-based sessions and unsupervised home-based sessions
Other: not reported
Control group / Comparison:
Stayed on previous medication, continued sedentary lifestyle, and supervised by private
physicians
Outcomes Mortality
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: Grant Ha 2155/3-2 from the Deutsche Forschungsgemeinschaft
(DFG), Bonn, Germany
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk It appears that groups were analysed according to original ran-
domised allocation
Incomplete outcome data? Low risk Detailed description of losses to follow-up and dropouts was
provided
Groups balanced at baseline? Low risk “At baseline, patients in the control group did not differ signifi-
cantly from those in the training group with respect to age, aeti-
ology of heart failure, NYHA functional class, duration of heart
failure, LVEF (left ventricular ejection fraction) or LVEDD (left
ventricular end diastolic diameter)”
Groups received same intervention? Low risk “Patients were on angiotensin-converting enzyme inhibitors
(100% in both groups), diuretics (training group 82%, control
70%), and digoxin (training 73%, control 70%, P5NS). Drug
treatment did not change between 4 weeks before enrolment
and study termination”
Hambrecht 2000
Methods Parallel-group RCT
Participants N randomised: 73 (exercise 36, control 37)
Diagnosis (% of participants):
Aetiology: IHD 16%, DCM 84%
NYHA: Class I and II 74%, Class III 26%
LVEF: 29% (SD 9)
Case mix: 100%, as above
Age, years: exercise 54 (SD 9), control 54 (SD 8)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: documented HF by signs, symptoms, and angiographic evidence of reduced
left ventricular function (LVEF < 40%) as a result of DCM or IHD; physical work
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Hambrecht 2000 (Continued)
capacity at baseline > 25 watts; clinical stability ≥ 3 months before study start
Exclusion: significant valvular heart disease, uncontrolled hypertension, DM, hyperc-
holesterolaemia, PVD, pulmonary disease, musculoskeletal abnormalities precluding ex-
ercise training
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 6 or 7 sessions/week
Duration: 10 to 20 minutes/session
Intensity: 70% of peak VO
Modality: cycle ergometer
Setting: first 2 weeks in hospital, remainder home based
Other: plus group sessions 1 hour twice weekly, walking, ball games, and calisthenics
Control group / Comparison:
Continued individually tailored cardiac medications, supervised by physicians
Outcomes Mortality
Country and setting Germany
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: Grant Ha 2155/3-2, from the Deutsche Forschungsgemeinschaft
(DFG), Bonn, Germany
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomly assigned to either a training group or
an inactive group using a list of random numbers”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Not reported
Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow-up were re-
ported
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Hambrecht 2000 (Continued)
Groups balanced at baseline? Low risk “No significant differences were observed between the two
groups with regard to demographic or clinical data, including
age, weight, LVEF, LVEDD (left ventricular end diastolic diam-
eter), NYHA or maximum oxygen uptake”
Groups received same intervention? Unclear risk Co-interventions in the control group were not reported
HF ACTION 2009
Methods Parallel group RCT
Participants N randomised: 2331 (exercise 1159, control 1172)
Diagnosis (% of participants):
Aetiology: IHD 51%
NYHA: Class II 63%, Class III 35%, Class IV 1%
LVEF: 25% (SD not reported)
Case mix: 100%, as above
Age, years: exercise 59 (SD not reported), control 59 (SD not reported)
Male: 72%
White: 62%
Inclusion/exclusion criteria:
Inclusion:LVEF < 35%; NYHAClass II to IVHF for previous 3months despite a 6-week
period of treatment; optimal HF therapy at stable doses for 6 weeks before enrolment
or documented rationale for variation, including intolerance, contraindication, partici-
pant preference, and personal physician’s judgement; sufficient stability, by investigator
judgement, to begin an exercise programme
Exclusion: (selected) age < 18 years; co-morbid disease or behavioural or other limitations
that interfere with performing exercise training or preventing the completion of 1 year
of exercise training; major cardiovascular event or cardiovascular procedure, including
implantable cardioverter-defibrillator use and cardiac re-synchronisation,within previous
6 weeks
Interventions Exercise:
Total duration: 30 months
Aerobic/resistance/mix: aerobic
Frequency: 3 to 5 sessions/week
Duration: 15 to 35 minutes/session
Intensity: 60% to 70% HR reserve
Modality: cycling or walking
Setting: first 36 sessions were supervised, then participant was advised to follow a 5 days/
week home-based exercise programme
Other: none reported
Control group / Comparison:
Usual care: all participants, regardless of group allocation, received self-management
educational materials consistent with guidelines of American College of Cardiology and
American Heart Association
Outcomes Mortality, hospitalisation, HRQoL (KCCQ), cost-effectiveness
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HF ACTION 2009 (Continued)
Country and setting USA
Multi-centre
Follow-up Median 30.1 months (after randomisation)
Notes Study authors were contacted for further details of outcome findings, but no information
was provided
Source of funding: Study authors were funded by various bodies, including National
Institutes of Health and various pharmaceutical companies, particularly GEMedical and
Roche
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The trial uses a permuted block randomization scheme strati-
fied by center and by the etiology of the patient’s heart failure
(ischemic vs nonischemic)”
Allocation concealment (selection bias) Low risk “Patients are randomized at the enrolling centers using an inter-
active voice response”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Event outcomes were blinded
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk “Statistical comparisons of the treatment arms with respect to
clinical outcomes were performed according to the intention-
to-treat principle”
Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow-up were re-
ported
Groups balanced at baseline? Low risk Table 1 of the publication shows that the 2 groups were well
balanced
Groups received same intervention? Low risk “All patients, regardless of group allocation, received self-man-
agement educational materials...consistent with guidelines of
American College of Cardiology and American Heart Associa-
tion”
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Jolly 2009
Methods Parallel-group RCT
Participants N randomised: 169 (exercise 84, control 85)
Diagnosis (% of participants):
Aetiology: data not available
NYHA: Class I 6%, Class II 74%, Class III 20%
LVEF: ≤ 40%
Age, years: exercise 65.9 (SD 12.5), control 70 (SD 12.5)
Male: 75%
White: 85.1%
Inclusion/exclusion criteria:
Inclusion: LVEF ≤ 40% on echocardiogram and severity of at least NYHA group II in
the previous 24 months; had to have been clinically stable for 4 weeks and in receipt
of optimal medical treatment and in care of a specialist HF nurse team from 2 acute
hospital trusts and 1 primary care trust, not considered high-risk for a home-based
exercise programme
Exclusion: NYHA Class IV;MI or re-vascularisation within past 4 months; hypotension;
unstable angina; ventricular or symptomatic arrhythmias; obstructive abortive valvular
disease; COPD; hypertrophic obstructive cardiomyopathy; severe musculoskeletal prob-
lems preventing exercise; case note-reported dementia or current severe psychiatric dis-
order
Interventions Exercise:
Total duration: 6-month programme progressive with aim that participants would achieve
the following:
- Aerobic/resistance/mix: mix
- Frequency: 5 times/week
- Duration: 20 to 30 minutes
- Intensity: 70% peak VO or Borg 12 to 13
Modality: aerobic and resistance elements (upper and lower limb exercises)
Setting: first 3 sessions supervised centre-based followed by home-based programme with
home visits by nurse at 4, 10, and 20 weeks and telephone support at 6, 15, and 24
weeks; intervention manual provided
Other: specialist HF nurse care
Control group / Comparison:
Specialist HF nurse care
Outcomes HRQoL (MLWHF questionnaire); composite of death, hospital admissions, generic
quality of life (EQ-5D)
Country and setting UK
West Midlands, community
Follow-up 6-Month and 12-month follow-up (after randomisation)
Notes Source of funding: Department of Health’s Policy Research Programme, as part of a
joint DH/British Heart Foundation Heart Failure research initiative
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “An independent clinical trials unit using a computerized pro-
gramme undertook randomization after each patient had con-
sented and undergone the baseline tests and questionnaire”
Allocation concealment (selection bias) Low risk “An independent clinical trials unit using a computerized pro-
gramme undertook randomization after each patient had con-
sented and undergone the baseline tests and questionnaire”
Blinding (performance bias and detection
bias)
All outcomes
High risk “…, the nurse undertaking the assessment was blinded to the
treatment allocation of the patient, but owing to staffing is-
sues, this occurred in only 62% of participants followed up at 6
months”
Selective reporting (reporting bias) Low risk All primary outcomes and most secondary outcomes described
in the methods were reported
Stated in themethods that blood pressure and incremental shut-
tle walking test were not collected at 12 months
Intention-to-treat analysis? Low risk “...between- and within-group analyses for primary and sec-
ondary outcomes at 6 and 12 months were performed according
to intention to treat”
Incomplete outcome data? Low risk Dropouts and clinical events were fully reported
Outcomes available for 161 (95%) participants at 6 months
and for 157 (92%) participants at 12 months. Non-imputed
data were reported, and sensitivity analysis was undertaken to
examine the impact of missing data
Groups balanced at baseline? Unclear risk “Baseline characteristics were broadly comparable, the exception
being that the exercise group was somewhat younger and had
higher HADS depression scores and a lower systolic blood pres-
sure”
Groups received same intervention? Low risk “Both groups received specialist heart failure nurse input in pri-
mary and secondary care through clinic and home visits that in-
cluded the provision of information about heart failure, advice
about self-management and monitoring of their condition, and
titration of beta-blocker therapy”
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Jónsdóttir 2006a
Methods Parallel-group RCT
Participants N randomised: 43 (exercise 21, control 22)
Diagnosis (% of participants):
Aetiology: ischaemic 79%, AF 12%, valvular 7%, hypertension 2%
NYHA: Class II and III
LVEF: exercise 41.5 (SD 13.6), control 40.6% (SD 13.7)
Case mix: as above
Age, years: exercise 68 (SD 7), control 69 (SD 5)
Male: 79%
White: not reported
Inclusion/exclusion criteria:
Inclusion: CHF diagnosis; on CHF medication; clinical symptoms of CHF; clinically
stable > 3 months before study entrance; fulfilling 1 of the following criteria: previous
MI, hospitalised because of CHF, lung oedema, and cardiac enlargement on X-ray
Exclusion: chronic obstructive lung disease, orthopaedic disabilities, psychiatric disabili-
ties, cancer, senility, age > 80 years
Interventions Exercise:
Total duration: 5 months
Aerobic/resistance/mix: mix
Frequency: 2 sessions/week
Duration: 45 minutes
Intensity: not reported
Modality: cycling, free weights, and elastic rubber bands (Thera-bands)
Setting: hospital outpatients, supervised by physiotherapists
Other: training group given 3 educational lectures about nutrition, physical activity, and
relaxation, in addition to the exercise programme
Control group / Comparison:
Usual medical care (continued previous level of physical activity, which varied from
performing little physical activity to taking a daily walk outdoors)
Outcomes Rehospitalisation; mortality
Country and setting Iceland
Single centre
Follow-up 12 months and 28 months (after randomisation)
Notes Source of funding: none reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
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Jónsdóttir 2006a (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Although not reported as an ITT analysis, groups did appear to
be analysed according to the original randomised allocation
Incomplete outcome data? Low risk No losses to follow-up
Groups balanced at baseline? Low risk Table 2 of the publication suggests that the 2 groups were well
balanced
Groups received same intervention? Low risk Yes, both groups appeared to receive the same interventions apart
from the CR intervention
Kaltsatou 2014
Methods Parallel-group RCT - 2 arms
Participants N randomised: 57 (dance 19, formal exercise 19, control 19)
Diagnosis (% of participants):
Aetiology: coronary artery disease 29.8%, hypertension 24.6%, valvular heart disease 24.
6%, arrhythmia 21.1%
NYHA: not reported
LVEF: dance 49.3 ± 3.4%, formal exercise 49.1 ± 2.4%, control 49.6 ± 3.5%
Case mix: as above
Age, years: dance 67.2 (SD 4.2), formal exercise 67.1 (SD 7.2), control 67.2 (SD 5)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: NYHA II/III, heart failure with at least 3 months’ clinical stability, no partic-
ipation in any form of regular exercise
Exclusion: unstable angina, myocardial infarction within last 5 months, uncontrolled hy-
pertension, chronic obstructive pulmonary disease, insulin-dependent diabetes mellitus,
severe neurological or orthopaedic problems that would hinder the patient’s participa-
tion in the exercise programme
Interventions Exercise:
Total duration: 32 weeks
Aerobic/resistance/mix: mix (resistance training included in the formal exercise group)
Frequency: 3 sessions/week
Duration: 60 minutes
Intensity: moderate: exercise perceived exertion 13 to 14 (somewhat hard) on the Borg 6
to 20 category scale
Modality: dancing, cycling, or treadmill
84Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kaltsatou 2014 (Continued)
Setting: home setting (supervised training at a public gym)
Other: not reported
Control group / Comparison:
Usual care (no formal intervention was provided, and participants were asked to continue
with usual sedentary lifestyle)
Outcomes HRQoL (Greek version of SF-36)
Country and setting Greece
Single centre
Follow-up 8 months
Notes Formal exercise was structured by a group of experienced exercise trainers specialising
in cardiac rehabilitation. Dance intervention was designed by a dance teacher with
experience in rehabilitation
Source of funding: no specific grant from any funding agency in public, commercial,
or not-for-profit sectors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “simple random allocation (drawing lots)”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “All tests were conducted and interpreted by the same
researcher blinded to the identity of the subjects”
Selective reporting (reporting bias) Unclear risk No protocol available
Intention-to-treat analysis? Low risk Although the term ITT was not stated, it appears from
the CONSORT diagram that ITT analysis was under-
taken
Incomplete outcome data? Low risk Loss to follow-up comparable and low in all groups, with
reasons reported
In the dance group, 1/19 were lost to follow-up
In the formal exercise group, 3/19 were lost to follow-
up
In the control group, 2/19 were lost to follow-up
Groups balanced at baseline? Low risk No differences between groups
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Groups received same intervention? Low risk “The participants had to be in a clinically stable condi-
tion for at least three months before entering the study
and remained in a stable medication regimen and diet
during the study”
Keteyian 1996
Methods Parallel-group RCT
Participants N randomised: 40 (exercise 21, control 19)
Diagnosis (% of participants):
Aetiology: DCM 40%, IHD 60%
NYHA: Class II 67.5%, Class III 32.5%
LVEF: 21% (SD 7)
Case mix: 100%, as above
Age, years: 56 (SD 11)
Male: 100%
White: 62.5% (remainder black)
Inclusion/exclusion criteria:
Inclusion: NYHA Class II or III, resting EF < 35% measured by echocardiography or
gated equilibrium radionuclide angiography, no change in medical therapy ≥ 30 days
before randomisation
Exclusion: AF, acute MI 3 months, angina pectoris at rest or induced by exercise, current
enrolment in another clinical trial, current participation in a regular exercise programme
(at least twice weekly)
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week (rate of perceived exertion 12 to 14)
Duration: 33 minutes
Intensity: 60% to 80% peak HR
Modality: treadmills, stationary cycles, rowing machines, arm ergometers
Setting: outpatient clinic
Other: none reported
Control group / Comparison:
Usual medical care.
Participants were instructed to maintain their normal daily activity habits and not to
begin an exercise regimen
Outcomes Mortality, hospital admissions
Country and setting North America
Single centre
Follow-up 6 months (after randomisation)
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Keteyian 1996 (Continued)
Notes Study authors were contacted for further details of outcome findings but provided no
information. Each participant’s physician was asked to not change the drug regimen
during the study, if possible
Source of funding: Astra Merck
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were randomly assigned to the exercise group or the
control group”
Allocation concealment (selection bias) Unclear risk “Each patient’s assignment was sealed in an envelope until com-
pletion of the second exercise test”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk “Of the 40 patients entered into the study, only those who also
completed the exercise tests at weeks 12 and 24 were considered
in the data analysis”
Incomplete outcome data? Low risk “Fifteen patients in the exercise group completed the study. Two
patients dropped out because of noncardiac medical conditions
(progressive, limiting arthritis in one patient and newly diag-
nosed cancer in the other) that developed within 1 month of the
start of the exercise program. One patient developed atrial fibril-
lation between week 12 and week 24; 3 other patients stopped
exercising for personal reasons before week 12 and refused fol-
low-up testing. Fourteen of the 19 patients in the control group
completed the study. Two dropped out for personal reasons and
refused follow-up testing, one developed atrial fibrillation be-
tween week 12 and week 24, one was hospitalized at week 22
for an acute myocardial infarction, and one died suddenly”
Groups balanced at baseline? Low risk “Among patients who completed the study, no differences in
demographic characteristics were seen between the two study
groups after randomization”
Groups received same intervention? Unclear risk Co-interventions in the control group were not reported
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Klecha 2007
Methods Parallel-group RCT
Participants N randomised: 50 (exercise 25, control 25)
Diagnosis (% of participants):
Aetiology: IHD 100%
NYHA: Class II: exercise 56%, control 60%; Class III: exercise 44%, control 40%
LVEF: exercise mean 27.4% (SD 5.7), control mean 28.5% (SD 5.2)
Case mix: 100%, as above
Age, years: exercise 59.6 (SD 10.2), control 61.2 (SD 9.5)
Male: exercise 80%, control 72%
White: not reported
Inclusion/exclusion criteria:
Inclusion: ischaemic HF in NYHA Classes II and III > 6 months, clinically stable > 6
weeks, LVEF < 35%
Exclusion: uncontrolled arterial hypertension; history of major ventricular arrhythmias,
acute coronary syndrome, percutaneous coronary intervention, or brain event 3 months
before the study; AF or other arrhythmia making it impossible to perform MRI; pre-
vious coronary artery bypass grafting; implantable cardioverter-defibrillator; permanent
pacemaker or presence of metal parts in the body; signs of osteoarticular dysfunction
excluding participation in physical training; DM; COPD; anaemia
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: 25 minutes/session
Intensity: 80% predicted HR at VO max
Modality: cycling
Setting: centre-based
Other: none reported
Control group / Comparison:
Standard medical care only
Outcomes Mortality
Country and setting Poland
Single centre
Follow-up 26 weeks (after randomisation)
Notes Source of funding: KBN (The Polish State Committee for Scientific Research), grant
no. 3 PO5D 047 23
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
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Klecha 2007 (Continued)
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Not implicit, but numbers used suggest that groups were anal-
ysed according to randomised allocation
Incomplete outcome data? Low risk No participants were lost to follow-up
Groups balanced at baseline? Low risk “At baseline the groups did not differ significantly in clinical
characteristics. The only exception was smoking, the training
group consisted of significantly more ex-smokers”
Groups received same intervention? Unclear risk Not reported
Klocek 2005
Methods Parallel-group RCT
Participants N randomised: 42 (exercise group A 14, exercise group B 14, control group 14)
Diagnosis (% of participants):
Exercise group A
Aetiology: ischaemic 100%
NYHA: Class II/III exercise group A 55%, control group 100%
LVEF: exercise group A mean 33.6% (SD 3.6), control group 33.2% (SD 3.8)
Exercise group B
Aetiology: ischaemic 100%
NYHA: Class II/III exercise group B 75%, control group 100%
LVEF: exercise group B mean 34.2% (SD 4.2), control group 33.2% (SD 3.8)
Case mix: 100%, as above
Age, years: exercise group A 54 (SD 7), control group 55 (SD 9), exercise group B 57
(SD 8), control 55 (SD 9)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: stable CHF, LVEF < 40% on echocardiography ≤ 1 month before inclusion,
age < 65 years
Exclusion: moderate or severe pulmonary disease; orthostatic blood pressure fall (> 20
mmHg); MI, unstable angina, heart surgery, or coronary angioplasty within 3 months
before inclusion as well as inability to perform bicycle training
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Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: group A: 20 minutes/session (4 minutes constant workload with 1 minute rest
repeated 5 times)
Intensity: group A: 60% max HR
Duration: group B: 25 minutes/session (exercise workload gradually increased after each
5-minute training period to a total of 25 minutes)
Intensity: group B: up to 75% max HR
Modality: cycle ergometer
Setting: CR, outpatient unit under supervision of the physician and the rehabilitation
specialist
Other: none reported
Control group / Comparison:
Controls were asked to not change their degree of physical activity during the study
Outcomes HRQoL (Psychological General Wellbeing Index)
Country and setting Poland
Single centre
Follow-up 26 weeks (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk “Results of baseline QoL examinations were not known to the
patients and their physicians or to the persons performing the
randomisation”
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk It appears that groups were analysed according to initial random
allocation
Incomplete outcome data? Unclear risk No information was presented on loss to follow-up nor dropouts
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Klocek 2005 (Continued)
Groups balanced at baseline? Low risk “At baseline there were no significant differences in between
groups in left ventricular ejection fraction and other basic pa-
rameters of left ventricular function”
“At the start of the study, mean PGWB [Psychological General
Wellbeing Index] total index was similar in groups A and B.
Controls had lower total index than patients in group B”
Groups received same intervention? Unclear risk Details of co-interventions were not reported, although the de-
gree of follow-up was stated to be equivalent
Koukouvou 2004
Methods Parallel-group RCT
Participants N randomised: 26 (exercise 16, control 10)
Diagnosis (% of participants):
Aetiology: DCM 7%, ischaemic 100%
NYHA: Class II 58%, Class III 42%
LVEF: < 40%
Case mix: 100%, as above
Age, years: exercise 52 (SD 9), control 53 (SD 11)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: aetiology of CHF either ischaemic heart disease or DCM; diagnosis of CHF
mainly based on clinical signs (NYHA Class II and III), radiological findings, and
echocardiographically determined EF < 40% and shortening fraction < 30%
Exclusion: recentMI or unstable angina; aortic stenosis; DM; uncontrolled hypertension;
musculoskeletal limitations or other contraindications for participating in an exercise
training programme; documented exercise-induced severe ischaemia or serious arrhyth-
mias, or both
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: mix
Frequency: 3 or 4 sessions/week
Duration: 60 minutes/session
Intensity: 50% to 75% peak VO
Modality: cycle ergometer, walking or jogging, stair climber, and step-aerobics
- Plus ’light’ resistance exercise (not defined)
Setting: supervised exercise training programme at institution
Other: none reported
Control group / Comparison:
Not reported
Outcomes HRQoL (MLWHF questionnaire and Spritzer Quality of Life Index)
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Country and setting Greece
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The psychological tests were assessed from all patients in the
first week of admission, before randomization to study groups
and the end of the study by the same physician, who was not
familiar with the patients”
Selective reporting (reporting bias) Low risk All outcomes outlined in the methods were reported
Intention-to-treat analysis? Low risk Not stated explicitly, but analysis appears to be done according
to initial group allocation
Incomplete outcome data? Unclear risk Losses to follow-up, dropouts not reported
Groups balanced at baseline? Low risk “The two groups of patients participating in the study were
similar as regards their clinical data”
Groups received same intervention? Unclear risk Not reported
Lang 2018
Methods Parallel-group RCT
Participants N randomised: 50 (exercise 25, control 25)
Diagnosis (% of participants):
Aetiology: ischaemic Intervention 32%, control 64%
NYHA: Class II: intervention 60%, control 64%; Class III: intervention 36%, control
32%
LVEF: ≥ 45%
Case mix: 100%, as above
Age, years: exercise 71.8 (SD 9.9), control 76.0 (SD 6.6)
Male: exercise 36%, control 56%
White: not reported
92Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lang 2018 (Continued)
Inclusion/exclusion criteria:
Inclusion: LVEF ≥ 45% within 6 months of randomisation
Exclusion: cardiac rehab within 6 months, contraindication to exercise
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 2 to 3 times/week
Duration: not reported
Intensity: not reported
Modality: walking or chair-based
Setting: home-based
The REACH-HF Manual; a participant ‘Progress Tracker’ booklet to record symptoms,
physical activity, and other actions related to self-care; support for caregivers; and facili-
tation by cardiac nurses or physiotherapists, including assessment of individual patient
and caregiver needs and concerns and tailoring of the intervention content to address
these were provided; this elementwas supported by a 3-day training course for facilitators
on how to deliver the intervention using a patient-centred style of communication
Control group / Comparison:
Usual care (“...intervention and control group patients received usual medical manage-
ment for HF according to current guidelines”)
Outcomes Primary outcome: MLWHF questionnaire
Secondary outcomes: mortality, hospitalisation, Heart-QoL, EQ-5D-3L, costs
Country and setting United Kingdom
Single centre
Follow-up 4 months and 6 months
Notes Funding source: National Institute for Health Research (NIHR) under its Grants for
Applied Research Programme (Grant Reference No. RP-PG-1210-12004)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants will be randomly allocated in a 1:1 ratio to either
interventionor control group armswithout stratification ormin-
imisation. Randomisation numbers will be computer generated
and assigned in strict sequence. At the point of randomisation,
participants will be assigned the next randomisation number in
the sequence. To maintain concealment and minimise selection
bias, randomisation will be performed after the baseline visit by
amember of Peninsula Clinical Trials Unit (CTU), independent
from investigator teams, using a secure, web-based randomisa-
tion system”
Allocation concealment (selection bias) Low risk As above
93Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lang 2018 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk “We assessed the fidelity of blinding by asking outcome assessors
at each follow-up visit to guess patient group allocation. Un-
blinding of groups did not take place until after data analysis and
the blinded results had been presented to the Trial Management
Group and interpretation of results was agreed”
Selective reporting (reporting bias) Low risk All pre-specified outcomes were reported as in the published
protocol
Intention-to-treat analysis? Low risk “All analyses are based on the intention to treat principle (pa-
tients are analysed according to their original random allocation)
using observed data only”
Incomplete outcome data? Low risk All participants were accounted for in a CONSORT flow dia-
gram
Groups balanced at baseline? High risk “There was evidence of imbalance between intervention and
control group patients in terms of their baseline demographic
characteristics (see Table 1). Compared with the control group,
the intervention group included a higher proportion of females,
and lower proportions of patients with an ischaemic diagnosis,
with atrial flutter/atrial fibrillation, and with chronic renal fail-
ure; also, the intervention group had a younger mean age”
Groups received same intervention? Low risk Both groups received usual care
McKelvie 2002
Methods Parallel-group RCT
Participants N randomised: 181 (exercise 90, control 91)
Diagnosis (% of participants):
Aetiology: ischaemic 76%, hypertensive 7%, valvular 5%, other 12%
NYHA: Class I to III
LVEF: < 40%
Case mix: 100%, as above
Age, years: exercise 64.8 ± 1.1 (SD 10.5), control 66.1 (SD 9.4)
Male: control 80, exercise 82
White: not reported
Inclusion/exclusion criteria:
Inclusion: documented clinical signs and symptoms of HF; LVEF < 40%; NYHA func-
tional class I to III; 6-minute walk test distance < 500 m
Exclusion: inability to attend regular exercise training sessions; exercise testing limited by
angina or leg claudication; abnormal blood pressure response to exercise testing (systolic
blood pressure during exercise > 250 mmHg or diastolic blood pressure response > 15
mmHg, systolic blood pressure response decrease > 20 mmHg after normal increase or
decrease below the resting level); cerebrovascular or musculoskeletal disease preventing
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exercise testing or training; respiratory limitation (forced expired volume in 1 second, or
vital capacity < 60% of predicted, or both); poorly controlled cardiac arrhythmias; any
non-cardiac condition affecting regular exercise training or decreasing survival
Interventions Exercise:
Total duration: 9 months (3 supervised, 6 home-based)
Aerobic/resistance/mix: mix
Frequency: 2 sessions/week
Duration: aerobic; 30 minutes/session
Intensity: aerobic: 60% to 70% max HR. Resistance: 40% of 1-repetition maximum,
with 10 repetitions for arm exercises and 15 repetitions for leg exercises, with an increase
over 5 weeks to an intensity of 60% for 1-repetition maximum and a total of 3 sets of
each exercise per session
Modality: aerobic: cycle, treadmill, and arm ergometry exercise. Resistance: arm curl,
knee extension, and leg press performed individually with each limb
After 3 months of supervised training, participants in the exercise group were provided
an exercise cycle and a set of free weights with instructions to continue training at home
3 times/week for the remainder of the study
Setting: supervised for 3 months at rehabilitation centre and unsupervised for 9 months
at home
Other: none reported
Control group / Comparison:
Usual medical care. Control participants were not provided a formal exercise prescription
but were encouraged to continue their usual level of physical activity and were not
discouraged from regular physical activity
Outcomes HRQoL (MLWHF questionnaire); mortality; composite of mortality and hospital ad-
mission for HF
Country and setting Canada
Multi-centre
Follow-up 12 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The predetermined allocation sequence was based on a stream
of computer-generated pseudorandom numbers from a uniform
distribution stratified by center and with a blocking factor of 4”
Allocation concealment (selection bias) Low risk “Eligible patients were registered in a log and treatment group
determined by opening the next sequential study allocation en-
velope”
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Blinding (performance bias and detection
bias)
All outcomes
Low risk “Outcome measures were performed in a blinded fashion. Indi-
viduals responsible for supervising and recording the results of
the outcome measurements were unaware of the patients group
assignment”
Selective reporting (reporting bias) Unclear risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Although ITT analysis was not reported, groups appear to have
been analysed according to the original randomised allocation
Incomplete outcome data? Low risk “In the control group, 83 patients completed 3 months of fol-
low-up (reasons for incompletion: death 3; other problems 4;
worsening heart failure 1) and 75 patients completed 12months
of follow-up (reasons for incompletion: death 8; withdrawal 2;
other problems 3; worsening heart failure 2; refused testing 1).
For the exercise group, 80 patients completed 3 months of fol-
low-up (reasons for incompletion: death 1; withdrawal 5; other
problems 1; worsening failure 2; refused testing 1) and 64 pa-
tients completed 12 months of follow-up (reasons for incomple-
tion: death 9; withdrawal 6; other problems 7; worsening heart
failure 3; refused testing 1)”
No imputation nor sensitivity analysis was undertaken to assess
the impact of loss to follow-up
Groups balanced at baseline? Low risk “There were no differences between the control and exercise
training groups with respect to age, resting ejection fraction,
New York Heart Association class, cause of heart failure, or du-
ration of heart failure”
Groups received same intervention? Unclear risk “All patients were reviewed monthly throughout the study”
Mehani 2013
Methods Parallel-group RCT
Participants N randomised: 40 (exercise 20, control 20)
Diagnosis (% of participants):
Aetiology: ischaemic 76%, hypertensive 7%, valvular 5%, other 12%
NYHA: Class I to III
LVEF: exercise 33.09 ± 4.77%, comparator 35.8 ± 6.87%
Case mix: 100%, as above
Age, years: exercise 56.4 (SD 5.829), control 54.6 (SD 9.264)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: > 8 months’ history of DCM with 3 months’ clinical stability on optimal
medical therapy
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Exclusion: significant coronary disease by history or angiography to exclude ischaemic
causes; evidence for secondary causes of cardiomyopathy as long-standing or uncontrolled
hypertension; primary valvular disease; atrial fibrillation (AF); severe functional mitral
regurgitation (MR); clinical evidence of pulmonary disease (chronic obstructive lung
disease, moderate to severe pulmonary hypertension)
Interventions Exercise:
Total duration: 28 weeks
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: aerobic; 45 minutes/session
Intensity: aerobic: maximal 80% of heart rate reserve
Modality: aerobic: circuit training (stairmaster, bicycle, treadmill)
Setting: hospital (supervised)
Other: none reported
Control group / Comparison:
Usual care (2 weekly physician visits with medication adjustments)
Outcomes Hospital admissions, mortality
Country and setting Iran
Single centre
Follow-up 7 months
Notes Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “the patients were randomly assigned into two groups (training
and control groups) by arrangement into numerical numbers
from 1 to 40, then odd numbers were allocated as a training
group and the even numbers were allocated as a control group”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk HRQoL assessment was self-administered. Blinding was not re-
ported for other outcomes
Selective reporting (reporting bias) Unclear risk No protocol was available
Intention-to-treat analysis? Low risk Although the term ITT was not stated, it appears from the
CONSORT diagram that an ITT analysis was undertaken
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Incomplete outcome data? Low risk Loss to follow-up similar across groups, with reasons given
Exercise: 5/20 were lost to follow-up
Control: 5/20 were lost to follow-up
Groups balanced at baseline? Low risk “At baseline, there were no statistical significant differences be-
tween both groups as regards to age, body mass index, NYHA
classification, left ventricular internal dimensions at diastole and
systole”
Groups received same intervention? Low risk With the exception of the exercise-based intervention, all par-
ticipants underwent the same visits, except for exercise, and re-
ceived the same disease information
Mueller 2007
Methods Parallel-group RCT
Participants N randomised: 50 (exercise 25, control 25)
Diagnosis (% of participants):
Aetiology: ischaemic, DCM (% not reported)
NYHA: not reported
LVEF: < 40% (% not reported)
Case mix: 100%, as above
Age, years: 55 (SD 10)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: CHF documented by clinical, angiographic, or echocardiographic criteria;
resting EF < 40%
Exclusion: not reported
Interventions Exercise:
Total duration: 1 month
Aerobic/resistance/mix: aerobic
Frequency: 5 sessions/week
Duration: 30 minutes/session cycling, 90 minutes walking each day
Intensity: Borg 12 to 14 (60% to 80% max HR)
Modality: cycling and walking
Setting: indoor cycling sessions were supervised directly by a medical resident; outdoor
walking sessions were supervised by exercise physiologists
Other: resided at the rehabilitation centre for 1 month; programme also included edu-
cation and low-fat meals prepared daily by the centre’s cook
Control group / Comparison:
Usual medical care
Outcomes Morbidity, mortality
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Country and setting Switzerland
Single centre
Follow-up 6.2 years (after randomisation)
Notes Source of funding: RAHN-Medizinfonds, Zurich; Schweizerische Herzstiftung,
Switzerland
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk Outcomes described in the methods were reported in the results
Intention-to-treat analysis? Low risk ITT was not stated explicitly; however, groups appear to have
been analysed according to the original allocation
Incomplete outcome data? Low risk “Data from one patient in the control group was not available at
the two-month evaluation due to refusal to complete testing.”
“Among subjects in the exercise group, 9 died, and one refused
repeat testing. Among patients in the control group, 12 died and
two refused repeat testing. Therefore, 14 and 13 patients per-
formed six-year evaluations in the exercise and control groups,
respectively”
QUORUM diagram reported and detailed text provided; no
imputation undertaken
Groups balanced at baseline? Low risk “No differences were observed between the exercise and control
groups initially in clinical or demographic data, including age,
height, weight, pulmonary function or medication status”
Groups received same intervention? Unclear risk “Patients in the exercise group resided at the rehabilitation centre
for one month. Control subjects received usual clinical care,
including verbal encouragement to remain physically active”
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Myers 2000
Methods Parallel-group RCT
Participants N randomised: 25 (exercise 12, control 13)
Diagnosis (% of participants):
Aetiology: ischaemic 100%
NYHA: not reported
LVEF: exercise 31.5% (SD 7), control 33.3% (SD 6)
Case mix: 100%, as above
Age, years: exercise 56 (SD 5), control 55 (SD 7)
Male: 100%
White: not reported
Inclusion/exclusion criteria:
Inclusion: MI, diagnosis of HF and stable symptoms, LVEF < 40%
Exclusion: pulmonary disease
Interventions Exercise:
Total duration: 2 months
Aerobic/resistance/mix: aerobic
Frequency: walking: 2 sessions daily; cycling: 4 sessions/week
Duration: walking: 1 hour; cycling: 45 minutes
Intensity: walking: not reported; cycling: 60% to 70% peak VO
Modality: walking and cycling
Setting: centre-based; supervised by physicians
Other: exercise groups received educational sessions and low-fat meals prepared 3 times
daily
Control group / Comparison:
Usual clinical follow-up
Outcomes Hospitalisation, mortality
Country and setting Switzerland
Single centre
Follow-up 2 months and 12 months (after randomisation)
Notes “After the initial 2-months exercise training or control period, both groups were encour-
aged to remain physically active over the subsequent 10 months, although no formal
program was implemented”
Source of funding: supported in part by a grant from Schweizerische Herzstiftung,
Switzerland
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
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Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Although not explicit, participants appeared to be analysed ac-
cording to the initial random allocation
Incomplete outcome data? Low risk Losses to follow-up were reported
Groups balanced at baseline? Low risk “No differences were observed between the 2 groups initially
in clinical or demographic data, including age, height, weight,
resting blood pressure, pulmonary function, ejection fraction,
or maximal oxygen uptake”
Groups received same intervention? Low risk Yes, both groups appeared to receive the same interventions,
apart from the CR intervention
Nilsson 2008
Methods Parallel-group RCT
Participants N randomised: 80 (exercise 40, control 40)
Diagnosis (% of participants):
Aetiology: ischaemic cardiomyopathy 69%, idiopathicDCM18%, hypertensiveHF13%
NYHA: Class II 47%, Class III 35%
LVEF: exercise 31% (SD 8), control 31% (SD 9)
Case mix: 100%, as above
Age, years: 70.1 (SD 7.9)
Male: 79%
White: not reported
Inclusion/exclusion criteria:
Inclusion: stable CHF and LVEF < 40% or ≥ 40% with clinical symptoms of diastolic
HF
Exclusion: acute MI within 4 weeks; unstable angina pectoris; serious rhythm distur-
bance; symptomatic PVD; severe COPD, with forced expiratory vital capacity < 50%
of expected measured by spirometry; 6-minute walking distance > 550 m; workload on
the cycle ergometer test > 110 watts; significant co-morbidities that would prevent entry
into the study due to terminal disease or inability to exercise (e.g. severe musculoskeletal
disorder, advanced valvular disease); in long-term care establishment
Interventions Exercise:
Total duration: 4 months
Aerobic/resistance/mix: aerobic
Frequency: 2 sessions/week
Duration: 50 minutes
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Intensity: 15 to 18 on Borg scale
Modality: fast walking, side-stepping, and leg lifts in combination with overhead arm
reaches
Setting: hospital outpatient department
Other: 15 to 30 minutes of counselling with CHF nurse for participants in the exercise
group (4 hours in total)
Control group / Comparison:
Control group was not provided with exercise prescriptions and was encouraged to
continue usual levels of physical activity
Outcomes HRQoL (MLWHF questionnaire); mortality
Country and setting Norway
Single centre
Follow-up 12 months (after randomisation)
Notes All training sessions were supervised by a physiotherapist - a specialist in heart rehabili-
tation
Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “computer-generated table of random numbers”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Three physicians and 3 nurses who were blinded to the clinical
data and group assignments of the patients carried out all the
follow-up tests. Patients were told not to reveal to which groups
they belonged”
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk “Intention-to-treat analyses were performed”
Incomplete outcome data? Low risk 35/40 (88%) in the exercise training group and 37/40 (93%) in
the control group were available at 12 months
Groups balanced at baseline? Low risk Table 1 of the publication suggests no differences between the
2 groups
Groups received same intervention? Low risk Yes
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Norman 2012
Methods Parallel-group RCT
Participants N randomised: 42 (exercise 22, control 20)
Diagnosis (% of participants):
Aetiology: ischaemic 50%, non-ischaemic 50%
NYHA: Class II: exercise 64%, control 45%; Class III: exercise 36%, control 55%
LVEF: exercise: mean 33% (SD 7), control: mean 32% (SD)
Age, years: exercise 57 (SD 12), control 63 (SD 15)
Male: 57.5%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age≥ 21 years with HF; oriented to person, place, and time; able to speak and
read English; resting LVEF≤ 40% and stable on optimal medical therapy for at least 30
days
Exclusion: clinical evidence of decompensated HF; unstable angina pectoris; MI; coro-
nary artery bypass surgery; biventricular pacemaker < 3 months ago; orthopaedic or neu-
romuscular limitations preventing participation in aerobic or resistance exercise training;
participation in an aerobic exercise programme during the past 12 months
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: mix
Frequency: aerobic 3 days/week, resistance 2 days/week
Duration: aerobic: 30minutes/session (30minutes’ warm-up); resistance: 8 to 10 exercises
(upper and lower extremities) performed for 1 set of 10 to 15 repetitions
Intensity: aerobic: 40% to 70% HR reserve, or Borg 11 to 14; resistance: not reported
Modality: aerobic: not reported; resistance: weightmachines, free weights, or elastic bands
based on exercise performance
Setting: 3 weeks: supervised, 21 weeks: hospital’s wellness centre or home
Other: group meetings that addressed the same educational topics as were addressed in
the control group but also information on problem-solving barriers to exercise, relapse
management, and symptoms experienced during exercise
Control group / Comparison:
“Attention control”
Instructions to continue with normal level of activity; no instructions given to withhold
or stop activity
Outcomes HRQoL (KCCQ); SF-36; mortality
Country and setting USA
Single centre
Follow-up 24 weeks (after randomisation)
Notes Study conducted in 2 sequential 12-week phases
Phase 1: separate weekly group meetings of both groups during weeks 1 to 3, then
separate biweekly meetings during weeks 4 to 12
Phase 2: following the groups for an additional 12 weeks without group sessions
Other trial report:
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Norman 2012 (Continued)
Pozehl B, Duncan K, Hertzog M, Norman JF. Heart failure exercise and training camp:
effects of a multicomponent exercise training intervention in patients with heart failure.
Heart Lung 2010;39(6 Suppl):S1-13
Source of funding:R-15 AREAGrant from theNational Institute of Health (#NR0092
15-01)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
High risk “Research assistants who were blinded to group assignment as-
sisted in some of the data collection. However, because of bud-
get constraints, the investigators who were not blinded to group
assignment were also involved in data collection”
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Not stated, but groups were analysed according to randomised
allocation
Incomplete outcome data? Low risk Due to mortality and dropout, KCCQ scores were available for
37 participants (88%) at 24 weeks
Groups balanced at baseline? Low risk “…no significant difference noted between groups”
Groups received same intervention? Low risk Both groups received group sessions (attention control), so the
only difference between groups was the exercise-based interven-
tion
Passino 2006
Methods Parallel-group RCT
Participants N randomised: 85 (training 44, control 41)
Diagnosis (% of participants)*:
Aetiology: ischaemic 59%, DCM 41%
NYHA: Class I 16%, Class II 69%, Class III 34%
LVEF: training 35% (SD 9.3), control 32.3 (SD 14.1)
Case mix: 100%, as above
Age, years: exercise 60 (SD 13), control 61 (SD 13)
Male: 87%
White: not reported
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Passino 2006 (Continued)
Inclusion/exclusion criteria:
Inclusion: impaired left ventricular systolic function (EF < 45%) and exercise capacity
(peak VO < 25 mL/min/kg)
Exclusion: NYHA Class IV; MI or unstable angina < 6 months before the examination;
exercise-limiting disease; severe pulmonary or renal disease
*Baseline data available for only 85 participants
Interventions Exercise:
Total duration: 9 months
Aerobic/resistance/mix: aerobic
Frequency: > 3 sessions/week
Duration: 30 minutes/session
Intensity: 65% max VO
Modality: cycle
Setting: home-based
Other: not reported
Control group / Comparison:
Not reported
Outcomes HRQoL (MLWHF questionnaire)
Morbidity
Country and setting Italy
Not reported
Follow-up 9 months (after randomisation)
Notes Source of funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Exercise test assessor was blinded
Selective reporting (reporting bias) Unclear risk Not reported
Intention-to-treat analysis? Low risk Although ITT was not stated, groups appear to have been anal-
ysed according to the original randomisation
Incomplete outcome data? Low risk Outcomes described in the methods were reported in the results
105Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Passino 2006 (Continued)
Groups balanced at baseline? Low risk “The two groups did not differ as to age, gender, NYHA func-
tional class, EF, pharmacologic treatment, or HF etiology (Table
1)”
Groups received same intervention? Low risk “Patients in [control] group underwent follow-up visits at the
third and ninth month to exclude changes in their usual lifestyle
and physical activity”
Pozehl 2008
Methods Parallel-group RCT
Participants N randomised: 21 (exercise 15, control 6)
Diagnosis (% of participants):
Aetiology: ischaemic 71%, non-ischaemic 29%
NYHA: Class II 39%, Class III 52%, Class IV 9%
LVEF: exercise 27.9% (SD 7.0), control 29.7% (SD 8.7)
Case mix: 100%, as above
Age, years: exercise 66.3 (SD 9.6), control 66 (SD 12.6)
Male: 90%
White: 100%
Inclusion/exclusion criteria:
Inclusion: ability to speak and read English; stable NYHA Class II to IV; no change in
medical therapy for 30 days; resting LVEF < 40% as measured by echocardiography or
gated equilibrium radionuclide angiography; medical diagnosis of HF ischaemic or non-
ischaemic; standard pharmacological therapy for HF (diuretics, angiotensin-converting
enzyme inhibitors, and beta blockers)
Exclusion: participation in a formal exercise programme < 30 days before this study;
clinical evidence of decompensated HF; any of the following medical conditions: AF,
acute MI < 3 months, unstable angina pectoris, end-stage renal disease, or orthopaedic
impediments to exercise
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: mix
Frequency: 3 sessions/week
Duration: 30 minutes aerobic, 20 minutes resistance
Intensity: 60% to 85% max VO , 12 to 14 Borg scale
Modality: aerobic: treadmill, stationary bike, rower, arm ergometer; resistance: light upper
body exercises (military press, biceps curl, lateral deltoid raises), and lower body exercises
(knee extension, side hip raise, hip extension) with 1 to 10 lb hand and ankle weights.
Wall push-ups, abdominal curl-ups, pelvic tilts, or a combination
Setting: first 12 weeks at the hospital and remaining sessions were unsupervised at the
rehabilitation centre
Other: strategies from social learning theory (goal-setting, feedback, problem-solving
guidance) utilised to facilitate, improve adherence to the training programme
Control group / Comparison:
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Pozehl 2008 (Continued)
Usual medical care
Outcomes Mortality
Country and setting USA
Single centre
Follow-up 6 months (after randomisation)
Notes Source of funding: AmericanHeart Association #9806406S andUniversity of Nebraska
Medical Center #OC-10-98
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk Outcomes described in the methods were reported in the results
Intention-to-treat analysis? Low risk Although not stated, groups appear to have been analysed ac-
cording to the initial randomised allocation
Incomplete outcome data? Low risk “One subject in the control group died of myocardial infarction
and one subject in the exercise training group was diagnosed
with cancer and unable to continue the exercise training”
No imputation undertaken
Groups balanced at baseline? Low risk “Subjects did not differ in fatigue or dyspnea by type of HF
(ischemic vs. nonischemic) or years since diagnosis ofHF (length
of time since diagnosis)”
Groups received same intervention? Unclear risk Not reported
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Reeves 2017
Methods Parallel-group RCT
Participants N randomised: 27 (exercise 15, control 12)
Diagnosis (% of participants):
Aetiology: preserved EF: exercise 42%, control 40%
NYHA: not reported
LVEF: exercise 40 ± 13%, control 34 ± 18%
Case mix: 100%, as above
Age, years: exercise 72.7 (SD 10.8), control 71.8 (SD 9.1)
Male: exercise 47%, control 33%
White: 47% in exercise group, 42% in control group
Inclusion/exclusion criteria:
Inclusion: ADHF diagnosed by acute worsening of HF symptoms; at least 1 sign of HF
and change in medical treatment consistent with HF; aged ≥ 60 years; independence
with basic activities of daily living before hospitalisation; achievement of clinical stability
allowing study participation; ability to ambulate at least 4 m; planned return home post
discharge
Exclusion: acute coronary syndrome, severe aortic stenosis, end-stage HF requiring ad-
vanced therapies or home intravenous inotropic therapy, functional status limited by
condition other than HF at the time of enrollment, advanced chronic kidney disease
defined as estimated glomerular filtration rate 20mL/min/1.73m², terminal illness other
than HF, active participation in supervised exercise training before hospitalisation, in-
ability or unwillingness to adhere with the study protocol
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: mix
Frequency: 3 sessions/week
Duration: 60 minutes
Intensity: individually tailored: initially low intensity, rising to 13 (“somewhat hard”) on
self-reported score
Modality: endurance and strength training
Setting: hospital (supervised) and home (unsupervised)
Other: components of exercise include static and dynamic balance training (e.g. standing
with narrow base of support, standing and reaching); mobility training (e.g. dynamic
start and stop, changing direction while walking); functional strength training focused
on lower extremities (e.g. chair rise; step-ups); endurance training (sustained walking
preferred)
Control group / Comparison:
Usual care (regular physician visits with medication adjustments) plus regular contact
with study personnel
Outcomes All-cause hospital admissions
Country and setting USA
Multi-centre
Follow-up 6 months
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Reeves 2017 (Continued)
Notes Exercise was individually tailored and was delivered by trained internationalists in hos-
pital over 12 weeks along with a home exercise prescription (unsupervised low-intensity
walking at usual pace for up to 30minutes and simple functional strengthening exercises)
Source of funding: NIH Grants R01AG045551 and R01AG18915; The Claude D.
Pepper Older Americans Independence Centre ofWake Forest School ofMedicine Win-
ston-Salem, NC, NIH Grant P30AG021332; the Kermit Glenn Phillips II Endowed
Chair in Cardiology; Dean’s Faculty Achievement, Jefferson Glenn Philips II Endowed
Chair in Cardiology; Dean’s Faculty Achievement Award, Jefferson College of Health
Professions, Philadelphia, PA; and Oristano Family Research Fund
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were randomized using a computer-generated list
SAS software”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “Follow-up assessments were collected by trained, blinded asses-
sors according to standardized protocols”
Selective reporting (reporting bias) Low risk
Intention-to-treat analysis? Low risk “Intention-to-treat analysis performed for all-cause hospital ad-
missions, with comparisons made using analysis of covariance
with heart failure category (ejection fraction <45% or ≥45%)”
Incomplete outcome data? Unclear risk Three dropouts from total (N = 24) but no further details or
reasons given
Groups balanced at baseline? Low risk “Baseline characteristics were balanced between the study arms”
Groups received same intervention? Low risk Control group received “attention” consisting of at leastmonthly
contact with study personnel via scheduled phone calls and fol-
low-up assessments
Wall 2010
Methods Parallel-group RCT
Participants N randomised: 19 (exercise 9, control 10)
Diagnosis (% of participants):
Aetiology: not reported
NYHA: mean exercise 2 (SE 0), mean control 2.13 (SE 0.13)
LVEF: ≤ 60%
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Wall 2010 (Continued)
Case mix: as above
Age, years: exercise 69 (SD 4.44), control 70 (SD 4.05)
Male: 58%
White: 100%
Inclusion/exclusion criteria:
Inclusion: diagnosis of NYHA Class I to III congestive HF; EF≤ 60%; systolic dysfunc-
tion; physician approval; ability to complete a minimum of 3 minutes of a modified
Bruce protocol stress test
Exclusion: failure to meet any of the inclusion criteria; inability to speak English; notice-
able cognitive impairment
Interventions Exercise:
Total duration: 12 months
Aerobic/resistance/mix: aerobic
Frequency: 3 sessions/week
Duration: > 15 minutes
Intensity: not reported
Modality: treadmill
Lifestyler® treadmill provided for 1 year of in-home use; 3 supervised exercise sessions
at hospital with CR specialist. Weekly in-home exercise visits with CR specialist, month
1. Monthly in-home exercise visits with CR specialist, months 2 to 12. Also received
comprehensive disease management programme
Setting: 3 hospital based; the remainder at home
Other: not reported
Control group / Comparison:
Comprehensive disease management - by dedicated case manager (participant education
on nutrition, medications, and disease management; an oximetry assessment; constant
monitoring of symptomatic changes and disease status)
Outcomes Disease-specific HRQoL (Chronic Heart Failure Questionnaire), mortality
Country and setting USA
Single centre
Follow-up 12 months (after randomisation)
Notes Source of funding: ATPM/CDC/ATSDR Cooperative Agreement No. U50/
CCU300860
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
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Wall 2010 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported
Intention-to-treat analysis? Low risk Although not stated, it is clear from the CONSORT diagram
that 2 groups were analysed according to ITT
Incomplete outcome data? Low risk QUORUM flow diagram report suggests that 19 were included
in the analysis
15 participants (79%) completed final follow-up measures at
month 12
Groups balanced at baseline? Low risk Table 3 of the publication suggests there is no difference between
the 2 groups (except dyspnoea score)
Groups received same intervention? Low risk Both groups received comprehensive disease management
Willenheimer 2001
Methods Parallel-group RCT
Participants N randomised: 54 (exercise 27, control 27)
Diagnosis (% of participants):
Aetiology: ischaemic 80%, non-ischaemic 20%
NYHA: exercise 2.1 (SD 0.7), control 2.4 (0.7)
LVEF: exercise 35% (SD 12), control 38% (SD 10)
Case mix: 100%, as above
Age, years: exercise 64 (SD 5), control 64 (SD 9)
Male: exercise 73%, control 70%
White: not reported
Inclusion/exclusion criteria:
Inclusion: 8 points on Boston heart failure criteria; LVEF 0.45 at the most recent ra-
dionuclide or echocardiographic examination (not older than 1 year at inclusion); age
75 years
Exclusion: change in clinical status or medication (or both) within 4 weeks before in-
clusion; MI, heart surgery, or coronary angioplasty within 3 months before inclusion;
inability to perform a bicycle test; exercise-terminating angina pectoris, ST depressions
(> 2 mm in > 1 lead), blood pressure fall (>.10 mm Hg), or arrhythmia (e.g. ventricu-
lar tachycardia/fibrillation, ventricular extrasystoles, supraventricular tachycardia > 170
bpm) at the most recent maximal exercise test (including the baseline test); pulmonary
disease judged to be the main exercise-limiting factor or peak expiratory flow rate < 50%
of age- and sex-adjusted reference values, or both; NYHA Class IV; clinically significant
aortic stenosis
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Willenheimer 2001 (Continued)
Interventions Exercise:
Total duration: 4 months
Aerobic/resistance/mix: aerobic/interval
Frequency: 2 to 3 sessions/week
Duration: 15 minutes/session, increasing to 45 minutes/session
Intensity: 80% peak VO , or 15 on Borg score
Modality: cycle ergometry
Setting: group sessions supervised by physiotherapist
Other: none
Control group / Comparison:
Control participants were asked to not change their degree of physical activity during the
active study period. Neither training participants nor controls were instructed regarding
physical activity during the 6-month extended follow-up
Outcomes HRQoL (Patient’s Global Assessment of Quality of Life); mortality
Country and setting Sweden
Single centre
Follow-up 10 months (after randomisation)
Notes Source of funding: Swedish Society for Patients With Heart and Lung Diseases
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome assessors blinded; participants, clinical carers not
blinded
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Although ITT is not implicit, it appears that groups were anal-
ysed according to the original randomised allocation
Incomplete outcome data? High risk Outcomes were available for only 43/54 (80%) participants ran-
domised at 10 months’ follow-up. No imputation or sensitivity
analysis was undertaken to assess effects of loss to follow-up.
Study authors stated that participants available at 10 months’
follow-up are representative
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Willenheimer 2001 (Continued)
Groups balanced at baseline? Low risk “There was no difference between training (n = 22) and control
(n = 27) patients as regards baseline variables”
Groups received same intervention? Low risk “No change in medication allowed during study”
Witham 2005
Methods Parallel-group RCT
Participants N randomised: 82 (exercise 41, control 41)
Diagnosis (% of participants):
Aetiology: IHD 66%
NYHA: Class II 56%, Class III 44%
LVEF: not reported
Case mix: as above
Age, years: exercise 80 (SD 6), control 81 (SD 4)
Male: 55%
White: not reported
Inclusion/exclusion criteria:
Inclusion: age ≥ 70 years with clinical diagnosis of CHF according to European Society
of Cardiology guidelines; NYHA Class II or III symptoms and evidence of LVSD on
echocardiography, contrast ventriculography, or radionuclide ventriculography; evidence
of LVSD
Exclusion: uncontrolled AF, significant aortic stenosis, sustained ventricular tachycardia,
recent MI, inability to walk without human assistance, abbreviated mental score < 6 of
10, currently undergoing physiotherapy or rehabilitation
Interventions Exercise:
Total duration: 6 months
Aerobic/resistance/mix: mix
Frequency: 2 to 3 sessions/week
Duration: 20 minutes
Intensity: Borg 11 to 13
Modality: walking and wrist/ankle weights
Setting: 3 months: hospital-based by senior physiotherapist; 3 months: home-based
After 3 months of supervised training, participants in the exercise group were asked to
continue to perform exercises at home 2 or 3 times/week with the aid of video or audio
cassette with demonstrations, instructions, and music. No face-to-face contact was had
with the physiotherapist during this period
Other: not reported
Control group / Comparison:
Usual medical care
Outcomes Disease-specific health-related quality-of-life (Guyatt Chronic Heart Failure Question-
naire); mortality; hospitalisation
Country and setting UK
Single centre
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Witham 2005 (Continued)
Follow-up 6 months (after randomisation)
Notes Source of funding:Grant 2006/918 fromTheHealth Foundation (formerly PPPHealth
Foundation), London, United Kingdom
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A researcher not otherwise connected with the operation of the
study prepared cards contained in numbered, sealed envelopes
from computer-generated random number tables”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk “An experienced research nurse who was blinded to treatment
allocation performed all assessments”
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk It appears from the QUORUM diagram that groups were anal-
ysed according to the initial random allocation
Incomplete outcome data? Low risk 75/82 (91%) and 68/82 (83%) were available at 3 months’ and
6 months’ follow-up, respectively
Groups balanced at baseline? Low risk Table 1 of the publication shows that groups were well balanced
Groups received same intervention? Low risk Yes, both groups appear to have received usual medical care; the
only difference between groups was the exercise intervention
Witham 2012
Methods Parallel-group RCT
Participants N randomised: 107 (exercise 53, control 54)
Diagnosis (% of participants):
Aetiology: ischaemic 62.6%
NYHA: Class II 79%, Class III 21%
LVEF: not reported
Case mix: as above
Age, years: exercise 80.4 (SD 5.8), control 79.5 (SD 4.9)
Male: exercise 35%; control 37%
White: 100%
Inclusion/exclusion criteria:
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Witham 2012 (Continued)
Inclusion: age ≥ 70 years with confirmed diagnosis of HF due to LVSD (NYHA Class
II and III) and history of symptoms and signs of congestive HF
Exclusion: wheelchair bound, unwilling or unable to give informed consent, aortic steno-
sis with peak gradient > 30 mmHg, sustained ventricular tachycardia or ventricular fib-
rillation outside the context of an acute MI, currently (within the past month) with
unstable angina or AF with ventricular rate > 100/min
Interventions Exercise:
Total duration: 24 weeks
Aerobic/resistance/mix: mix
Frequency: 2 sessions/week
Duration: ≤ 60 minutes
Intensity: not reported
Modality: home, walking
Setting: hospital and home*
Other: cognitive and behavioural techniques were incorporated into first 8-week hospi-
tal-based rehabilitation; resistance training with elasticised bands
Control group / Comparison:
Usual medical care (given a booklet with general advice on diet, exercise, and lifestyle);
not discouraged from exercising if already in the habit of doing so
Outcomes Disease-specific HRQoL (MLWHF questionnaire); HRQoL (EuroQoL-5D); mortality;
hospital admission; cost
Country and setting UK
Single centre
Follow-up 24 weeks (after randomisation)
Notes *8 weeks in hospital delivered by experienced physiotherapist, 16-week home-based
(telephoned every 2 weeks for 8 weeks by physiotherapists, then monthly for the final 8
week)
Source of funding:Chief Scientist Office (Scottish Government), Grant number CZH/
4/426
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Using off-site telephone randomization service, randomization
was performed without stratification and with block sizes be-
tween 8 and 16, depending on the size of each planned exercise
class”
Allocation concealment (selection bias) Low risk “…the project coordinator passed the participants’ details to the
research physiotherapist who obtained group allocation, ensur-
ing that the project coordinator remained blind to group assign-
ments”
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Witham 2012 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk Analyses were by ITT
Incomplete outcome data? Low risk 89/104 (86%) and 87/104 (83%) were available for follow-up
at 8 and 24 weeks, respectively
Groups balanced at baseline? Low risk Table 1 of the publication suggests no differences between the
2 groups
Groups received same intervention? Low risk It appeared that both groups received the same care, except for
the exercise intervention
Yeh 2011
Methods Parallel-group RCT
Participants N randomised: 100 (Tai Chi (exercise) 50, education (control) 50)
Diagnosis (% of participants):
Aetiology: ischaemic 54%, non-ischaemic 46%
NYHA: Class I 20%, Class II 63%, Class III 17%
LVEF: mean 29% (SD 8%)
Case mix: 100%, as above
Age, years: exercise 68.1 (SD 11.9), control 66.6 (SD 12.1)
Male: 64%
White: 86%
Inclusion/exclusion criteria:
Inclusion: EF ≤ 40% in past 2 years, stable medical regimen, NYHA Class I to III HF
Exclusion: unstable angina, MI, or major surgery in past 3 months; history of cardiac ar-
rest in past 6 months; history of cardiac re-synchronisation therapy in the past 3 months;
unstable serious ventricular arrhythmias; unstable structural valve disease; current par-
ticipation in conventional CR programme; diagnosis of peripartum cardiomyopathy
within preceding 6 months; inability to perform a bicycle stress test; lower extremity
amputation or other inability to ambulance owing to condition other than HF; severe
cognitive dysfunction (Mini-Mental State Examination score ≤ 24); inability to speak
English; regular practice of Tai Chi
Interventions Exercise:
Total duration: 12 weeks
Aerobic/resistance/mix: aerobic
Frequency: 2 sessions/week (for 12 weeks) and encouraged to practice at home at least 3
times/week
Duration: 1-hour class (30 minutes’ warm-up)
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Yeh 2011 (Continued)
Intensity: not reported
Modality: Tai Chi movements
- Weeks 2 to 5: warm-up + raising the power; withdraw and push
- Weeks 6 to 9: 1 + grasp sparrow’s tail, brush knee twist step
- Weeks 10 to 12: 2 + wave hands like clouds
Participants were given 45-minute instructional videotape that outlined the exercises
presented in class as an aid to practice
Participants also received the same educational pamphlets used in the education (control)
group, with a brief (< 5 minutes) explanation towards the end of 1 Tai Chi session weekly
Setting: centre-based and home-based
Other: none reported
Control group / Comparison:
Educational group (’attention control’): nurse practitioner-led educational session (same
duration and frequency as Tai Chi group classes)
Participants were asked to not start Tai Chi classes during the study
Outcomes HRQoL (MLWHF questionnaire); mortality; hospital admission
Country and setting USA
Multi-site
Follow-up 12 weeks and 6 months (after randomisation)
Notes Single-blind
Source of funding: ROI AT002454 Award from the National Center for Complemen-
tary and Alternative Medicine; in part by RR 01032 from the Beth Isreal Deaconess
Medical Center General Clinical Research Center from the National Institutes of Health
(NIH)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The trial uses a permuted block randomization with variable
block size to generate treatment assignment”
Allocation concealment (selection bias) Unclear risk “Patients who chose to were randomly assigned to receive a 12-
week tai chi exercise program or a heart health education pro-
gram (attention control)”
Blinding (performance bias and detection
bias)
All outcomes
Low risk “We masked all the study staff performing all tests to each par-
ticipant’s group allocation”
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the
results
Intention-to-treat analysis? Low risk All participants were included in the analysis regardless of their
attendance
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Yeh 2011 (Continued)
Incomplete outcome data? Low risk Figure 1 of the publication shows 91% to 96% complete data
across HRQoL and exercise outcomes
Groups balanced at baseline? Low risk “The 2 groups were generally similar in demographics, clinical
classification of heart disease severity, and rates of comorbidities”
Groups received same intervention? Low risk Yes, both groups received comprehensive disease management
ACE: angiotensin-converting enzyme; AF: atrial fibrillation; BL: baseline; bpm: beats/min; CBT: cognitive-behavioural therapy; CHF:
chronic heart failure; CONSORT: CONsolidated Standards of Reporting Trials; COPD: chronic obstructive pulmonary disease;
CR: cardiac rehabilitation; CRT: cardiac re-synchronisation therapy; DCM: dilated cardiomyopathy; DM: diabetes mellitus; DSM-
IV: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; EF: ejection fraction; EQ-5D: EuroQoL Group Quality
of Life Questionnaire based on 5 dimensions; EQ-5D-3L: EuroQoL Group Quality of Life Questionnaire based on a 3-level
scale; GP: general practitioner; HADS: Hospital Anxiety and Depression Scale; HAM-D: Hamilton Depression Rating Scale; HF:
heart failure; HFrEF: heart failure with reduced ejection fraction; HR: heart rate; HRQoL: health-related quality of life; ICD:
implantable cardioverter-defibrillator; IHD: ischaemic heart disease; ITT: intention-to-treat; KCCQ: Kansas City Cardiomyopathy
Questionnaire; LVEDD: left ventricular end-diastolic diameter; LVEF: left ventricular ejection fraction; LVSD: left ventricular systolic
dysfunction; max: maximum; MDMP: XXX; MET: metabolic equivalent; MI: myocardial infarction; MOS: Medical Outcomes
Survey;MLWHF:Minnesota LivingWithHeart Failure questionnaire;MR:mitral regurgitation;MRI: magnetic resonance imaging;
NIH: National Institutes of Health; NIHR: National Institute for Health Research; NYHA: New York Heart Association; PVD:
peripheral vascular disease; RCT: randomised controlled trial; RPE: rate of perceived exertion; SC: subcutaneous; SD: standard
deviation; SE: standard error; SF-36: Short Form-36; SPPB: Short Physical Performance Battery; STEMI: ST-elevation myocardial
infarction; UC: usual care; VO : oxygen consumption.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abreu 2015 Relevant outcomes not reported. EmailedAbreu on 18October 2018 to clarify outcomes but received
no response
Adamopoulos 2001 Relevant outcomes not reported. Attempt to contact Adamopolous on 4 October 2018 to clarify
outcomes was unsuccessful
Agvall 2013 Not exercise-based cardiac rehabilitation intervention
Ahmad 2014 Relevant outcomes not reported. Emailed Ahmad on 18 October 2018 to clarify outcomes but
received no response
Alves 2012 Relevant outcomes not reported. Attempt to contact Alves on 4 October 2018 to clarify outcomes
was unsuccessful
Ambrosy 2016 < 6 months’ follow-up
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(Continued)
Ambrosy 2017 No usable data
Aronov 2015 Abstract - study authors contacted; no usable data provided
Ascione 2013 < 6 months’ follow-up
Bachman 2015 Inappropriate intervention - hawthorn extract
Banks 2015 < 6 months’ follow-up
Barrow 2008 < 6 months’ follow-up
Belardinelli 2005 < 6 months’ follow-up
Belardinelli 2013 Not a randomised controlled trial
Bernocchi 2016 Combined population with chronic obstructive pulmonary disease and heart failure
Bittencourt 2015 < 6 months’ follow-up
Borland 2014 < 6 months’ follow-up
Boyd 2015 Relevant outcomes not reported. Emailed Boyd on 18October 2018 to clarify outcomes but received
no response
Brand 2014 Abstract - study authors contacted; no usable data provided
Briffa 2005 No heart failure
Brotons 2009 No exercise-based cardiac rehabilitation intervention
Cameron 2015 No exercise-based cardiac rehabilitation intervention - memory training
Chang 2005 Relevant outcomes not reported. Attempt to contact Chang on 4 October 2018 to clarify outcomes
was unsuccessful
Chrysohoou 2013 < 6 months’ follow-up
Chrysohoou 2014 < 6 months’ follow-up
Chrysohoou 2016 < 6 months’ follow-up
Coats 1992 < 6 months’ follow-up
Collins 2004 < 6 months’ follow-up
Corvera-Tindel 2004 < 6 months’ follow-up
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Cowie 2011 < 6 months’ follow-up
Cowie 2012 < 6 months’ follow-up
Deng 2006 Relevant outcomes not reported. Attempt to contact Deng on 4 October 2018 to clarify outcomes
was unsuccessful
Dingli 2002 Relevant outcomes not reported. Attempt to contact Xu on 4 October 2018 to clarify outcomes was
unsuccessful
Doukky 2016 No exercise-based cardiac rehabilitation intervention
Duncan 2014 Relevant outcomes not reported. Emailed Duncan on 18 October 2018 to clarify outcomes but
received no response
Edelmann 2011 < 6 months’ follow-up
Erbs 2003 Relevant outcomes not reported. Emailed Erbs on 4 October 2018 to clarify outcomes but received
no response
Erbs 2010 Relevant outcomes not reported. Emailed Erbs on 4 October 2018 to clarify outcomes but received
no response
ExTraMATCH 2004 Meta-analysis
Fernhall 2013 Not a randomised controlled trial
Fischer 2015 Wrong population - animal model
Franco 2006 < 6 months’ follow-up
Fu 2013 < 6 months’ follow-up
Galenko 2016 No usable data - assessment tool used to measure HRQoL not stated
Gary 2004 Relevant outcomes not reported. Attempt to contact Gary on 4 October 2018 to clarify outcomes
was unsuccessful
Gary 2007 < 6 months’ follow-up
Gelbrich 2014 No exercise-based cardiac rehabilitation intervention
Haykowsky 2007 Meta-analysis
Hollriegal 2016 Relevant outcomes not reported. Emailed Hollriegal on 18 October 2018 to clarify outcomes but
received no response
Huang 2014 Abstract - study authors contacted; no usable data
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Hwang 2015 No exercise-based cardiac rehabilitation intervention
Hwang 2016 Relevant outcomes not reported. Emailed Hwang on 18 October 2018 to clarify outcomes but
received no response
Inglis 2006 Inappropriate intervention - exercise advice only
Jónsdóttir 2006b < 6 months’ follow-up
Kaltsatou 2013 Duplicate
Kelly 2016 Not a randomised controlled trial
Keteyian 2016 Not a randomised controlled trial
Kiilavuori 1999 Relevant outcomes not reported. Attempt to contactKiilavuori on 4October 2018 to clarify outcomes
was unsuccessful
Kitzman 2010 < 6 months’ follow-up
Kitzman 2013 < 6 months’ follow-up
Kitzman 2016 Not a randomised controlled trial
Kobayashi 2003 Relevant outcomes not reported. Emailed Kobayashi on 4 October 2018 to clarify outcomes but
received no response
Kolesnikova 2015 Abstract - study authors contacted; no usable data
Korzeniowska-Kubacka 2010 Not a randomised controlled trial
Koufaki 2014 Comparator contained exercise training
Koukoui 2015 Not a randomised controlled trial
Larsen 2016 Not a randomised controlled trial
Lewinter 2014 Abstract - study authors contacted; no usable data
Lloyd-Williams 2002 Meta-analysis
Masterson 2014 Relevant outcomes not reported. Attempt to contact Masterson on 18 October 2018 to clarify
outcomes was unsuccessful
McCarthy 2013 Not a randomised controlled trial
Mediano 2016 Not a randomised controlled trial
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Mehralian 2014 Inappropriate intervention - education only
Mendes 2014 Not a randomised controlled trial
Meyer 2005 Relevant outcomes not reported. EmailedMeyer on 4 October 2018 to clarify outcomes but received
no response
Molloy 2006 Relevant outcomes not reported. EmailedMolloy on 4October 2018 to clarify outcomes but received
no response
Myers 2001 Relevant outcomes not reported. Myers contacted on 4 October 2018 and confirmed no relevant
outcomes were measured
Myers 2002 Relevant outcomes not reported. Myers contacted on 4 October 2018 and confirmed no relevant
outcomes were measured
Myers 2007 Relevant outcomes not reported. Myers contacted on 4 October 2018 and confirmed no relevant
outcomes were measured
Newton 2013 Abstract - study authors contacted; no usable data
Niebauer 2005a Relevant outcomes not reported. Emailed Niebauer on 4 October 2018 to clarify outcomes but
received no response
Niebauer 2005b Relevant outcomes not reported. Emailed Niebauer on 4 October 2018 to clarify outcomes but
received no response
Oka 2000 Relevant outcomes not reported. Emailed Oka on 4 October 2018 to clarify outcomes but received
no response
Oliveira 2015 < 6 months’ follow-up
Owen 2000 < 6 months’ follow-up
Parnell 2002 < 6 months’ follow-up
Passino 2008 Relevant outcomes not reported. Emailed Passino on 4October 2018 to clarify outcomes but received
no response
Pinto 2015 Relevant outcomes not reported. Attempt to contact Pinto on 18 October 2018 to clarify outcomes
was unsuccessful
Piotrowicz 2015 < 6 months’ follow-up
Ponikowski 1997 < 6 months’ follow-up
Pozehl 2003 < 6 months’ follow-up
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Pu 2001 Relevant outcomes not reported. Emailed Pu on 4 October 18 to clarify outcomes but received no
response
Roscani 2016 < 6 months’ follow-up
Sabelis 2004 Relevant outcomes not reported. Emailed Sabelis on 4October 2018 to clarify outcomes but received
no response
Santos 2015 Relevant outcomes not reported. Attempt to contact Santos on 18 October 2018 to clarify outcomes
was unsuccessful
Sarullo 2006 < 6 months’ follow-up
Scalvini 2016 Inappropriate comparator - control group received inpatient rehabilitation
Schuang 2014 Inappropriate intervention - education advice only
Selig 2004 < 6 months’ follow-up
Senden 2005 Relevant outcomes not reported. Emailed Senden on 4October 2018 to clarify outcomes but received
no response
Smart 2004 Meta-analysis
Smart 2007 < 6 months’ follow-up
Smolis-Bak 2015 Inappropriate comparator - control group received inpatient rehabilitation
Smolis-Bak 2017 Inappropriate comparator - control group received inpatient rehabilitation
Soska 2014 < 6 months’ follow-up
Stewart 1998 Inappropriate intervention - exercise advice only
Suna 2015 < 6 months’ follow-up
Sviridenko 2013 < 6 months’ follow-up
Takase 2015 < 6 months’ follow-up
Taylor-Piliae 2004 Meta-analysis
Tyni-Lenne 2001 < 6 months’ follow-up
van den Berg-Emons 2004 < 6 months’ follow-up
van Tol 2006 Meta-analysis
123Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Vasiliauskas 2007 Relevant outcomes not reported. Emailed Vasiliauskas on 4 October 2018 to clarify outcomes but
received no response
Von Oehsen 2013 < 6 months’ follow-up
Wagenaar 2014 No exercise-based cardiac rehabilitation intervention
Wielenga 1998 < 6 months’ follow-up
Williams 2007 Relevant outcomes not reported. Emailed Williams on 4 October 2018 to clarify outcomes but
received no response
Wisløff 2007 < 6 months’ follow-up
Yasushi 2015 Relevant outcomes not reported. Attempt to contact Yasushi on 18 October 2018 to clarify outcomes
was unsuccessful
Yeh 2004 < 6 months’ follow-up
Zhang 2003 < 6 months’ follow-up
Zhao 2005 Relevant outcomes not reported. Attempt to contact Zhao on 2018 to clarify outcomes was unsuc-
cessful
Characteristics of studies awaiting assessment [ordered by study ID]
ACTR12608000263392
Methods RCT
Participants 360 adults less than or equal to 6 weeks post acute admission to hospital with symptomatic congestive heart failure
as dominant clinical diagnosis
Interventions A supervised exercise programme consisting of 36 one-hour sessions of gym-based aerobic and resistance exercise
over 6 months with active encouragement of home-based exercise, administered in addition to an established disease
management programme including education, early review, telephone and outreach support, and optimal drug
titration. Comparator is an established disease management programme including education, early review, telephone
and outreach support, and optimal drug titration, as well as standard exercise advice
Outcomes Primary outcomes: all-cause 12-month death or re-admission
Secondary outcomes: depressive symptoms based on the Geriatric Depression Scale and the Cardiac Depression
Scale; time to first re-admission; time to first heart failure-related re-admission; number of hospitalisations; hospital
bed days occupied; days alive out of hospital; rates of adherence to exercise classes and educational sessions; exercise
adherence; walking capacity; functional decline; quality of life based on the Australian Quality of Life questionnaire;
programme costs; quality of sleep assessed by the Pittsburgh Sleep Quality Index
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Notes Note: the protocol is published and the trial has concluded. Results from an associated full RCT were published in
February 2018. This falls outside our search criteria; hence we have not included these data in this review update
ISRCTN86879094
Methods RCT
Participants Stable symptomatic HF with preserved ejection fraction (diagnosis according to criteria of the European Society of
Cardiology; Paulus 2007)
Interventions Experimental intervention: individually prescribed, supervised, combined endurance/strength training for 12
months (≥ 3 times/week)
Control intervention: usual care
Outcomes Primary:
• Combined outcome score (modified ’Packer score’; Packer 2001). This combined score classifies participants
as 1 (worsened), 0 (unchanged), or +1 (improved)
Secondary:
• Components of the primary endpoint (all-cause mortality, cardiovascular hospitalisations, change in NYHA
class, change in global self-assessment, change in peak VO
, change in E/e’)
• Change in echocardiographic parameters of diastolic function (left atrial volume index, grade of diastolic
function, E/e’, e’, ratio between early (E) and late (atrial - A) ventricular filling velocity (E/A), deceleration time,
isovolumic relaxation time), systolic function (LVEF), left ventricular dimensions (left ventricular end-diastolic
diameter), and structure (left ventricular mass index) after 6 months and 12 months
• Change in quality of life (SF-36, Minnesota Living With Heart Failure questionnaire, Hospital Anxiety and
Depression Scale) after 6 months and 12 months
• Change in ventilatory efficacy (VE/VCO
) and submaximal exercise capacity (anaerobic threshold, 6-minute walk distance) after 6 months and 12 months
• Change in neurohumoral activation (N-terminal pro brain natriuretic peptide) after 6 months and 12 months
• Safety and tolerability of training intervention
• Gender aspects of all primary and secondary endpoints
Notes Recruitment status: no longer recruiting. Trial shown as completed on 31.08.2015, on ISRCTN registry, but no
results posted. Study author contacted for further details
NCT01033591
Methods RCT
Participants Participants with HF with LVEF < 45%
Interventions Experimental: supervised exercise + optimised treatment according to European Society of Cardiology guidelines
No intervention: control optimised treatment according to European Society of Cardiology guidelines
Outcomes Primary outcomes:
• Change in HRQoL (SF-36 and Minnesota Living with Heart Failure Questionnaire)
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NCT01033591 (Continued)
Secondary outcomes:
• Change in functional capacity (6-minute walking test)
• Cardiac structural changes (B-type natriuretic peptide)
• Muscle strength (dynamometer)
• Body composition (fat and muscular weight)
All at 12 months
Notes Zuazagoitia A, Grandes G, Torcal J, Lekuona I, Echevarria P, Gómez MA, Domingo M, de la Torre MM, Ramírez
JI, Montoya I, Oyanguren J, Pinilla RO; EFICAR Group (Ejercicio Físico en la Insuficiencia Cardiaca). Rationale
and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality
of life of patients with HF in primary care: the EFICAR study protocol. BMC Public Health 2010;10:33
Protocol published
Recruitment status: unknown
Estimated study completion date: January 2015, on clinicaltrials.gov, but no results posted. Study author contacted
for further details
NCT01785121
Methods RCT
Participants 605 participants with HF (both patients with a preserved ejection fraction (HFpEF) and those with reduced ejection
fraction (HFrEF) can be included)
Interventions Patients randomised to the active intervention (Wii group) will be introduced to the Nintendo Wii game computer
in an introduction lesson of approximately 2 hours, and the Wii will be installed at home. During the first 3 months
after inclusion, participants will be phoned after 2, 4, 8, and 12 weeks to discuss their experiences with the Wii,
or to solve possible problems. Patients randomised to the control group (motivational support only) will receive
protocolised exercise advice from a member of the HF team (nurse, cardiologist, or physiotherapist). During the first
3 months after inclusion, participants will be phoned after 2, 4, 8, and 12 weeks to discuss their current activity
Outcomes HRQoL (Minnesota Living With Heart Failure Questionnaire (MLWHFQ))
Notes Protocol published. Trial completed April 2018, as reported on clinicaltrials.gov, but no results posted. Study authors
contacted for additional details
NCT02078947
Methods RCT
Participants 180 participants, 40 years of age and older, with heart failure with preserved ejection fraction
Interventions High-intensity exercise, moderate continuous exercise, or usual care
Outcomes Primary outcome measures:
Change in peak VO after 3 months
Secondary outcome measures:
Change in E/e’ (representing diastolic filling pressure) at baseline and at 3 months
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Change in E/e’ at baseline and at 12 months
Change in Peak VO at baseline and at 12 months
Change in NTproBNP at baseline and at 3 months
Change in NTproBNP at baseline and at 12 months
Change in health-related quality of life at baseline and at 3 months
Change in health-related quality of life at baseline and at 12 months
Change in left atrial volume index (LAVI) at baseline and at 3 months
Change in left atrial volume index (LAVI) at baseline and at 12 months
Change in e’ medial at baseline and at 3 months
Change in e’ at baseline and at 12 months
Change in submaximal exercise capacity at baseline and at 3 months
Change in submaximal exercise capacity at baseline and at 12 months
Change in VE/VCO slope at baseline and at 3 months
Change in VE/VCO slope at baseline and at 12 months
Change in flow-mediated dilation (FMD) at baseline and at 3 months
Change in flow-mediated dilation (FMD) at baseline and at 12 months
Notes Other study ID numbers: EU 602405-2; estimated study completion date: June 2018; reported on clinicaltrials.gov,
but no results posted. Study authors contacted
NCT02696486
Methods RCT
Participants 16 participants (55 years and older) with a diagnosis of HF with preserved ejection fraction (HFpEF)
Interventions Study participants will receive medically supervised aerobic and resistance exercise training for 1 hour per session, 3
times per week, for 6 weeks, at the Cardiac Rehab Centre, then will transition to home-based or YMCA partnership-
based exercise with staff follow-up contact for an additional 3 weeks
Outcomes Primary outcome measures:
Change in quality of life (QoL) score before and after exercise training (ET) [Time Frame: 9 weeks]
Secondary outcome measures:
Change in exercise capacity/tolerance before and after ET using cardiopulmonary exercise testing [Time Frame: 9
weeks]: symptom-limited treadmill testing with expired gas measurement and analysis; exercise capacity measured as
peak VO (peak exercise oxygen uptake) in mL/min/kg; continuous monitoring of 12-lead electrocardiogram and
blood pressure measured every 2 minutes; peak VO defined as highest VO value of the last 30 seconds before
termination of exercise; exercise time and peak workload measured for exercise tolerance; demonstrated ability to co-
ordinate patient transition from clinic to home-based or YMCA partnership-based exercise programme with weekly
staff follow-up within the study timeline [Time Frame: 9 weeks]: captured 90-day hospital re-admission data starting
on study enrollment date and within participants’ study timeline [Time Frame: 90 days]
Notes Recruitment completed. Actual primary completion date reported in clinicaltrials.gov as January 2017. No results
posted. Study authors contacted
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NCT02903225
Methods RCT
Participants 40 participants 18 to 80 years of age, males and females, with HF LVEF≤ 40%
Interventions Exercise training L on a 3 days/week basis over 24 weeks (68 to 74 sessions). Each session started with a 10-minute
warm-up walking period followed by 20 minutes of breathing exercises and free non-resistance movements of limbs.
This stage was followed by pedaling during 20 minutes at a circuit resistance training protocol with a stationary
cycle ergometer. Each session ended with a cool-down period (5 minutes) including diverse stretching manoeuvres
of engaged muscle groups. The initial bicycle-ergometer workload (WL) was defined as 50% of maximum achieved
in previous stress testing
Outcomes Primary outcome measures:
• Clinical events [Time Frame: 6 months]: change in New York Heart Association Functional Class; numbers of
hospitalisations 6 months before and after the date of enrolment; temporary or permanent withdrawal from the
study protocol (due to persistent atrial or ventricular arrhythmias; worsening of congestive heart failure symptoms;
myocardial infarction; unstable angina; need for cardiac interventions: pacemaker, implantable cardioverter-
defibrillator, coronary re-vascularisation, or cardiac transplantation; stroke or transient ischaemic attack; severe
peripheral intermittent claudication or death observed during training or follow-up sessions)
• Mean heart rate [Time Frame: 6 months]: mean value of 12-minute electrocardiogram recordings was
considered the resting heart rate (beats per minute)
• 6-Minute walk test [Time Frame: 6 months]: walking along a 20-metre-long corridor at their own pace, with
the aim of covering as much ground as possible in 6 minutes. The distance walked was expressed in metres
• Left ventricular ejection fraction [Time Frame: 1 year]: area-length method was measured to obtain biplane
left ventricle volumes. Left ventricle ejection fraction was derived from the standard equation (%)
• Quality of life [Time Frame: 6 months]: all participants completed the Short Form-36 Health Survey (SF-36),
available in its Spanish version, for measuring physical and mental quality of life
• Stress test [Time Frame: 6 months]: symptom-limited exercise testing, measured in metabolic units (MET)
• Square root of mean squared successive differences of R-R intervals (rMSSD) [Time Frame: 6 months]: short-
term continuous electrocardiographic recordings were performed for heart rate variability analysis. In the time
domain, the square root of the mean squared successive differences of R-R intervals (rMSSD) was calculated. Units:
ms
• Heart rate power high-frequency (HF) [Time Frame: 6 months]: high frequency (HF), from 0.15 to 0.40 Hz
of the power spectral analysis, was calculated. Units: ms²/Hz
Notes Recruitment completed. Study reported at ClinicalTrials.gov to be completed November 2014. No results posted.
Study authors contacted
ET: exercise training; FMD: flow-mediated dilation; HF: heart failure; HFpEF: heart failure with preserved ejection fraction; HFrEF:
heart failure with reduced ejection fraction; HRQoL: health-related quality of life; LAVI: left atrial volume index; LVEF: left ventric-
ular ejection fraction; MET: metabolic equivalent; MLWHFQ: Minnesota Living With Heart Failure Questionnaire; NTproBNP:
N-terminal prohormone of brain natriuretic peptide; NYHA: New York Heart Association; QoL: quality of life; RCT: randomised
controlled trial; rMSSD: mean squared successive differences of R-R intervals; SF-36: Short Form-36; VE: ventilatory efficacy;
VCO : carbon dioxide production; VO : oxygen uptake; WL: workload.
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NCT01914315
Trial name or title Rehabilitation Program in Heart Failure With Preserved Ejection Fraction
Methods RCT
Participants 1100 participants
Interventions Participants will participate in a 6-month cardiac rehabilitation programme, consisting of structured, 60-
minute, bi-weekly exercise training sessions, according to a pre-defined protocol. Institutional activity will be
complemented by 120 minutes of weekly home exercise prescribed by a specialist in cardiac rehabilitation.
Following discharge, participants in the comparator arm will return to the IM outpatient clinics at 2 to 4
weeks and at 3 and 6 months for consultation. These scheduled consultations will comprise history taking,
recording of any new events, physical examination, and recommendations as clinically indicated. Target values
for blood pressure and glucose control will be in accordance with current guidelines, and special emphasis
will be given to management of fluid retention
Outcomes Primary outcomes: combined all-cause mortality and hospitalisations at 12 months’ follow-up
Secondary clinical outcomes: will be collected during 3- and 6-month follow-up visits and will include the
following: blood pressure averages; HbA1C levels; assessment of NYHA class and global clinical assessment, 6-
minutewalk test, andquality of life data as evaluated by theEQ-5Dquestionnaire; all-causemortality endpoint
[Time Frame: 12 months after randomisation]; heart failure hospitalisations [Time Frame: 12 months after
randomisation]; number of HF hospitalisations as assessed byHF specialists blinded to participant allocation.
Assessment will include medical record and hospital discharge letter review
Starting date October 2013
Contact information Dr. Robert Klempfner Heart Rehabilitation Institute, Sheba Medical Center
Notes WHO International Clinical Rrials Registry Platform states that trial is still recruiting
NCT02196038
Trial name or title A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF)
Methods RCT
Participants 360 participants ≥ 60 years old hospitalised with ADHF
Interventions 12-Week novel, progressive, multi-domain rehabilitation and exercise training intervention or attention con-
trol. The multi-domain rehabilitation intervention will include endurance, mobility, strength, and balance
training and will be tailored according to participant performance in each of these domains. It will begin
upon randomisation during hospitalisation and will continue 3 times per week in an outpatient setting
Outcomes All participants will undergo measures of physical function and quality of life at baseline, 1 month, and 3
months. Clinical events will be monitored for 6 months following the index hospitalisation
Starting date September 2014
129Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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Contact information Principal investigator: Dalane W Kitzman, MD; Wake Forest University Health Sciences, Winston-Salem,
North Carolina, USA
Notes Estimated study completion date: November 2020
NCT03041376
Trial name or title Effect of Pedometer-Based Walking Intervention on Functional Capacity and Neurohumoral Modulation in
PatientsWithChronicHeart FailureWith PreservedEjectionFraction: AMulticenterRandomizedControlled
Trial
Methods RCT
Participants 200 physically inactive patients with chronic heart failure with preserved or mid-range ejection fraction
Interventions The 6-month intervention will consist of an individualised pedometer-based walking programme with weekly
step goals, monthly face-to-face sessions with the physician, and monthly telephone calls with the research
nurse. The intervention will be based on effective behavioural principles (goal-setting, self-monitoring, per-
sonalised feedback)
Outcomes Primary outcome: change in 6-minute walk distance at 6 months
Secondary outcomes: changes in serum biomarkers levels, pulmonary congestion assessed by ultrasound,
average daily step count measured by accelerometry, anthropometric measures, symptoms of depression,
health-related quality of life, self-efficacy, MAGGIC Risk Score
Starting date April 2017
Contact information Jan Belohlavek, Charles University, Czech Republic
Notes Estimated study completion date: 31 January 2020
ADHF: acute decompensated heart failure; EQ-5D: EuroQoL Group Quality of Life Questionnaire based on 5 dimensions; HbA1C:
glycosylated haemoglobin; HF: heart failure; NYHA: New YorkHeart Association; RCT: randomised controlled trial; WHO:World
Health Organization.
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D A T A A N D A N A L Y S E S
Comparison 1. All exercise interventions versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality up to 12
months’ follow-up
27 2596 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.66, 1.21]
2 All-cause mortality more than
12 months’ follow-up
6 2845 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.75, 1.02]
3 Hospital admission up to 12
months’ follow-up
21 2182 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.60, 0.83]
4 Hospital admission more than
12 months’ follow-up
6 2691 Risk Ratio (M-H, Random, 95% CI) 0.70 [0.47, 1.05]
5 Hospital admission heart failure
only
14 1114 Risk Ratio (M-H, Fixed, 95% CI) 0.59 [0.42, 0.84]
6 Health-related quality of life -
MLWHF up to 12 months’
follow-up
17 1995 Mean Difference (IV, Random, 95% CI) -7.11 [-10.49, -3.73]
7 Health-related quality of life -
MLWHF and other scales up
to 12 months’ follow-up
26 3833 Std. Mean Difference (IV, Random, 95% CI) -0.60 [-0.82, -0.39]
8 Health-related quality of life
- MLWHF more than 12
months’ follow-up
3 329 Mean Difference (IV, Random, 95% CI) -9.49 [-17.48, -1.50]
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Analysis 1.1. Comparison 1 All exercise interventions versus usual care, Outcome 1 All-cause mortality up
to 12 months’ follow-up.
Review: Exercise-based cardiac rehabilitation for adults with heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 1 All-cause mortality up to 12 months’ follow-up
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2016 5/170 8/173 9.7 % 0.64 [ 0.21, 1.91 ]
Austin 2005 5/100 4/100 4.9 % 1.25 [ 0.35, 4.52 ]
Chen 2018 0/31 2/31 3.1 % 0.20 [ 0.01, 4.00 ]
Dalal 2018 4/107 4/109 4.9 % 1.02 [ 0.26, 3.97 ]
DANREHAB 2008 4/45 3/46 3.6 % 1.36 [ 0.32, 5.75 ]
Davidson 2010 4/53 11/52 13.6 % 0.36 [ 0.12, 1.05 ]
Dracup 2007 9/87 8/86 9.9 % 1.11 [ 0.45, 2.75 ]
Du 2018 1/67 1/65 1.2 % 0.97 [ 0.06, 15.19 ]
Gary 2010 (1) 1/20 0/17 0.7 % 2.57 [ 0.11, 59.30 ]
Gary 2010 (2) 0/18 1/19 1.8 % 0.35 [ 0.02, 8.09 ]
Giannuzzi 2003 0/45 1/45 1.8 % 0.33 [ 0.01, 7.97 ]
Gottlieb 1999 1/17 0/18 0.6 % 3.17 [ 0.14, 72.80 ]
Hambrecht 1995 1/12 0/10 0.7 % 2.54 [ 0.11, 56.25 ]
Hambrecht 1998 1/10 1/10 1.2 % 1.00 [ 0.07, 13.87 ]
Hambrecht 2000 3/36 2/37 2.4 % 1.54 [ 0.27, 8.69 ]
Jolly 2009 7/84 5/85 6.1 % 1.42 [ 0.47, 4.29 ]
Keteyian 1996 0/21 1/19 1.9 % 0.30 [ 0.01, 7.02 ]
McKelvie 2002 9/90 8/91 9.8 % 1.14 [ 0.46, 2.82 ]
Mehani 2013 0/20 2/20 3.1 % 0.20 [ 0.01, 3.92 ]
Myers 2000 1/12 0/13 0.6 % 3.23 [ 0.14, 72.46 ]
Nilsson 2008 2/40 1/40 1.2 % 2.00 [ 0.19, 21.18 ]
Norman 2012 1/22 0/20 0.6 % 2.74 [ 0.12, 63.63 ]
Pozehl 2008 0/15 1/6 2.6 % 0.15 [ 0.01, 3.16 ]
Wall 2010 1/9 1/10 1.2 % 1.11 [ 0.08, 15.28 ]
Willenheimer 2001 3/27 2/27 2.5 % 1.50 [ 0.27, 8.28 ]
0.001 0.01 0.1 1 10 100 1000
Favours exercise Favours control
(Continued . . . )
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Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Witham 2005 1/41 3/41 3.7 % 0.33 [ 0.04, 3.07 ]
Witham 2012 3/53 2/54 2.4 % 1.53 [ 0.27, 8.78 ]
Yeh 2011 0/50 3/50 4.3 % 0.14 [ 0.01, 2.70 ]
Total (95% CI) 1302 1294 100.0 % 0.89 [ 0.66, 1.21 ]
Total events: 67 (Exercise), 75 (Control)
Heterogeneity: Chi2 = 15.85, df = 27 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.73 (P = 0.47)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours exercise Favours control
(1) exercise alone
(2) comprehensive rehabilitation (CBT and exercise)
Analysis 1.2. Comparison 1 All exercise interventions versus usual care, Outcome 2 All-cause mortality
more than 12 months’ follow-up.
Review: Exercise-based cardiac rehabilitation for adults with heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 2 All-cause mortality more than 12 months’ follow-up
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 31/100 38/100 13.6 % 0.82 [ 0.56, 1.20 ]
Belardinelli 1999 9/50 20/49 7.2 % 0.44 [ 0.22, 0.87 ]
Belardinelli 2012 4/63 10/60 3.7 % 0.38 [ 0.13, 1.15 ]
HF ACTION 2009 189/1159 198/1171 70.5 % 0.96 [ 0.80, 1.16 ]
J nsd ttir 2006a 2/21 2/22 0.7 % 1.05 [ 0.16, 6.77 ]
Mueller 2007 9/25 12/25 4.3 % 0.75 [ 0.39, 1.46 ]
Total (95% CI) 1418 1427 100.0 % 0.88 [ 0.75, 1.02 ]
Total events: 244 (Exercise), 280 (Control)
0.01 0.1 1 10 100
Favours experimental Favours control
(Continued . . . )
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Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 7.54, df = 5 (P = 0.18); I2 =34%
Test for overall effect: Z = 1.69 (P = 0.092)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
Analysis 1.3. Comparison 1 All exercise interventions versus usual care, Outcome 3 Hospital admission up
to 12 months’ follow-up.
Review: Exercise-based cardiac rehabilitation for adults with heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 3 Hospital admission up to 12 months’ follow-up
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Antonicelli 2016 25/170 60/173 22.8 % 0.42 [ 0.28, 0.64 ]
Austin 2005 9/100 19/100 7.3 % 0.47 [ 0.23, 1.00 ]
Bocalini 2008 0/22 3/20 1.4 % 0.13 [ 0.01, 2.38 ]
Chen 2018 11/31 8/31 3.1 % 1.38 [ 0.64, 2.95 ]
Dalal 2018 19/107 24/109 9.1 % 0.81 [ 0.47, 1.38 ]
Davidson 2010 23/53 36/52 13.9 % 0.63 [ 0.44, 0.90 ]
Dracup 2007 35/87 37/86 14.3 % 0.94 [ 0.66, 1.33 ]
Du 2018 1/67 1/65 0.4 % 0.97 [ 0.06, 15.19 ]
Giallauria 2008 3/30 7/31 2.6 % 0.44 [ 0.13, 1.55 ]
Giannuzzi 2003 2/45 1/45 0.4 % 2.00 [ 0.19, 21.28 ]
Gielen 2003 1/10 0/10 0.2 % 3.00 [ 0.14, 65.90 ]
Hambrecht 1995 0/12 1/10 0.6 % 0.28 [ 0.01, 6.25 ]
Jolly 2009 16/84 20/85 7.6 % 0.81 [ 0.45, 1.45 ]
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Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
J nsd ttir 2006a 2/21 5/22 1.9 % 0.42 [ 0.09, 1.93 ]
Keteyian 1996 0/21 1/19 0.6 % 0.30 [ 0.01, 7.02 ]
Lang 2018 4/25 7/25 2.7 % 0.57 [ 0.19, 1.71 ]
Mehani 2013 3/20 0/20 0.2 % 7.00 [ 0.38, 127.32 ]
Passino 2006 0/44 2/41 1.0 % 0.19 [ 0.01, 3.78 ]
Witham 2005 10/41 11/41 4.2 % 0.91 [ 0.43, 1.90 ]
Witham 2012 14/53 11/54 4.2 % 1.30 [ 0.65, 2.59 ]
Yeh 2011 2/50 4/50 1.5 % 0.50 [ 0.10, 2.61 ]
Total (95% CI) 1093 1089 100.0 % 0.70 [ 0.60, 0.83 ]
Total events: 180 (Exercise), 258 (Control)
Heterogeneity: Chi2 = 24.56, df = 20 (P = 0.22); I2 =19%
Test for overall effect: Z = 4.30 (P = 0.000017)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 All exercise interventions versus usual care, Outcome 4 Hospital admission
more than 12 months’ follow-up.
Review: Exercise-based cardiac rehabilitation for adults with heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 4 Hospital admission more than 12 months’ follow-up
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Belardinelli 1999 5/50 14/49 10.4 % 0.35 [ 0.14, 0.90 ]
Belardinelli 2012 8/63 25/60 13.9 % 0.30 [ 0.15, 0.62 ]
Cowie 2014 (1) 9/15 5/8 14.6 % 0.96 [ 0.49, 1.89 ]
Cowie 2014 (2) 6/15 5/8 12.2 % 0.64 [ 0.28, 1.45 ]
HF ACTION 2009 729/1159 760/1171 25.2 % 0.97 [ 0.91, 1.03 ]
J nsd ttir 2006a 7/21 11/22 13.6 % 0.67 [ 0.32, 1.39 ]
Mueller 2007 8/25 5/25 10.1 % 1.60 [ 0.61, 4.22 ]
Total (95% CI) 1348 1343 100.0 % 0.70 [ 0.47, 1.05 ]
Total events: 772 (Exercise), 825 (Control)
Heterogeneity: Tau2 = 0.16; Chi2 = 17.81, df = 6 (P = 0.01); I2 =66%
Test for overall effect: Z = 1.73 (P = 0.083)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 All exercise interventions versus usual care, Outcome 5 Hospital admission
heart failure only.
Review: Exercise-based cardiac rehabilitation for adults with heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 5 Hospital admission heart failure only
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Belardinelli 1999 5/50 14/49 21.1 % 0.35 [ 0.14, 0.90 ]
Chen 2018 12/31 9/31 13.5 % 1.33 [ 0.66, 2.70 ]
Cowie 2014 (1) 3/15 5/8 9.8 % 0.32 [ 0.10, 1.01 ]
Cowie 2014 (2) 8/15 5/8 9.8 % 0.85 [ 0.42, 1.75 ]
Dalal 2018 3/107 6/109 8.9 % 0.51 [ 0.13, 1.98 ]
Giannuzzi 2003 2/45 1/45 1.5 % 2.00 [ 0.19, 21.28 ]
Hambrecht 1995 0/12 1/10 2.4 % 0.28 [ 0.01, 6.25 ]
Jolly 2009 4/84 2/85 3.0 % 2.02 [ 0.38, 10.75 ]
J nsd ttir 2006a 0/21 3/22 5.1 % 0.15 [ 0.01, 2.73 ]
Lang 2018 0/25 4/25 6.7 % 0.11 [ 0.01, 1.96 ]
Mueller 2007 2/25 3/25 4.5 % 0.67 [ 0.12, 3.65 ]
Myers 2000 0/12 2/13 3.6 % 0.22 [ 0.01, 4.08 ]
Passino 2006 0/44 2/41 3.9 % 0.19 [ 0.01, 3.78 ]
Willenheimer 2001 0/23 3/27 4.8 % 0.17 [ 0.01, 3.07 ]
Witham 2012 1/53 1/54 1.5 % 1.02 [ 0.07, 15.87 ]
Total (95% CI) 562 552 100.0 % 0.59 [ 0.42, 0.84 ]
Total events: 40 (Exercise), 61 (Control)
Heterogeneity: Chi2 = 15.81, df = 14 (P = 0.32); I2 =11%
Test for overall effect: Z = 2.94 (P = 0.0033)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 All exercise interventions versus usual care, Outcome 6 Health-related quality
of life - MLWHF up to 12 months’ follow-up.
Review: Exercise-based cardiac rehabilitation for adults with heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 6 Health-related quality of life - MLWHF up to 12 months’ follow-up
Study or subgroup Exercise Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Antonicelli 2016 150 28.6 (12.3) 163 44.5 (12.3) 7.6 % -15.90 [ -18.63, -13.17 ]
Austin 2005 85 22.9 (14.7) 94 36.9 (21.3) 6.7 % -14.00 [ -19.32, -8.68 ]
Belardinelli 1999 48 40 (19) 46 51 (22) 5.4 % -11.00 [ -19.33, -2.67 ]
Chen 2018 31 19.4 (12.2) 29 34.3 (14.4) 6.1 % -14.90 [ -21.68, -8.12 ]
Dalal 2018 92 24.1 (20.9) 93 27.5 (23.2) 6.3 % -3.40 [ -9.76, 2.96 ]
Davidson 2010 50 52.9 (15.7) 42 56.4 (18.3) 6.0 % -3.50 [ -10.54, 3.54 ]
Dracup 2007 86 35.7 (23.7) 87 43.2 (27.3) 5.7 % -7.50 [ -15.12, 0.12 ]
Du 2018 67 36.9 (21.59) 65 41 (22.4) 5.8 % -4.10 [ -11.61, 3.41 ]
Gary 2010 (1) 17 25.6 (19.7) 14 28.9 (29.9) 2.4 % -3.30 [ -21.55, 14.95 ]
Gary 2010 (2) 15 24.2 (16.3) 16 34.3 (23.6) 3.3 % -10.10 [ -24.30, 4.10 ]
Jolly 2009 77 37.6 (21) 80 34.9 (24.8) 5.9 % 2.70 [ -4.48, 9.88 ]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 5.7 % -11.10 [ -18.65, -3.55 ]
Lang 2018 22 29.2 (25.8) 23 38.7 (30.1) 2.8 % -9.50 [ -25.86, 6.86 ]
McKelvie 2002 57 -3.4 (18.1) 67 -3.3 (13.9) 6.5 % -0.10 [ -5.86, 5.66 ]
Nilsson 2008 35 23 (14) 37 28 (20) 5.6 % -5.00 [ -12.94, 2.94 ]
Passino 2006 44 32 (26.5) 41 53 (32) 3.8 % -21.00 [ -33.54, -8.46 ]
Witham 2012 43 15.4 (14.8) 44 11.3 (12.1) 6.6 % 4.10 [ -1.59, 9.79 ]
Yeh 2011 50 13 (4) 50 18 (6) 7.8 % -5.00 [ -7.00, -3.00 ]
Total (95% CI) 985 1010 100.0 % -7.11 [ -10.49, -3.73 ]
Heterogeneity: Tau2 = 36.91; Chi2 = 93.22, df = 17 (P<0.00001); I2 =82%
Test for overall effect: Z = 4.12 (P = 0.000037)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 All exercise interventions versus usual care, Outcome 7 Health-related quality
of life - MLWHF and other scales up to 12 months’ follow-up.
Review: Exercise-based cardiac rehabilitation for adults with heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 7 Health-related quality of life - MLWHF and other scales up to 12 months’ follow-up
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Antonicelli 2016 150 28.6 (12.3) 163 44.5 (12.3) 4.3 % -1.29 [ -1.53, -1.05 ]
Austin 2005 85 22.9 (14.7) 94 36.9 (21.3) 4.2 % -0.76 [ -1.06, -0.45 ]
Belardinelli 1999 48 40 (19) 46 51 (22) 3.9 % -0.53 [ -0.94, -0.12 ]
Bocalini 2008 22 -87 (4) 20 -81 (6) 3.2 % -1.17 [ -1.83, -0.51 ]
Chen 2018 31 19.4 (12.2) 29 34.3 (14.4) 3.5 % -1.11 [ -1.65, -0.56 ]
Dalal 2018 92 24.1 (20.9) 93 27.5 (23.2) 4.2 % -0.15 [ -0.44, 0.14 ]
DANREHAB 2008 19 -42.7 (9.1) 15 -37.4 (11.4) 3.1 % -0.51 [ -1.20, 0.18 ]
Davidson 2010 50 52.9 (15.7) 42 56.4 (18.3) 3.9 % -0.20 [ -0.62, 0.21 ]
Dehkordi AH 2015 30 -63.34 (12.69) 31 -58.43 (8.67) 3.7 % -0.45 [ -0.96, 0.06 ]
Dracup 2007 86 35.7 (23.7) 87 43.2 (27.3) 4.2 % -0.29 [ -0.59, 0.01 ]
Du 2018 67 36.9 (21.59) 65 41 (22.4) 4.1 % -0.19 [ -0.53, 0.16 ]
Gary 2010 (1) 15 24.2 (16.3) 16 34.3 (23.6) 3.0 % -0.48 [ -1.20, 0.23 ]
Gary 2010 (2) 17 25.6 (19.7) 14 28.9 (29.9) 3.1 % -0.13 [ -0.84, 0.58 ]
HF ACTION 2009 828 72.8 (20.4) 784 71.4 (21.3) 4.6 % 0.07 [ -0.03, 0.16 ]
Jolly 2009 77 37.6 (21) 80 34.9 (24.8) 4.2 % 0.12 [ -0.20, 0.43 ]
J nsd ttir 2006a 21 -47.55 (8.7) 20 -44.1 (14.04) 3.3 % -0.29 [ -0.91, 0.32 ]
Kaltsatou 2014 (3) 16 -5.7 (3) 9 0.8 (1.2) 2.1 % -2.49 [ -3.60, -1.38 ]
Kaltsatou 2014 (4) 18 -6.5 (2.4) 8 0.8 (1.2) 1.7 % -3.33 [ -4.62, -2.04 ]
Klocek 2005 (5) 14 -109 (23.5) 7 -71.7 (23.5) 2.2 % -1.52 [ -2.57, -0.48 ]
Klocek 2005 (6) 14 -99 (23.5) 7 -71.7 (23.5) 2.3 % -1.12 [ -2.10, -0.13 ]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 3.1 % -0.99 [ -1.69, -0.28 ]
Lang 2018 22 29.2 (25.8) 23 38.7 (30.1) 3.4 % -0.33 [ -0.92, 0.26 ]
Nilsson 2008 35 23 (14) 37 28 (20) 3.8 % -0.29 [ -0.75, 0.18 ]
Norman 2012 19 -81 (18.2) 18 -77.9 (11.6) 3.2 % -0.20 [ -0.84, 0.45 ]
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(. . . Continued)
Study or subgroup Exercise Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Passino 2006 44 32 (26.5) 41 53 (32) 3.9 % -0.71 [ -1.15, -0.27 ]
Reeves 2017 12 -65 (19) 12 -63 (22) 2.8 % -0.09 [ -0.89, 0.71 ]
Willenheimer 2001 20 -0.7 (0.8) 17 0 (1) 3.2 % -0.76 [ -1.44, -0.09 ]
Witham 2005 36 -69 (13) 32 -65 (10) 3.7 % -0.34 [ -0.82, 0.14 ]
Yeh 2011 50 13 (4) 50 18 (6) 3.9 % -0.97 [ -1.39, -0.56 ]
Total (95% CI) 1954 1879 100.0 % -0.60 [ -0.82, -0.39 ]
Heterogeneity: Tau2 = 0.26; Chi2 = 215.03, df = 28 (P<0.00001); I2 =87%
Test for overall effect: Z = 5.54 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 All exercise interventions versus usual care, Outcome 8 Health-related quality
of life - MLWHF more than 12 months’ follow-up.
Review: Exercise-based cardiac rehabilitation for adults with heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 8 Health-related quality of life - MLWHF more than 12 months’ follow-up
Study or subgroup Exercise Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Austin 2005 57 35.5 (21.7) 55 37.1 (24.9) 30.0 % -1.60 [ -10.26, 7.06 ]
Belardinelli 1999 48 44 (21) 46 54 (22) 29.9 % -10.00 [ -18.70, -1.30 ]
Belardinelli 2012 63 43 (12) 60 58 (14) 40.1 % -15.00 [ -19.62, -10.38 ]
Total (95% CI) 168 161 100.0 % -9.49 [ -17.48, -1.50 ]
Heterogeneity: Tau2 = 35.87; Chi2 = 7.33, df = 2 (P = 0.03); I2 =73%
Test for overall effect: Z = 2.33 (P = 0.020)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Health-related quality of life results
Trial first author (year) Follow-up Measure Outcome values (or
change from baseline)
at follow-up
Mean (standard devia-
tion)
Control vs exercise, be-
tween-group P value
Between-group differ-
ence
Antonicelli (2016) 6 months MLWHF total 44.5 (12.3) vs 28.6 (12.
3); P < 0.001
Exercise > Control
Austin (2005/8) 6 months
5 years
MLWHF Physical
MLWHF Emotional
MLWHF Total
EQ-5D
MLWHF Physical
MLWHF Emotional
MLWHF Total
EQ-5D
20.4 (12.2) vs 12.6 (9.7)
; P < 0.0001*
8.0 (7.1) vs 4.4 (10.4); P
< 0.01*
36.9 (24.0) vs 22.9 (17.
8); P < 0.001*
0.58 (0.19) vs 0.70 (0.
16); P < 0.0001*
Exercise > Control
Exercise > Control
Exercise > Control
Exercise > Control
Exercise = Control
Exercise = Control
Exercise = Control
Exercise = Control
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Table 1. Health-related quality of life results (Continued)
19.3 (23.5) vs 18.3 (11.
2); P = 0.66*
7.6 (7.1) vs 7.4 (6.5); P
= 0.88*
37.1 (24.9) vs 35.5 (21.
7); P = 0.72*
0.58 (0.22) vs 0.64 (0.
19); P = 0.12*
Belardinelli (1999) 2 months
15 months
29 months
MLWHF total 52 (29) vs 40 (19); P < 0.
001
52 (20) vs 39 (20); P < 0.
001
54 (22) vs 44 (21); P < 0.
001
Exercise > Control
Exercise > Control
Exercise > Control
Belardinelli (2012) 10 years MWLHF total 58 (14) vs 43 (12); P < 0.
001
Exercise > Control
Bocalini (2008) 6 months WHOQoL
Physical
Psychological
Social
Environmental
2 (1) vs 23 (4); P < 0.
0001*
1 (1) vs 20 (2); P < 0.
0001*
3 (2) vs 16 (1); P < 0.
0001*
2 (1) vs 15 (2); P < 0.
0001*
Exercise > Control
Exercise > Control
Exercise > Control
Exercise > Control
Chen (2018) 6 months Physical (SPPB)
MLWHF total
8.9 (2.3) vs 10.0 (2.1); P
= 0.059
34.3 (14.4) vs 19.4 (12.
2); P < 0.001
Exercise = Control
Exercise > Control
Dalal (2018) 12 months MLWHF total
Physical
Emotional
Heart QoL Global
Heart QoL Physical
Heart QoL Emotional
EQ-5D-3L
27.5 (23.2) vs 24.1 (20.
9); P = 0.025
14.5 (11.8) vs 12.2 (10.
8); P = 0.016
5.5 (6.4) vs 5.1 (5.8); P
= 0.273
1.9 (0.9) vs 1.9 (0.9); P
= 0.823
1.7 (0.9) vs 1.8 (0.9); P
= 0.869
2.3 (0.8) vs 2.3 (0.8); P
= 0.683
0.739 (0.263) vs 0.752
(0.240); P = 0.487
Exercise > Control
Exercise > Control
Exercise = Control
Exercise = Control
Exercise = Control
Exercise = Control
Exercise = Control
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Table 1. Health-related quality of life results (Continued)
DANREHAB (2008) 12 months SF-36 PCS
SF-36MCS
37.4 (11.4) vs 42.7 (9.1)
*; P = 0.14
50.5 (10.0) vs 49.7 (8.8)
*; P = 0.81
Exercise = Control
Exercise = Control
Davidson (2010) 12 months MLWHF total 56.4 (18.3) vs 52.9 (15.
7); P = 0.33
Exercise = Control
Dracup (2007) 6 months MLWHF Physical
MLWHF Emotional
MLWHF Total
19.4 (11.5) vs 16.1 (10.
0); P = 0.04*
10.5 (7.4) vs 7.8 (6.6); P
= 0.01*
43.2 (26.5) vs 35.7 (23.
7); P = 0.05
Exercise > Control
Exercise > Control
Exercise > Control
Du (2017) 6 months MLWHF total
SF-36
41 (22.4) vs 36.9 (21.59)
; P = 0.535
54.5 (25.31) vs 53.9 (22.
78); P = 0.697
Exercise = Control
Exercise = Control
Gary (2010) Comp 6 months MLWHF total 34.3 (23.6) vs 24.2 (16.
3); P = 0.18*
Exercise = Control
Gary (2010) Exer 6 months MLWHF total 28.9 (29.9) vs 25.6 (19.
7); P = 0.71*
Exercise = Control
Hassenpour-Dehkrodi
(2015)
6 months MacNew 58.43 (8.67) vs 63.34
(12.69); P < 0.05
Exercise > Control
Gottlieb (1999) 6 months MLWHF total
MOS PF
MOS RL
MOS GH
NR (NR) vs 22 (20); NR
NR (NR) vs 68 (28); NR
NR (NR) vs 50 (42); NR
NR (NR) vs 361 (224);
NR
NR
NR
NR
NR
HF-ACTION (2009) 12 months KCCQ+ 71.4 (21.3) vs 72.8 (20.
4)
Exercise > Control**
Jolly (2009) 6 months
12 months
MLWHF total
EQ-5D
MLWHF total
EQ-5D
34.5 (24.0) vs 36.3 (24.
1); P = 0.30
0.62 (0.32) vs 0.66 (0.
24); P = 0.004
34.9 (24.8) vs 37.6 (21.
0); P = 0.80
0.69 (0.28) vs 0.68 (0.
21); P = 0.07
Exercise = Control
Exercise > Control
Exercise = Control
Exercise = Control
Jónsdóttir (2006) 6 months Icelandic quality of life
questionnaire
4.10 (14.04) vs 47.55 (8.
7); P = 0.34
Exercise = Control
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Table 1. Health-related quality of life results (Continued)
Kaltsatou 2014 (dance) 8 months SF-36 (physical)+
SF-36 (mental)+
SF-36 (total)+
-0.6 (0.9) vs 3.3 (1.6); P
< 0.05
-0.2 (0.5) vs 3.1 (1.3); P
< 0.05
-0.8 (1.2) vs 6.5 (2.4); P
< 0.05
Exercise > Control
Exercise > Control
Exercise > Control
Kaltsatou 2014 (exer-
cise)
8 months SF-36 (physical)+
SF-36 (mental)+
SF-36 (total)+
-0.6 (0.9) vs 2.9 (1.5); P
< 0.05
-0.2 (0.5) vs 2.7 (2.2); P
< 0.05
-0.8 (1.2) vs 5.7 (3.0); P
< 0.05
Exercise > Control
Exercise > Control
Exercise > Control
Klocek (2005)
(Const or Prog)
6.5 months PGWB total 99.0 vs 109.0 (training
grp A) vs 71.7 (training
grp B); P < 0.01
Exercise > Control
Koukouvou (2004) 6 months MLWHF total
Spritzer QLI total
34.1 (13.0) vs 45.1 (9.9)
; P = 0.05*
7.1 (1.1) vs 9.1 (1.1); P
< 0.0001*
Exercise > Control
Exercise > Control
Lang (2018) 6 months MLWHF total
Heart-QoL
EQ-5D-5L
29.2 (25.8) vs 38.7 (30.
1); P > 0.05
2.0 (1.0) vs 1.9 (1.0); P
> 0.05
0.65 (0.31) vs 0.55 (0.
29); P > 0.05
Exercise = Control
Exercise = Control
Exercise = Control
McKelvie (2002) 12 months MLWHF total+ -3.3 (13.9) vs -3.4 (18.1)
; P = 0.98
Exercise = Control
Nilsson (2008) 12 months MLWHF total 28 (20) vs 22 (12); P = 0.
003
Exercise > Control
Norman (2012) 6 months KCCQ 77.9 (11.6) vs 81.0 (18.
2); P = 0.78
Exercise = Control
Passino (2006) 9.75 months MLWHF total 53 (32) vs 32 (26.5); P <
0.0001*
Exercise > Control
Reeves (2017) 3 months KCCQ 63 (22) vs 65 (19); P > 0.
05*
Exercise = Control
Willenheimer (2001) 10 months PGAQoL 0 (1) vs 0.7 (0.9); P = 0.
023
Exercise > Control
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Table 1. Health-related quality of life results (Continued)
Witham (2005) 6 months GCHFQ 69 (13) vs 65 (10); P = 0.
48
Exercise = Control
Witham (2012)*** 6 months MLWHF total 15.4 (14.8) vs 11.3 (12.
1); P > 0.05
Exercise = Control
Yeh (2011) 12 months MLWHF total 18 (6) vs 13 (4); P < 0.
0001
Exercise > Control
*P values: calculated by authors of this Cochrane review ; +: change in outcome from baseline; **We have calculated the between P
value for this trial based on individual participant data; ***Data obtained from study authors.
EQ-5D: EuroQoL Group Quality of Life Questionnaire based on 5 dimensions; EQ-5D-3L: EuroQoL Group Quality of Life Ques-
tionnaire based on 3-level scale; GCHFQ: Guyatt Chronic Heart Failure Questionnaire; GH: general health; KCCQ: Kansas City
Cardiomyopathy Questionnaire; MacNew: MacNew Heart Disease Health-RelatedQuality of Life questionnaire; MCS: Mental Com-
ponent Score;MLWHF:Minnesota LivingWithHeart Failure questionnaire; MOS:Medical SurveyOutcome; NR: not reported; PCS:
Physical Component Score; PF: Physical functioning; PGAQoL: Patient’s Global Assessment of Quality of Life; PGWB: Psychological
General Well-Being index; QLI: quality of life index; QoL: quality of life; RL: role limitation; SF-36: Short Form-36; SPPB: Short
Physical Performance Battery; WHOQoL: World Health Organization Quality of Life questionnaire.
Exercise = Control: no statistically significant difference (P > 0.05) in HRQoL between exercise and control groups at follow-up.
Exercise > Control: statistically significant (P ≤ 0.05) higher HRQoL in exercise group compared to control group at follow-up.
Exercise < Control: statistically significant (P ≤ 0.05) lower HRQoL in exercise group versus control group at follow-up.
Table 2. Costs and cost-effectiveness
Author (year) Georgiou
(2001)
HF-ACTION
Reed (2010)
Witham (2012) Cowie (2014)
Centre and
home
Dalal (2018) Lang (2018)
Year of costs
Country
Currency
1998
US
USD
2008
US
USD
2010
UK
GBP
2013/2014
UK
GBP
2016
UK
GBP
2016
UK
GBP
Intervention cost
Mean costs/pa-
tient
4,563 6,483 (SD 4,
884)
474.75 Not reported 418.39 362.61
Costs considered Staffing, space
rental,
equipment, pa-
tients’ lost wages
Staffing, pa-
tient time, travel,
parking
Staffing, equip-
ment, staff and
patient travel
Staffing, equip-
ment, consum-
ables*
(*home training
only)
Primary and sec-
ondary care, so-
cial care, drugs,
NHS and inter-
vention costs
Staffing, equip-
ment, staff travel
Cost-effectiveness
Follow-up
period
15.5 years Mean 2.5 years 6 months 5 years NR NR
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Table 2. Costs and cost-effectiveness (Continued)
To-
tal mean health-
care cost/patient
(exercise)
5,282* 57,338 (SD 81,
343)+
1888.24 (SD
3111)
221.
58 (hospital) and
196.53 (home)
NR NR
To-
tal mean health-
care costs per
patient (control)
2,055* 56,177 (SD 92,
749)+
1943.93 (SD
4551)
Not calculated NR NR
Incremental
healthcare costs
3227* 1,161 (95% CI -
6,205 to 8,404)
-
447.85 (95% CI
-1696.00 to 931.
00)
NR NR NR
Additional
healthcare costs
considered
Hospitalisations Medication, pro-
ce-
dures, outpatient
visits, emergency
visits, hospitali-
sations, tests
Inpa-
tient and outpa-
tient admissions,
pri-
mary care con-
tacts, medication
NR NR NR
Mean healthcare
benefit (exercise)
10.24 life-years 2.02 QALYs (SD
1.00)
NR NR 0.74 QALYs (SD
0.22)
NR
Mean health care
benefit (control)
7.96 life-years 1.99 QALYs (SD
1.01)
NR NR 0.76 QALYs (SD
0.21)
NR
Incremen-
tal mean health-
care benefit
1.82 life-years 0.03 (95%CI -0.
06 to 0.11)
NR NR NR NR
Incremen-
tal cost-effective-
ness ratio
1,773 per life-
year saved
NR NR NR NR NR
CI: confidence interval; GBP: GB pounds; NR: not reported; QALY: quality-adjusted life year; SD: standard deviation; USD: US
dollars.
Table 3. Univariate meta-regression analysis
All-cause mortality
P value
All hospitalisations
P value
MLWHF
P value
All HRQoL outcomes
P value
Type of rehabilitation
(exercise only vs com-
prehensive)
0.72 0.55 0.22 0.49
146Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 3. Univariate meta-regression analysis (Continued)
Type of exercise (aer-
obic training alone vs
aerobic plus resistance
training)
0.93 0.06 0.15 0.66
Exercise dose (number
of weeks ×number of
sessions/week ×average
duration of session in
hours)
0.10 0.44 0.89 0.71
Exercise setting (hospi-
tal only, home
only, both hospital and
home)
0.09 0.60 0.62 0.08
Single vs multi-centre 0.46 0.60 0.09 0.06
Publication date 0.20 0.78 0.67 0.74
Risk of bias 0.28 0.05 0.01 0.01
CI: confidence interval; HRQoL: health-related quality of life; MLWHF: Minnesota Living With Heart Failure questionnaire.
Table 4. Trial level subgroup analysis
Author (year) Outcome(s) Subgroup(s) Results (P value) Data analysis
methods
Predefined
HF ACTION
(O’Connor 2009)
Composite primary
endpoint of all-
cause mortality or
hospitalisation, me-
dian follow-up 30
months
Age (≤ 70 years vs
> 70 years), gender
(males vs females),
race (white vs non-
white), heart failure
aetiology (ischaemic
vs non-ischaemic),
baseline LVEF (≤
25% vs > 25%)
, baseline NHYA
(II vs III/IV), pre-
vious re-vascularisa-
tion, history of MI,
on ACE or beta
blocker at baseline
“there was no sig-
nificant interaction
of exercise training
with any of the fac-
tors defining these
subgroups” (P > 0.
05)
Interaction test on
hazard ratio
Yes
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Table 4. Trial level subgroup analysis (Continued)
HF ACTION
(Flynn 2009)
Kansas City Car-
diomyopathy Ques-
tionnaire (KCCQ),
overall score up to
36 months
Age, LVEF (≤ 25%
or > 25%), previous
re-vascularisation
(coronary artery by-
pass graft surgery or
percutaneous coro-
nary inter-
vention, or no pre-
vious re-vascularisa-
tion), history of my-
ocardial infarction,
and KCCQ overall
summary score at
baseline (0 to 50, 50
to 75, or 75 to 100)
No significant sub-
group interactions
(P > 0.05)
Interaction test Yes
HF ACTION
(Keteyian 2012)
All-cause mortality
or hos-
pitalisation and car-
diovascular mortal-
ity or HF hospital-
isation, median fol-
low-up28.2months
Exercise volume de-
fined as metabolic
equivalent (MET)-
hour per week (i.
e. product of exer-
cise intensity (where
1 MET is 3.5 mL
VO /kg/min) and
hours of exercise per
week)
Exercise volume was
linear loga-
rithmic predictor (P
= 0.03) for all-cause
mortality or hospi-
talisation. For car-
diovascular mortal-
ity or HF hospitali-
sation, exercise vol-
ume was a signifi-
cant (P < 0.001) lin-
ear and logarithmic
predictor
Moderate exer-
cise volumes of 3 to
5 metabolic equiv-
alent (MET)-hours
and 5 to 7 MET-
hours per week were
associated with re-
ductions in subse-
quent risk that ex-
ceeded 30%
Regres-
sion-based methods
(based only on exer-
cise group data)
Post hoc
HF ACTION
(Pina 2013)
Kansas City Car-
diomyopathy Ques-
tionnaire
(KCCQ)
Haemoglobin …in-
teraction…by Hgb
by exercise training
were not significant
for the overall sum-
mary scale (P = 0.65
for the jumpof base-
line to 3 months, P
= 0.56 for the slope
Interaction test Post hoc
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Table 4. Trial level subgroup analysis (Continued)
of 3 months to the
end of the study).
Results for KCCQ
subscales were simi-
lar to results for the
overall sum-
mary scale; none of
the 3-way interac-
tion terms were sta-
tistically significant
HF ACTION
(Mentz 2013)
Mortality/hospi-
talisation, mortality,
and CV mortality/
HF hospitalisation
Chronic obstructive
pulmonary disease
(COPD)
No evidence to sug-
gest an
interaction between
exercise training and
COPD status for
any of the clinical
endpoints (all P < 0.
15)
Interaction test Post hoc
HF ACTION
(Mentz 2013)
Mortality/hos-
pitalisation, mortal-
ity, and CV mortal-
ity/HF hospitalisa-
tion/exercise capac-
ity/HRQoL
Race (white/black/
other)
No interaction be-
tween race and as-
signment to exercise
training on clini-
cal outcomes. How-
ever, here was evi-
dence for an interac-
tion between black
race
and exercise train-
ing for change in
6-minute walk dis-
tance. No other ex-
ercise or health sta-
tus variable demon-
strated a statistically
significant interac-
tion with race and
exercise training
Interaction test Post hoc
HF-ACTION
(Zeitler 2015)
All-cause death
or hospitalisation
Ventricular pacing
status
Interaction tests for
reduction
in all-cause death
and device type (P
< 0.33) and reduc-
tion in CV death
or CV hospitalisa-
tion (P < 0.19) did
not meet statistical
Interaction test Post hoc
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Table 4. Trial level subgroup analysis (Continued)
significance
HF-ACTION
(Banks 2016)
6-Minute walk dis-
tance (6MWD) and
peak VO
Diabetes mellitus No evidence of an
interaction between
DM and exercise
training on any clin-
ical outcomes
Interaction test Post hoc
HF-ACTION
(Parikh 2016)
Kansas City Car-
diomyopathy Ques-
tionnaire
(KCCQ) and exer-
cise capacity
Angina pectoris Evidence of an in-
teraction
between baseline AP
and exercise train-
ing and change in
peak VO (interac-
tion P < 0.019) but
not with change in
HRQoL or change
in 6MWD (interac-
tion P > 0.1). Ex-
ercise training (vs
usual care) was as-
sociatedwith greater
peak VO improve-
ment in patients
with AP (treatment
effect + 1.25 mL/
kg/min, 95% CI 0.
64 to 1.85) than
in patients without
AP (treatment effect
= 0.45 mL/kg/min,
95% CI 0.18 to 0.
72)
Interaction test Post hoc
HF-ACTION
(Luo 2017)
Mortality/hos-
pitalisation, mortal-
ity, and CV mortal-
ity/HF hospitalisa-
tion/exercise capac-
ity/HRQoL
Atrial fibrillation No significant in-
teractions between
baseline AF status
and randomisation
group for change
in quality of life
and functional ca-
pacity from baseline
to 3 months. No ev-
idence
of a differential ef-
fect of exercise train-
ing based on events
andAF status (all in-
teractions P > 0.10)
Interaction test Post hoc
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Table 4. Trial level subgroup analysis (Continued)
HF-ACTION
(Verma 2017)
Mortality/hos-
pitalisation, mortal-
ity, and CV mortal-
ity/HF hospitalisa-
tion/exercise capac-
ity/HRQoL
Having a partner,
SES (education be-
yond high school,
income USD25,
000, and employed)
No inter-
action between any
of the partner status
or SES variables and
exercise training for
outcomes (all P > 0.
5)
Interaction test Post hoc
Dalal 2018 MLWHF, follow-up
12 months
Baseline NT-
proBNP level, pres-
ence of caregiver, re-
cruitment site, du-
ration of HF
“We found no ev-
idence of a signifi-
cant subgroup treat-
ment interaction on
the primary out-
come at 12 months
by NT-pro-
BNP level, presence
of caregiver, recruit-
ment site, or dura-
tion of HF”
Interaction test Yes
6MWD: 6-minute walking distance; ACE: angiotensin-converting enzyme; AF: atrial fibrillation; CI: confidence interval; COPD:
chronic obstructive pulmonary disease; CV: cardiovascular; DM: diabetes mellitus; HF: heart failure; HRQoL: health-related quality
of life; KCCQ: Kansas City Cardiomyopathy Questionnaire; LVEF: left ventricular ejection fraction; MET: metabolic equivalent;
MI: myocardial infarction; MLWHF: Minnesota Living With Heart Failure questionnaire; NTproBNP: N-terminal prohormone
of brain natriuretic peptide; NYHA: New York Heart Association; SES: socioeconomic status; VO : oxygen uptake.
A P P E N D I C E S
Appendix 1. Search strategy January 2018
CENTRAL
#1 MeSH descriptor: [Myocardial Ischemia] explode all trees
#2 (myocard* near isch*mi*):ti or (myocard* near isch*mi*):ab
#3 (isch*mi* near heart):ti or (isch*mi* near heart):ab
#4 MeSH descriptor: [Coronary Artery Bypass] explode all trees
#5 (coronary):ti or (coronary):ab
#6 MeSH descriptor: [Coronary Disease] explode all trees
#7 MeSH descriptor: [Myocardial Revascularization] explode all trees
#8 MeSH descriptor: [Myocardial Infarction] explode all trees
#9 (myocard* near infarct*):ti or (myocard* near infarct*):ab
#10 (heart near infarct*):ti or (heart near infarct*):ab
#11 MeSH descriptor: [Angina Pectoris] explode all trees
#12 (angina):ti or (angina):ab
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#13 MeSH descriptor: [Heart Failure] explode all trees
#14 (heart and (failure or attack)):ti or (heart and (failure or attack)):ab
#15 (Heart diseases):ti or (Heart diseases):ab
#16 MeSH descriptor: [Heart Diseases] explode all trees
#17 (heart and (disease*)):ti or (heart and (disease*)):ab
#18 (myocard*):ti or (myocard*):ab
#19 (cardiac*):ti or (cardiac*):ab
#20 (CABG):ti or (CABG):ab
#21 (PTCA):ti or (PTCA):ab
#22 (stent* and (heart or cardiac*)):ti or (stent* and (heart or cardiac*)):ab
#23 MeSH descriptor: [Heart Bypass, Left] explode all trees
#24 (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”):ti or (HFNEF or HFPEF or HFREF or “HF NEF”
or “HF PEF” or “HF REF”):ab
#25 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #
20 or #21 or #22 or #23 or #24
#26 MeSH descriptor: [Rehabilitation Centers] this term only
#27 MeSH descriptor: [Exercise Therapy] explode all trees
#28 MeSH descriptor: [Sports] this term only
#29 MeSH descriptor: [Physical Exertion] explode all trees
#30 (rehabilitat*):ti or (rehabilitat*):ab
#31 (physical* near (fit* or train* or therap* or activit*)):ti or (physical* near (fit* or train* or therap* or activit*)):ab
#32 MeSH descriptor: [Exercise] explode all trees
#33 (train*) near (strength* or aerobic or exercise*):ti or (train*) near (strength* or aerobic or exercise*):ab
#34 ((exercise* or fitness) near/3 (treatment or intervent* or program*)):ti or ((exercise* or fitness) near/3 (treatment or intervent* or
program*)):ab
#35 MeSH descriptor: [Rehabilitation] explode all trees
#36 MeSH descriptor: [Patient Education as Topic] this term only
#37 (patient* near/3 educat*):ti or (patient* near/3 educat*):ab
#38 ((lifestyle or life-style) near/3 (intervent* or program* or treatment*)):ti or ((lifestyle or life-style) near/3 (intervent* or program*
or treatment*)):ab
#39 MeSH descriptor: [Self Care] explode all trees
#40 MeSH descriptor: [Ambulatory Care] explode all trees
#41 MeSH descriptor: [Psychotherapy] explode all trees
#42 (psychotherap*):ti or (psychotherap*):ab
#43 (psycholog* near intervent*):ti or (psycholog* near intervent*):ab
#44 (relax*):ti or (relax*):ab
#45 MeSH descriptor: [Mind-Body Therapies] explode all trees
#46 ((Mind or Body) and (Relaxation Techniques)):ti or ((Mind or Body) and (Relaxation Techniques)):ab
#47 MeSH descriptor: [Counseling] explode all trees
#48 (counseling or counselling):ti or (counseling or counselling):ab
#49 MeSH descriptor: [Cognitive Therapy] explode all trees
#50 MeSH descriptor: [Behavior Therapy] explode all trees
#51 ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):ti or ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):
ab
#52 MeSH descriptor: [Stress, Psychological] explode all trees
#53 (stress near manage*):ti or (stress near manage*):ab
#54 (cognitive* near therap*):ti or (cognitive* near therap*):ab
#55 MeSH descriptor: [Meditation] explode all trees
#56 (meditat*):ti or (meditat*):ab
#57 MeSH descriptor: [Anxiety] this term only
#58 ((manage*) near (anxiety or depres*)):ti or ((manage*) near (anxiety or depres*)):ab
#59 (CBT):ti or (CBT):ab
#60 (hypnotherap*):ti or (hypnotherap*):ab
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#61 (goal near/3 (setting)):ti or (goal near/3 (setting)):ab
#62 ((psycho-educat*) or (psychoeducat*)):ti ((psycho-educat*) or (psychoeducat*)):ab
#63 (motivat* near (interv*)):ti or (motivat* near (interv*)):ab
#64 MeSH descriptor: [Psychopathology] explode all trees
#65 (psychopathol*):ti or (psychopathol*):ab
#66 MeSH descriptor: [Autogenic Training] explode all trees
#67 (autogenic*):ti or (autogenic*):ab
#68 (self near (manage* or care or motivat*)):ti or (self near (manage* or care or motivat*)):ab
#69 (distress*):ti or (distress*):ab
#70 (psychosocial* or psycho-social):ti or (psychosocial* or psycho-social):ab
#71 MeSH descriptor: [Health Education] explode all trees
#72 (nutrition or diet or health near (education)):ti or (nutrition or diet or health near (education)):ab
#73 (heart manual):ti or (heart manual):ab
#74 #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37
#75 #38 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56
or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73
#76 #74 or #75
#77 #76 and #25
#78 #77 Publication Year from 2013 to 2018, in Trials
MEDLINE
1. exp Myocardial Ischemia/
2. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4. exp Coronary Artery Bypass/
5. coronary.ti,ab.
6. exp Coronary Disease/
7. exp Myocardial Revascularization/
8. Myocardial Infarction/
9. (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 infarct$5).ti,ab.
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp Heart Failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
16. or/1-15
17. exp Heart Diseases/
18. (heart adj5 disease$2).ti,ab.
19. myocard$5.ti,ab.
20. cardiac$2.ti,ab.
21. CABG.ti,ab.
22. PTCA.ti,ab.
23. (stent$4 and (heart or cardiac$4)).ti,ab.
24. Heart Bypass, Left/ or exp Heart Bypass, Right/
25. or/17-24
26. *Rehabilitation Centers/
27. exp Exercise Therapy/
28. *Rehabilitation/
29. exp Sports/
30. Physical Exertion/ or exertion.ti,ab.
31. exp Exercise/
153Exercise-based cardiac rehabilitation for adults with heart failure (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
32. rehabilitat$5.ti,ab.
33. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
34. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
35. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
36. Patient Education as Topic/
37. (patient$2 adj5 educat$4).ti,ab.
38. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
39. *Self Care/
40. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
41. *Ambulatory Care/
42. exp Psychotherapy/
43. psychotherap$2.ti,ab.
44. (psycholog$5 adj5 intervent$5).ti,ab.
45. relax$6.ti,ab.
46. exp Relaxation Therapy/ or exp Mind-Body Therapies/
47. exp Counseling/
48. (counselling or counseling).ti,ab.
49. exp Cognitive Therapy/
50. exp Behavior Therapy/
51. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
52. *Stress, Psychological/
53. (stress adj5 management).ti,ab.
54. (cognitive adj5 therap$2).ti,ab.
55. meditat$4.ti,ab.
56. *Meditation/
57. exp Anxiety/
58. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
59. CBT.ti,ab.
60. hypnotherap$5.ti,ab.
61. (goal adj5 setting).ti,ab.
62. (goal$2 adj5 setting).ti,ab.
63. (psycho-educat$5 or psychoeducat$5).ti,ab.
64. (motivat$5 adj5 (intervention or interv$3)).ti,ab.
65. Psychopathology/
66. psychopathol$4.ti,ab.
67. psychosocial$4.ti,ab.
68. distress$4.ti,ab.
69. exp Health Education/
70. (health adj5 education).ti,ab.
71. (heart adj5 manual).ti,ab.
72. Autogenic Training/
73. autogenic$5.ti,ab.
74. or/26-39
75. or/40-73
76. 16 or 25
77. 74 or 75
78. 76 and 77
79. randomized controlled trial/
80. randomized controlled trial.pt.
81. controlled clinical trial.pt.
82. controlled clinical trial/
83. Random Allocation/
84. Double-Blind Method/
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85. single-blind method/
86. (random$ or placebo$).ti,ab.
87. ((singl$3 or doubl$3 or tripl$3 or trebl$3) adj5 (blind$3 or mask$3)).ti,ab.
88. exp Research Design/
89. Clinical Trial.pt.
90. exp clinical trial/
91. (clinic$3 adj trial$2).ti,ab.
92. or/79-91
93. 78 and 92
94. (Animals not Humans).sh.
95. 93 not 94
96. limit 95 to yr=“2013-Current”
Embase
1. exp heart disease/
2. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4. exp coronary artery disease/
5. transluminal coronary angioplasty/
6. (coronary adj5 (disease$2 or bypass$2 or thrombo$5 or angioplasty$2)).ti,ab.
7. exp heart infarction/
8. (myocard$5 adj5 infarct$5).ti,ab.
9. (heart adj5 infarct$5).ti,ab.
10. heart muscle revascularization/
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp congestive heart failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
16. or/1-15
17. (heart adj5 disease$2).ti,ab.
18. cardiac$2.ti,ab.
19. CABG.ti,ab.
20. PTCA.ti,ab.
21. (stent$4 and heart).ti,ab.
22. exp extracorporeal circulation/
23. or/17-22
24. 16 or 23
25. *Psychotherapy/
26. psychotherapy$2.ti,ab.
27. (psycholog$5 adj5 intervent$5).ti,ab.
28. relax$6.ti,ab.
29. relaxation training/
30. *counselling/
31. (counselling or counseling).ti,ab.
32. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
33. stress management/
34. (stress adj5 management).ti,ab.
35. *Mediation/
36. meditat$5.ti,ab.
37. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
38. CBT.ti,ab.
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39. hypnotherap$2.ti,ab.
40. (goal$2 adj5 setting).ti,ab.
41. (psycho-educat$5 or psychoeducat$5).ti,ab.
42. (motivat$5 adj5 intervent$6).ti,ab.
43. exp psychosocial care/ or exp psychosocial rehabilitation/
44. psychosocial.ti,ab.
45. exp health education/
46. (health adj5 education).ti,ab.
47. (heart adj5 manual).ti,ab.
48. autogenic training/
49. autogenic.ti,ab.
50. *Rehabilitation/
51. rehabilitation center/
52. rehabil$.ti,ab.
53. exp Sport/
54. exp Kinesiotherapy/
55. exp Exercise/
56. exp Physiotherapy/
57. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
58. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
59. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
60. (aerobic$4 adj5 exercise$4).ti,ab.
61. (kinesiotherapy or physiotherapy).ti,ab.
62. patient education/
63. (patient$2 adj5 educat$4).ti,ab.
64. ((((lifestyle or life) adj1 style) or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
65. exp self care/
66. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
67. exp ambulatory care/
68. (psycho-educat$5 or psychoeducat$5).ti,ab.
69. (motivat$5 adj5 intervent$6).ti,ab.
70. psychosocial care/ or psychosocial rehabilitation/
71. psychosocial.ti,ab.
72. exp health education/
73. (health adj5 education).ti,ab.
74. (heart adj5 manual).ti,ab.
75. autogenic training/
76. autogenic$5.ti,ab.
77. (psycho-educat$5 or psychoeducat$5).ti,ab.
78. (motivat$5 adj5 intervent$6).ti,ab.
79. psychosocial care/ or psychosocial rehabilitation/
80. psychosocial.ti,ab.
81. exp health education/
82. (health adj5 education).ti,ab.
83. (heart adj5 manual).ti,ab.
84. or/25-50
85. or/51-83
86. 84 or 85
87. (random$ or placebo$).ti,ab.
88. ((singl$4 or doubl$4 or tripl$4 or trebl$4) adj5 (blind$4 or mask$4)).ti,ab.
89. (controlled adj1 clinical adj1 trial).ti,ab.
90. randomized controlled trial/
91. or/87-90
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92. 24 and 86
93. 91 and 92
94. (animal$ not human$).sh,hw.
95. 93 not 94
96. limit 95 to yr=“2013-Current”
CINAHL
1. TI((myocard* N5 ischaemi*) or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*)) OR AB((myocard* N5
ischaemi*) or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*))
2. TI(coronary) or AB(coronary)
3. TI((myocard* N5 infarc*) or (heart N5 infarc*)) or AB((myocard* N5 infarc*) or (heart N5 infarc*))
4. TI(angina) OR AB(angina)
5. TI(heart N5 failure) or AB(heart N5 failure)
6. TI(heart N5 diseas*) or AB(heart N5 diseas*)
7. TI(cardiac) or AB(cardiac)
8. TI(CABG) or AB(CABG)
9. TI(PTCA) or AB(PTCA)
10. TI(Stent* and (heart or cardiac*)) or AB(Stent* and (heart or cardiac*))
11. (MH “Myocardial Ischemia+”)
12. (MH “Myocardial Infarction+”)
13. (MH “Coronary Artery Bypass+”)
14. (MH “Coronary Disease+”)
15. TI(cardiac N5 patient*) or AB(cardiac N5 patient*)
16. TI(Cardiomyopathies) or AB(Cardiomyopathies)
17. (MH “Myocardial Revascularization+”)
18. (MH “Heart Diseases+”)
19. (MH “Cardiovascular Diseases+”)
20. (MH “Heart Failure+”)
21. (MH “Angina Pectoris+”)
22. TI(HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”) or AB(HFNEF or HFPEF or HFREF or “HF NEF”
or “HF PEF” or “HF REF”)
23. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18 OR S19 OR S20 OR S21 OR S22
24. (MM “Rehabilitation”)
25. (MM “Sports”)
26. (MM “Physical Activity”)
27. (MH “Muscle Strengthening+”)
28. (MH “Aerobic Exercises+”)
29. (MH “Physical Fitness+”)
30. (MH “Patient Education+”)
31. (MH “Therapeutic Exercise+”)
32. TI(rehabilitat*) or AB(rehabilitat*)
33. TI((physical* N5 fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*)) or
AB((physical* N5 fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*))
34. TI((train N5 strength) or (train N5 aerobic) or (train N5 exercis*)) or AB((train N5 strength) or (train N5 aerobic) or (train N5
exercis*))
35. TI((exercise N5 treatment) or (fitness N5 treatment) or (exercise N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*)
or (fitness N5 program) or (exercise N5 therapy) or (fitness N5 therapy)) or AB((exercise N5 treatment) or (fitness N5 treatment)
or (exercise N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*) or (fitness N5 program) or (exercise N5 therapy) or
(fitness N5 therapy))
36. TI(patient* N5 educat*) or AB(patient* N5 educat*)
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37. TI ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or (life-style N5 program*) or (lifestyle N5
treatment) or (life-style N5 treatment)) OR AB ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or
(life-style N5 program*) or (lifestyle N5 treatment) or (life-style N5 treatment))
38. (MH “Self Care+”)
39. TI((self N5 manage*) or (self N5 care) or (self N5 motivat*)) or AB((self N5 manage*) or (self N5 care) or (self N5 motivat*))
40. (MM “Ambulatory Care”)
41. TI(aerobic) or AB(aerobic)
42. TI(resistance W1 train*) or AB(resistance W1 train*)
43. TI(muscle W1 strength*) or AB(muscle W1 strength*)
44. TI(resistance W1 train*) or AB(resistance W1 train*)
45. TI(muscle W1 strength*) or AB(muscle W1 strength*)
46. (MH “Psychotherapy+”)
47. TI(psychotherap*) or AB(psychotherap*)
48. TI(psycholog* N5 intervent*) or AB(psycholog* N5 intervent*)
49. TI(relax) or AB(relax)
50. (MH “Relaxation Techniques+”)
51. TI(counselling or counseling) or AB(counselling or counseling)
52. (MH “Counseling+”)
53. TI((behavio?r* N5 modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change)) or AB((behavio?
r* N5 modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change))
54. (MM “Stress Management”)
55. TI(stress N5 manag*) or AB(stress N5 manag*)
56. TI(cognitive N5 therap*) or AB(cognitive N5 therap*)
57. (MM “Meditation”)
58. TI(meditat*) or AB(meditat*)
59. (MH “Anxiety+”)
60. TI((manage* N5 anxiety) or (manage* N5 depress*)) or AB((manage* N5 anxiety) or (manage* N5 depress*))
61. TI(CBT) or AB(CBT)
62. TI(hypnotherap*) or AB(hypnotherap*)
63. TI(goal* N5 setting) or AB(goal* N5 setting)
64. TI(psycho-educat* or psychoeducat*) or AB(psycho-educat* or psychoeducat*)
65. TI((motivat* N5 interv*) or (motivate* N5 intervent*)) or AB((motivat* N5 interv*) or (motivate* N5 intervent*))
66. TI(psychosocial*) or AB(psychosocial*)
67. (MH “Health Education+”)
68. TI(health N5 educat*) or AB(health N5 educat*)
69. TI(heart W1 manual) or AB(heart W1 manual)
70. TI(autogenic*) or AB(autogenic*)
71. S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38
OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45
72. S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60
OR S61 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70
73. S71 OR S72
74. S23 AND S73
75. PT CLINICAL TRIAL
76. (MH “Clinical Trials+”)
77. TI (random* or placebo*) or AB (random* or placebo*)
78. TI(singl* or double* or triple* or treble* and (blind* or mask*)) or AB(singl* or double* or triple* or treble* and (blind* or mask*))
79. TI(controlled w1 clinical w1 trials) or AB(controlled w1 clinical w1 trials)
80. S75 OR S76 OR S77 OR S78 OR S79
81. S74 AND S80 Publication Year: 2013-2018
PsycINFO
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1. exp heart disorders/
2. *Myocardial Infarctions/
3. exp Ischemia/
4. *Heart Surgery/
5. angioplasty.ti,ab.
6. (heart adj1 bypass).ti,ab.
7. coronary.ti,ab.
8. (ischemi$3 or ischaemi$3).ti,ab.
9. (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 (infarct$5 or failure or attack)).ti,ab.
11. angina.ti,ab.
12. (heart adj5 disease$2).ti,ab.
13. myocard$5.ti,ab.
14. cardiac$4.ti,ab.
15. CABG.ti,ab.
16. PTCA.ti,ab.
17. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
18. or/1-17
19. exp Physical Activity/
20. exp Sports/
21. *Physical Education/
22. exp Health Behavior/
23. *Physical Fitness/
24. (physical adj1 education).ti,ab.
25. exertion$6.ti,ab.
26. rehabilitat$6.ti,ab.
27. (physical adj5 (fit$5 or train$5 or therap$5 or activit$4)).ti,ab.
28. (train$4 adj5 (strength$4 or aerobic or exercise$2)).ti,ab.
29. ((exercise$3 or fitness) adj5 (treatment or intervent$4 or program$4 or therap$2)).ti,ab.
30. patient with education.ti,ab.
31. exp Client Education/
32. exp Health Promotion/
33. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
34. exp Outpatient Treatment/
35. or/19-34
36. exp Psychotherapy/
37. psychotherapy$2.ti,ab.
38. exp Treatment/
39. (psycholog$4 adj5 intervent$5).ti,ab.
40. exp Counseling/
41. exp Coping Behavior/
42. *Meditation/
43. *Autogenic Training/
44. exp Health Education/
45. relax$6.ti,ab.
46. (counselling or counseling).ti,ab.
47. ((behavior or behaviour) adj5 (modif$5 or therap$5 or rehabilit5 or change)).ti,ab.
48. (stress adj5 management).ti,ab.
49. meditat$5.ti,ab.
50. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
51. ((cbt or cognitive$2) adj5 therap$3).ti,ab.
52. hypnotherap$3.ti,ab.
53. (psycho-educat$6 or psychoeducat$6).ti,ab.
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54. (motivat$5 adj5 intervent$5).ti,ab.
55. (self adj5 manag$6).ti,ab.
56. autogenic$3.ti,ab.
57. (goal adj5 setting).ti,ab.
58. (health adj5 education).ti,ab.
59. (heart adj1 manual).ti,ab.
60. or/36-59
61. 18 and (35 or 60)
62. (random$5 or placebo$5).ti,ab.
63. ((single$4 or double$4 or triple$4) and (blind$4 or mask or sham$4 or dummy)).ti,ab.
64. RCT.ti,ab.
65. or/62-64
66. 61 and 65
67. limit 66 to yr=“2013-Current”
Web of Science
1. TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
2. TS=((coronary* or heart*) SAME (by?pass or disease*))
3. TS=((heart) SAME (infarct* or isch?emia or failure or attack))
4. TS=(angina or cardiac* or PTCA or CABG)
5. TS=(HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”)
6. #1 OR #2 OR #3 OR #4 OR #5
7. TS=(rehab* or educat*)
8. #6 AND #7
9. TS=(random* or placebo*)
10. TS=((singl* or doubl* or tripl* or trebl*) SAME (blind* or mask*))
11. TS=(“clinic* trial*”)
12. #9 OR #10 OR #11
13. #8 AND #12
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2013-2018
Appendix 2. Search strategy 2001
Cochrane Controlled Trials Register (2001, Issue 2)
1. HEART-FAILURE-CONGESTIVE*:ME
2. (HEART and FAILURE)
3. (CARDIAC and FAILURE)
4. ((#1 or #2) or #3)
5. REHABILITATION*:ME
6. EXERCISE*:ME
7. EXERCISE-THERAPY*:ME
8. SPORTS*:ME
9. PHYSICAL-EDUCATION-AND-TRAINING*:ME
10. EXERTION*:ME
11. REHABILITAT*
12. (PHYSICAL* near FIT)
13. (PHYSICAL* near FITNESS)
14. (PHYSICAL near TRAIN*)
15. (PHYSICAL* near ACTIVIT*)
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16. (TRAIN* near STRENGTH*)
17. (TRAIN* near AEROBIC*)
18. (AEROBIC* near EXERCISE*)
19. KINESIOTHERAP*
20. (EXERCISE* near TRAIN*)
21. (((((((((((((((#5 or #6) or #7) or #8) or #9) or #10) or #11) or #12) or #13) or #14) or #15) or #16) or #17) or #18) or #19) or #20)
22. (#4 and #21)
Appendix 3. Search strategies 2008
CENTRAL, in the Cochrane Library (2007, Issue 4)
#1MeSH descriptor Myocardial Ischemia explode all trees
#2(myocard* NEAR isch*mi*)
#3isch*mi* NEAR heart
#4MeSH descriptor Coronary Artery Bypass explode all trees
#5coronary
#6MeSH descriptor Coronary Disease explode all trees
#7MeSH descriptor Myocardial Revascularization explode all trees
#8MeSH descriptor Myocardial Infarction explode all trees
#9myocard* NEAR infarct*
#10heart NEAR infarct*
#11MeSH descriptor Angina Pectoris explode all trees
#12angina
#13MeSH descriptor Heart Failure, Congestive explode all trees
#14heart and (failure or attack)
#15MeSH descriptor Heart Diseases explode all trees
#16heart and disease*
#17myocard*
#18cardiac*
#19CABG
#20PTCA
#21stent* AND (heart or cardiac*)
#22MeSH descriptor Heart Bypass, Left explode all trees
#23MeSH descriptor Heart Bypass, Right explode all trees
#24(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR
#16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23)
#25MeSH descriptor Rehabilitation Centers, this term only
#26MeSH descriptor Exercise Therapy explode all trees
#27MeSH descriptor Sports, this term only
#28MeSH descriptor Exertion explode all trees
#29rehabilitat*
#30(physical* NEAR (fit* or train* or therap* or activit*))
#31MeSH descriptor Exercise explode all trees
#32(train*) near (strength* or aerobic or exercise*)
#33((exercise* or fitness) NEAR/3 (treatment or intervent* or program*))
#34MeSH descriptor Rehabilitation explode all trees
#35MeSH descriptor Patient Education explode all trees
#36(patient* NEAR/3 educat*)
#37((lifestyle or life-style) NEAR/3 (intervent* or program* or treatment*))
#38MeSH descriptor Self Care explode all trees
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#39MeSH descriptor Ambulatory Care explode all trees
#40MeSH descriptor Psychotherapy explode all trees
#41psychotherap*
#42psycholog* NEAR intervent*
#43relax*
#44MeSH descriptor Mind-Body and Relaxation Techniques explode all trees
#45MeSH descriptor Counseling explode all trees
#46counsel*ing
#47MeSH descriptor Cognitive Therapy explode all trees
#48MeSH descriptor Behavior Therapy explode all trees
#49(behavio*r*) NEAR/4 (modif* or therap* or rehab* or change)
#50MeSH descriptor Stress, Psychological explode all trees
#51stress NEAR manage*
#52cognitive* NEAR therap*
#53MeSH descriptor Meditation explode all trees
#54meditat*
#55MeSH descriptor Anxiety, this term only
#56(manage*) NEAR (anxiety or depres*)
#57CBT
#58hypnotherap*
#59goal NEAR/3 setting
#60(psycho-educat*) or (psychoeducat*)
#61motivat* NEAR interv*
#62MeSH descriptor Psychopathology explode all trees
#63psychopathol*
#64MeSH descriptor Autogenic Training explode all trees
#65autogenic*
#66self near (manage* or care or motivat*)
#67distress*
#68psychosocial* or psycho-social
#69MeSH descriptor Health Education explode all trees
#70(nutrition or diet or health) NEAR education
#71heart manual
#72(#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37)
#73(#38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR
#51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64 OR
#65 OR #66 OR #67 OR #68 OR #69 OR #70 OR #71)
#74(#72 OR #73)
#75(#74 AND #24)
MEDLINE dialog to week 1 2008
1. SEARCH: MYOCARDIAL-ISCHEMIA#.DE.
2. SEARCH: MYOCARD$4 NEAR (ISCHAEMI$2 OR ISCHEMI$2)
3. SEARCH: (ISCHAEMI$2 OR ISCHEMI$2) NEAR HEART
4. SEARCH: CORONARY-ARTERY-BYPASS#.DE.
5. SEARCH: CORONARY.TI,AB.
6. SEARCH: CORONARY-DISEASE#.DE.
7. SEARCH: MYOCARDIAL-REVASCULARIZATION#.DE.
8. SEARCH: MYOCARDIAL-INFARCTION#.DE.
9. SEARCH: MYOCARD$5 NEAR INFARCT$5
10. SEARCH: HEART NEAR INFARCT$5
11. SEARCH: ANGINA-PECTORIS#.DE.
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12. SEARCH: ANGINA.TI,AB.
13. SEARCH: HEART-FAILURE-CONGESTIVE#.DE.
14. SEARCH: HEART NEAR FAILURE
15. SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
16. SEARCH: HEART-DISEASES#.DE.
17. SEARCH: (HEART NEAR DISEASE$2).TI,AB.
18. SEARCH: MYOCARD$5.TI,AB.
19. SEARCH: CARDIAC$2.TI,AB.
20. SEARCH: CABG
21. SEARCH: PTCA
22. SEARCH: STENT$4 AND (HEART OR CARDIAC$4)
23. SEARCH: HEART-BYPASS-LEFT#.DE. OR HEART-BYPASS-RIGHT#.DE.
24. SEARCH: 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23
25. SEARCH: REHABILITATION-CENTERS.DE.
26. SEARCH: EXERCISE-THERAPY#.DE.
27. SEARCH: REHABILITATION.W..DE.
28. SEARCH: SPORTS#.W..DE.
29. SEARCH: EXERTION#.W..DE.
30. SEARCH: EXERCISE#.W..DE.
31. SEARCH: REHABILITAT$5.TI,AB.
32. SEARCH: PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$5 OR THERAP$5 OR ACTIVIT$5)
33. SEARCH: TRAIN$5 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)
34. SEARCH: (EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)
35. SEARCH: PATIENT-EDUCATION#.DE.
36. SEARCH: PATIENT$2 NEAR EDUCAT$4
37. SEARCH: (LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)
38. SEARCH: SELF-CARE.DE.
39. SEARCH: SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)
40. SEARCH: AMBULATORY-CARE.DE.
41. SEARCH: PSYCHOTHERAPY#.W..DE.
42. SEARCH: PSYCHOTHERAP$2.TI,AB.
43. SEARCH: PSYCHOLOG$5 NEAR INTERVENT$5
44. SEARCH: RELAX$6.TI,AB.
45. SEARCH: RELAXATION-TECHNIQUES#.DE. OR MIND-BODY-AND-RELAXATION-TECHNIQUES#.DE.
46. SEARCH: COUNSELING#.W..DE.
47. SEARCH: (COUNSELLING OR COUNSELING).TI,AB.
48. SEARCH: COGNITIVE-THERAPY#.DE.
49. SEARCH: BEHAVIOR-THERAPY#.DE.
50. SEARCH: (BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAP$2 OR CHANGE)
51. SEARCH: STRESS-PSYCHOLOGICAL#.DE.
52. SEARCH: STRESS NEAR MANAGEMENT
53. SEARCH: COGNITIVE NEAR THERAP$2
54. SEARCH: MEDITAT$4
55. SEARCH: MEDITATION#.W..DE.
56. SEARCH: ANXIETY#.W..DE.
57. SEARCH: MANAGE$5 NEAR (ANXIETY OR DEPRES$5)
58. SEARCH: CBT.TI,AB.
59. SEARCH: HYPNOTHERAP$5
60. SEARCH: GOAL NEAR SETTING
61. SEARCH: GOAL$2 NEAR SETTING
62. SEARCH: PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
63. SEARCH: MOTIVAT$5 NEAR (INTERVENTION OR INTERV$3)
64. SEARCH: PSYCHOPATHOLOGY#.W..DE.
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65. SEARCH: PSYCHOPATHOL$4.TI,AB.
66. SEARCH: PSYCHOSOCIAL$4.TI,AB.
67. SEARCH: DISTRESS$4.TI,AB.
68. SEARCH: HEALTH-EDUCATION#.DE.
69. SEARCH: HEALTH NEAR EDUCATION
70. SEARCH: HEART ADJ MANUAL
71. SEARCH: AUTOGENIC-TRAINING#.DE.
72. SEARCH: AUTOGENIC$5.TI.AB.
73. SEARCH: 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38
74. SEARCH: 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53
OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR
70 OR 71 OR 72
75. SEARCH: 15 OR 24
76. SEARCH: 73 or 74
77. SEARCH: 75 AND 76
78. SEARCH: RANDOMIZED-CONTROLLED-TRIALS#.DE.
79. SEARCH: PT=RANDOMIZED-CONTROLLED-TRIAL
80. SEARCH: PT=CONTROLLED-CLINICAL-TRIAL
81. SEARCH: CONTROLLED-CLINICAL-TRIALS#.DE.
82. SEARCH: RANDOM-ALLOCATION#.DE.
83. SEARCH: DOUBLE-BLIND-METHOD#.DE.
84. SEARCH: SINGLE-BLIND-METHOD#.DE.
85. SEARCH: (RANDOM$ OR PLACEBO$).TI,AB.
86. SEARCH: ((SINGL$3 OR DOUBL$3 OR TRIPL$3 OR TREBL$3) NEAR (BLIND$3 OR MASK$3)).TI,AB.
87. SEARCH: RESEARCH-DESIGN#.DE.
88. SEARCH: PT=CLINICAL-TRIAL#
89. SEARCH: CLINICAL-TRIALS#.DE.
90. SEARCH: (CLINIC$3 ADJ TRIAL$2).TI,AB.
91. SEARCH: 77 AND 90
92. SEARCH: (ANIMALS NOT HUMANS).SH.
93. SEARCH: 91 NOT 92
94. SEARCH: LIMIT 93 TO 2001-DATE
Embase dialog to week 1 2008
1. HEART-DISEASE#.DE.
2. (MYOCARD$4 NEAR (ISCHAEMI$2 OR ISCHEMI$2)).TI,AB.
3. ((ISCHAEMI$2 OR ISCHEMI$2) NEAR HEART).TI,AB.
4. CORONARY-ARTERY-DISEASE#.DE.
5. TRANSLUMINAL-CORONARY-ANGIOPLASTY#.DE.
6. (CORONARY NEAR (DISEASE$2 OR BYPASS$2 OR THROMBO$5 OR ANGIOPLAST$2)).TI,AB.
7. HEART-INFARCTION#.DE.
8. (MYOCARD$4 NEAR INFARCT$5).TI,AB.
9. (HEART NEAR INFARC$5).TI,AB.
10. HEART-MUSCLE-REVASCULARIZATION#.DE.
11. ANGINA-PECTORIS#.DE.
12. ANGINA.TI,AB.
13. CONGESTIVE-HEART-FAILURE#.DE.
14. (HEART NEAR FAILURE).TI,AB.
15. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
16. (HEART NEAR DISEASE$2).TI,AB.
17. CARDIAC$2.TI,AB.
18. CABG.TI,AB.
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19. PTCA.TI,AB.
20. STENT$4.TI,AB. AND HEART.TI,AB.
21. EXTRACORPOREAL-CIRCULATION#.DE.
22. 16 OR 17 OR 18 OR 19 OR 20 OR 21
23. 15 OR 22
24. PSYCHOTHERAPY#.W..DE.
25. PSYCHOTHERAP$2.TI,AB.
26. PSYCHOLOG$5 NEAR INTERVENT$5
27. RELAX$6.TI,AB.
28. RELAXATION-TRAINING#.DE.
29. COUNSELING#.W..DE.
30. (COUNSELLING OR COUNSELING).TI,AB.
31. (BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAPY$2 OR CHANGE)
32. STRESS-MANAGEMENT#.DE.
33. STRESS NEAR MANAGEMENT
34. MEDITATION#.W..DE.
35. MEDITAT$5.TI,AB.
36. MANAGE$5 NEAR (ANXIETY OR DEPRES$5)
37. CBT.TI,AB.
38. HYPNOTHERAP$2.TI,AB.
39. GOAL$2 NEAR SETTING
40. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
41. MOTIVAT$5 NEAR INTERVENT$6
42. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
43. PSYCHOSOCIAL.TI,AB.
44. HEALTH-EDUCATION#.DE.
45. HEALTH NEAR EDUCATION
46. HEART ADJ MANUAL
47. AUTOGENIC-TRAINING#.DE.
48. AUTOGENIC.TI,AB.
49. REHABILITATION#.W..DE.
50. REHABILITATION-CENTER#.DE.
51. REHABIL$.TI,AB.
52. SPORT#.W..DE.
53. KINESIOTHERAPY#.W..DE.
54. EXERCISE#.W..DE.
55. PHYSIOTHERAPY#.W..DE.
56. PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$5 OR THERAP$5 OR ACTIVIT$5)
57. TRAIN$5 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)
58. (EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)
59. AEROBIC$4 NEAR EXERCISE$4
60. (KINESIOTHERAPY OR PHYSIOTHERAPY).TI,AB.
61. PATIENT-EDUCATION#.DE.
62. PATIENT$2 NEAR EDUCAT$4
63. (LIFESTYLE OR LIFE ADJ STYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)
64. SELF-CARE#.DE.
65. SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)
66. AMBULATORY-CARE#.DE.
67. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
68. MOTIVAT$5 NEAR INTERVENT$6
69. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
70. PSYCHOSOCIAL.TI,AB.
71. HEALTH-EDUCATION#.DE.
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72. HEALTH NEAR EDUCATION
73. HEART ADJ MANUAL
74. AUTOGENIC-TRAINING#.DE.
75. AUTOGENIC.TI,AB.
76. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
77. MOTIVAT$5 NEAR INTERVENT$6
78. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
79. PSYCHOSOCIAL.TI,AB.
80. HEALTH-EDUCATION#.DE.
81. HEALTH NEAR EDUCATION
82. HEART ADJ MANUAL
83. 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or
42 or 43 or 44 or 45 or 46 or 47 or 48 or 49
84 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR
66 OR 67 OR 68 OR 69 OR 70 OR 71 OR 72 OR 73 OR 74 OR 75 OR 76 OR 77 OR 78 OR 79 OR 80 OR 81 OR 82
85. 83 OR 84
86. (RANDOM$ OR PLACEBO$).TI,AB.
87. (SINGL$4 OR DOUBLE$4 OR TRIPLE$4 OR TREBLE$4).TI,AB. AND (BLIND$4 OR MASK$4).TI,AB.
88. (CONTROLLED ADJ CLINICAL ADJ TRIAL).TI,AB.
89. RANDOMIZED-CONTROLLED-TRIAL#.DE.
90. 1 OR 2 OR 3 OR 4
91. 23 AND 85
92. 91 AND 92
93. LIMIT 92 TO 2001-2008
CINAHL dialog to week 1 2008
1. ((MYOCARD$4 OR HEART) NEAR (ISCHAEMI$2 OR ISCHEMI$2)).TI,AB.
2. CORONARY.TI,AB.
3. ((MYOCARD$4 OR HEART) NEAR INFARC$5).TI,AB.
4. ANGINA.TI,AB.
5. (HEART NEAR FAILURE).TI,AB.
6. (HEART NEAR DISEAS$2).TI,AB.
7. CARDIAC$2.TI,AB.
8. CABG
9. PTCA
10. STENT$4.TI,AB. AND (HEART OR CARDIAC$4).TI,AB.
11. MYOCARDIAL-ISCHEMIA#.DE.
12. MYOCARDIAL-INFARCTION#.DE.
13. CORONARY-ARTERY-BYPASS#.DE.
14. CORONARY-DISEASE#.DE.
15. CARDIAC-PATIENTS#.DE.
16. MYOCARDIAL-DISEASES#.DE.
17. MYOCARDIAL-REVASCULARIZATION#.DE.
18. HEART-DISEASES#.DE.
19. CARDIOVASCULAR-DISEASES#.DE.
20. HEART-FAILURE-CONGESTIVE#.DE.
21. ANGINA-PECTORIS#.DE.
22. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
OR 19 OR 20 OR 21
23. REHABILITATION#.W..DE.
24. SPORTS#.W..DE.
25. EXERCISE#.W..DE.
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26. PHYSICAL-ACTIVITY#.DE.
27. MUSCLE-STRENGTHENING#.DE.
28. AEROBIC-EXERCISES#.DE.
29. PHYSICAL-FITNESS#.DE.
30. PATIENT-EDUCATION#.DE.
31. THERAPEUTIC-EXERCISE#.DE.
32. REHABILITAT$5.TI,AB.
33. (PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$4 OR THERAP$5 OR ACTIVIT$4)).TI,AB.
34. (TRAIN$4 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)).TI,AB.
35. ((EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)).TI,AB.
36. (PATIENT$2 NEAR EDUCAT$4).TI,AB.
37. ((LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)).TI,AB.
38. SELF-CARE#.DE.
39. (SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)).TI,AB.
40. AMBULATORY-CARE#.DE.
41 AEROBIC.TI,AB.
42. RESISTANCE ADJ TRAIN$4
43. MUSCLE ADJ STRENGTH$5
44. AEROBIC.TI,AB.
45. RESISTANCE ADJ TRAIN$4
46. MUSCLE ADJ STRENGTH$5
47. PSYCHOTHERAPY#.W..DE.
48. PSYCHOTHERAP$2.TI,AB.
49. (PSYCHOLOG$5 NEAR INTERVENT$5).TI,AB.
50. RELAX.TI,AB.
51. RELAXATION-TECHNIQUES#.DE.
52. (COUNSELLING OR COUNSELING).TI,AB.
53. COUNSELING#.W..DE.
54. ((BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAP$2 OR CHANGE)).TI,AB.
55. STRESS-MANAGEMENT#.DE.
56. (STRESS NEAR MANAG$5).TI,AB.
57. (COGNITIVE NEAR THERAP$2).TI,AB.
58. MEDITATION#.W..DE.
59. MEDITAT$5.TI,AB.
60. ANXIETY#.W..DE.
61. (MANAGE$5 NEAR (ANXIETY OR DEPRESS$5)).TI,AB.
62. CBT.TI,AB.
63. HYPNOTHERAP$5.TI,AB.
64. (GOAL$2 NEAR SETTING).TI,AB.
65. (PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5).TI,AB.
66. (MOTIVAT$5 NEAR (INTERV$3 OR INTERVENT$5)).TI,AB.
67. PSYCHOSOCIAL$4.TI,AB.
68. HEALTH-EDUCATION#.DE.
69. (HEALTH NEAR EDUCAT$5).TI,AB.
70. HEART ADJ MANUAL
71. AUTOGENIC$3.TI,AB.
72. 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR
39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46
73. 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR
63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR 70 OR 71
74. 72 OR 73
75. 22 AND 74
76. PT=CLINICAL-TRIAL
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77. CLINICAL-TRIALS#.DE.
78. (RANDOM$5 OR PLACEBO$2).TI,AB.
79. (SINGL$ OR DOUBLE$ OR TRIPLE$ OR TREBLE$).TI,AB. AND (BLIND$ OR MASK$).TI,AB.
80. CONTROLLED ADJ CLINICAL ADJ TRIALS
81. 76 OR 77 OR 78 OR 79 OR 80
82. 75 AND 81
83. LIMIT 82 TO 2001-2008
PsycINFO dialog to January week 1 2008
1. SEARCH: HEART-DISORDERS#.DE.
2. SEARCH: MYOCARDIAL-INFARCTIONS.DE.
3. SEARCH: ISCHEMIA#.W..DE.
4. SEARCH: HEART-SURGERY.DE.
5. SEARCH: ANGIOPLASTY
6. SEARCH: HEART ADJ BYPASS
7. SEARCH: CORONARY.TI,AB.
8. SEARCH: (ISCHEMI$3 OR ISCHAEMI$3).TI,AB.
9. SEARCH: (MYOCARD$5 NEAR INFARCT$5).TI,AB.
10. SEARCH: (HEART NEAR (INFARC$5 OR FAILURE OR ATTACK)).TI,AB.
11. SEARCH: ANGINA.TI,AB.
12. SEARCH: (HEART NEAR DISEASE$2).TI,AB.
13. SEARCH: MYOCARD$5.TI,AB.
14. SEARCH: CARDIAC$4.TI,AB.
15. SEARCH: CABG.TI,AB.
16. SEARCH: PTCA.TI,AB.
17. SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16
18. SEARCH: PHYSICAL-ACTIVITY#.DE.
19. SEARCH: SPORTS#.W..DE.
20. SEARCH: PHYSICAL-EDUCATION.DE.
21. SEARCH: HEALTH-BEHAVIOR#.DE.
22. SEARCH: PHYSICAL-FITNESS.DE.
23. SEARCH: (PHYSICAL ADJ EDUCATION).TI,AB.
24 SEARCH: EXERTION.TI,AB.
25. SEARCH: REHABILITAT$6.TI,AB.
26. SEARCH: (PHYSICAL NEAR (FIT$5 OR TRAIN$5 OR THERAP$5 OR ACTIVIT$4)).TI,AB.
27. SEARCH: (TRAIN$4 NEAR (STRENGTH$4 OR AEROBIC OR EXERCISE$2)).TI,AB.
28. SEARCH: ((EXERCISE$3 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$4 OR
THERAP$2)).TI,AB.
29. SEARCH: (PATIENT WITH EDUCATION).TI,AB.
30. SEARCH: CLIENT-EDUCATION#.DE.
31. SEARCH: HEALTH-PROMOTION#.DE.
32. SEARCH: ((LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)).TI,AB.
33. SEARCH: OUTPATIENT-TREATMENT#.DE.
34. SEARCH: 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32
OR 33
35. SEARCH: PSYCHOTHERAPY#.W..DE.
36 SEARCH: PSYCHOTHERAP$2.TI,AB.
37 SEARCH: TREATMENT#.W..DE.
38 SEARCH: (PSYCHOLOG$4 NEAR INTERVENT$5).TI,AB.
39 SEARCH: COUNSELING#.W..DE.
40 SEARCH: COPING-BEHAVIOR#.DE.
41 SEARCH: MEDITATION.W..DE.
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42 SEARCH: AUTOGENIC-TRAINING.DE.
43 SEARCH: HEALTH-EDUCATION#.DE.
44. SEARCH: RELAX$6.TI,AB.
45. SEARCH: (COUNSELLING OR COUNSELING).TI,AB.
46. SEARCH: ((BEHAVIOUROR BEHAVIOR) NEAR (MODIF$5 ORTHERAP$5 OR REHABILIT$5 ORCHANGE)).TI,AB.
47. SEARCH: (STRESS NEAR MANAGE$5).TI,AB.
48. SEARCH: MEDITAT$5.TI,AB.
49. SEARCH: (MANAGE$5 NEAR (ANXIETY OR DEPRES$5)).TI,AB.
50. SEARCH: (CBT OR COGNITIV$2 NEAR THERAP$3).TI,AB.
51. SEARCH: HYPNOTHERAP$3.TI,AB.
52. SEARCH: (PSYCHO-EDUCAT$6 OR PSYCHOEDUCAT$6).TI,AB.
53. SEARCH: (MOTIVAT$5 NEAR INTERVENT$5).TI,AB.
54. SEARCH: (SELF NEAR MANAG$6).TI,AB.
55. SEARCH: AUTOGENIC$3.TI,AB.
56. SEARCH: (GOAL NEAR SETTING).TI,AB.
57. SEARCH: (HEALTH NEAR EDUCATION).TI,AB.
58. SEARCH: (HEART ADJ MANUAL).TI,AB.
59. SEARCH: 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49
OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58
60. SEARCH: 17 AND (34 OR 59)
61. SEARCH: (RANDOM$5 OR PLACEBO$5).TI,AB.
62. SEARCH: (DOUBLE$4 OR SINGLE$4 OR TRIPLE$4).TI,AB. AND (BLIND$4 OR MASK OR SHAM$4 OR
DUMMY).TI,AB.
63. SEARCH: RCT.TI,AB.
64. SEARCH: AT=TREATMENT$
65. SEARCH: 61 OR 62 OR 63 OR 64
66. SEARCH: 60 AND 66
67. SEARCH: LIMIT 66 TO YRS=2001-2008
ISI Proceedings, search date 1 April 2008
# 7 807 #5 and #6
Databases=STP Timespan=2001-2008
# 6 29,517 TS=(rehab* or educat*)
Databases=STP Timespan=2001-2008
# 5 52,687 #4 OR #3 OR #2 OR #1
Databases=STP Timespan=2001-2008
# 4 27,506 TS=(angina or cardiac* or PTCA or CABG)
Databases=STP Timespan=2001-2008
# 3 11,226 TS=((heart) SAME (infarct* or isch?emia or failure or attack))
Databases=STP Timespan=2001-2008
# 2 12,618 TS=((coronary* or heart*) SAME (by?pass or disease*))
Databases=STP Timespan=2001-2008
# 1 11,809 TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
Databases=STP Timespan=2001-2008
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Appendix 4. Search strategies 2013
CENTRAL in the Cochrane Library (2013, Issue 1)
1. MeSH descriptor: [Myocardial Ischemia] explode all trees
2. (myocard* near isch*mi*):ti or (myocard* near isch*mi*):ab
3. (isch*mi* near heart):ti or (isch*mi* near heart):ab
4. MeSH descriptor: [Coronary Artery Bypass] explode all trees
5. (coronary):ti or (coronary):ab
6. MeSH descriptor: [Coronary Disease] explode all trees
7. MeSH descriptor: [Myocardial Revascularization] explode all trees
8. MeSH descriptor: [Myocardial Infarction] explode all trees
9. (myocard* near infarct*):ti or (myocard* near infarct*):ab
10. (heart near infarct*):ti or (heart near infarct*):ab
11. MeSH descriptor: [Angina Pectoris] explode all trees
12. (angina):ti or (angina):ab
13. MeSH descriptor: [Heart Failure] explode all trees
14. (heart and (failure or attack)):ti or (heart and (failure or attack)):ab
15. (Heart diseases):ti or (Heart diseases):ab
16. MeSH descriptor: [Heart Diseases] explode all trees
17. (heart and (disease*)):ti or (heart and (disease*)):ab
18. (myocard*):ti or (myocard*):ab
19. (cardiac*):ti or (cardiac*):ab
20. (CABG):ti or (CABG):ab
21. (PTCA):ti or (PTCA):ab
22. (stent* and (heart or cardiac*)):ti or (stent* and (heart or cardiac*)):ab
23. MeSH descriptor: [Heart Bypass, Left] explode all trees
24. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”):ti or (HFNEF or HFPEF or HFREF or “HF NEF” or
“HF PEF” or “HF REF”):ab
25. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #
20 or #21 or #22 or #23 or #24)
26. MeSH descriptor: [Rehabilitation Centers] this term only
27. MeSH descriptor: [Exercise Therapy] explode all trees
28. MeSH descriptor: [Sports] this term only
29. MeSH descriptor: [Physical Exertion] explode all trees
30. (rehabilitat*):ti or (rehabilitat*):ab
31. (physical* near (fit* or train* or therap* or activit*)):ti or (physical* near (fit* or train* or therap* or activit*)):ab
32. MeSH descriptor: [Exercise] explode all trees
33. (train*) near (strength* or aerobic or exercise*):ti or (train*) near (strength* or aerobic or exercise*):ab
34. ((exercise* or fitness) near/3 (treatment or intervent* or program*)):ti or ((exercise* or fitness) near/3 (treatment or intervent* or
program*)):ab
35. MeSH descriptor: [Rehabilitation] explode all trees
36. MeSH descriptor: [Patient Education as Topic] this term only
37. (patient* near/3 educat*):ti or (patient* near/3 educat*):ab
38. ((lifestyle or life-style) near/3 (intervent* or program* or treatment*)):ti or ((lifestyle or life-style) near/3 (intervent* or program*
or treatment*)):ab
39. MeSH descriptor: [Self Care] explode all trees
40. MeSH descriptor: [Ambulatory Care] explode all trees
41. MeSH descriptor: [Psychotherapy] explode all trees
42. (psychotherap*):ti or (psychotherap*):ab
43. (psycholog* near intervent*):ti or (psycholog* near intervent*):ab
44. (relax*):ti or (relax*):ab
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45. MeSH descriptor: [Mind-Body Therapies] explode all trees
46. ((Mind or Body) and (Relaxation Techniques)):ti or ((Mind or Body) and (Relaxation Techniques)):ab
47. MeSH descriptor: [Counseling] explode all trees
48. (counseling or counselling):ti or (counseling or counselling):ab
49. MeSH descriptor: [Cognitive Therapy] explode all trees
50. MeSH descriptor: [Behavior Therapy] explode all trees
51. ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):ti or ((behavio*r*) near/4 (modif* or therap* or rehab* or change)):
ab
52. MeSH descriptor: [Stress, Psychological] explode all trees
53. (stress near manage*):ti or (stress near manage*):ab
54. (cognitive* near therap*):ti or (cognitive* near therap*):ab
55. MeSH descriptor: [Meditation] explode all trees
56. (meditat*):ti or (meditat*):ab
57. MeSH descriptor: [Anxiety] this term only
58. ((manage*) near (anxiety or depres*)):ti or ((manage*) near (anxiety or depres*)):ab
59. (CBT):ti or (CBT):ab
60. (hypnotherap*):ti or (hypnotherap*):ab
61. (goal near/3 (setting)):ti or (goal near/3 (setting)):ab
62. ((psycho-educat*) or (psychoeducat*)):ti ((psycho-educat*) or (psychoeducat*)):ab
63. (motivat* near (interv*)):ti or (motivat* near (interv*)):ab
64. MeSH descriptor: [Psychopathology] explode all trees
65. (psychopathol*):ti or (psychopathol*):ab
66. MeSH descriptor: [Autogenic Training] explode all trees
67. (autogenic*):ti or (autogenic*):ab
68. (self near (manage* or care or motivat*)):ti or (self near (manage* or care or motivat*)):ab
69. (distress*):ti or (distress*):ab
70. (psychosocial* or psycho-social):ti or (psychosocial* or psycho-social):ab
71. MeSH descriptor: [Health Education] explode all trees
72. (nutrition or diet or health near (education)):ti or (nutrition or diet or health near (education)):ab
73. (heart manual):ti or (heart manual):ab
74. (#26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37)
75. (#38 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56
or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73)
76. (#74 or #75)
77. (#76 and #25)
78. #77 from 2008, in Trials
MEDLINE Ovid 1946 to January week 4 2013
1. exp Myocardial Ischemia/
2. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4. exp Coronary Artery Bypass/
5. coronary.ti,ab.
6. exp Coronary Disease/
7. exp Myocardial Revascularization/
8. Myocardial Infarction/
9. (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 infarct$5).ti,ab.
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp Heart Failure/
14. (heart adj5 failure).ti,ab.
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15. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
16. or/1-15
17. exp Heart Diseases/
18. (heart adj5 disease$2).ti,ab.
19. myocard$5.ti,ab.
20. cardiac$2.ti,ab.
21. CABG.ti,ab.
22. PTCA.ti,ab.
23. (stent$4 and (heart or cardiac$4)).ti,ab.
24. Heart Bypass, Left/ or exp Heart Bypass, Right/
25. or/17-24
26. *Rehabilitation Centers/
27. exp Exercise Therapy/
28. *Rehabilitation/
29. exp Sports/
30. Physical Exertion/ or exertion.ti,ab.
31. exp Exercise/
32. rehabilitat$5.ti,ab.
33. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
34. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
35. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
36. Patient Education as Topic/
37. (patient$2 adj5 educat$4).ti,ab.
38. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
39. *Self Care/
40. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
41. *Ambulatory Care/
42. exp Psychotherapy/
43. psychotherap$2.ti,ab.
44. (psycholog$5 adj5 intervent$5).ti,ab.
45. relax$6.ti,ab.
46. exp Relaxation Therapy/ or exp Mind-Body Therapies/
47. exp Counseling/
48. (counselling or counseling).ti,ab.
49. exp Cognitive Therapy/
50. exp Behavior Therapy/
51. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
52. *Stress, Psychological/
53. (stress adj5 management).ti,ab.
54. (cognitive adj5 therap$2).ti,ab.
55. meditat$4.ti,ab.
56. *Meditation/
57. exp Anxiety/
58. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
59. CBT.ti,ab.
60. hypnotherap$5.ti,ab.
61. (goal adj5 setting).ti,ab.
62. (goal$2 adj5 setting).ti,ab.
63. (psycho-educat$5 or psychoeducat$5).ti,ab.
64. (motivat$5 adj5 (intervention or interv$3)).ti,ab.
65. Psychopathology/
66. psychopathol$4.ti,ab.
67. psychosocial$4.ti,ab.
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68. distress$4.ti,ab.
69. exp Health Education/
70. (health adj5 education).ti,ab.
71. (heart adj5 manual).ti,ab.
72. Autogenic Training/
73. autogenic$5.ti,ab.
74. or/26-39
75. or/40-73
76. 16 or 25
77. 74 or 75
78. 76 and 77
79. randomized controlled trial/
80. randomized controlled trial.pt.
81. controlled clinical trial.pt.
82. controlled clinical trial/
83. Random Allocation/
84. Double-Blind Method/
85. single-blind method/
86. (random$ or placebo$).ti,ab.
87. ((singl$3 or doubl$3 or tripl$3 or trebl$3) adj5 (blind$3 or mask$3)).ti,ab.
88. exp Research Design/
89. Clinical Trial.pt.
90. exp clinical trial/
91. (clinic$3 adj trial$2).ti,ab.
92. or/79-91
93. 78 and 92
94. (Animals not Humans).sh.
95. 93 not 94
96. limit 95 to yr=“2008 -Current”
MEDLINE In-Process and Other Non-Indexed Citations Ovid 5 February 2013
1. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
2. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
3. coronary.ti,ab.
4. (myocard$5 adj5 infarct$5).ti,ab.
5. (heart adj5 infarct$5).ti,ab.
6. angina.ti,ab.
7. (heart adj5 failure).ti,ab.
8. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
9. or/1-8
10. (heart adj5 disease$2).ti,ab.
11. myocard$5.ti,ab.
12. cardiac$2.ti,ab.
13. CABG.ti,ab.
14. PTCA.ti,ab.
15. (stent$4 and (heart or cardiac$4)).ti,ab.
16. or/10-15
17. Physical Exertion/ or exertion.ti,ab.
18. rehabilitat$5.ti,ab.
19. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
20. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
21. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
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22. (patient$2 adj5 educat$4).ti,ab.
23. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
24. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
25. psychotherap$2.ti,ab.
26. (psycholog$5 adj5 intervent$5).ti,ab.
27. relax$6.ti,ab.
28. (counselling or counseling).ti,ab.
29. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
30. (stress adj5 management).ti,ab.
31. (cognitive adj5 therap$2).ti,ab.
32. meditat$4.ti,ab.
33. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
34. CBT.ti,ab.
35. hypnotherap$5.ti,ab.
36. (goal adj5 setting).ti,ab.
37. (goal$2 adj5 setting).ti,ab.
38. (psycho-educat$5 or psychoeducat$5).ti,ab.
39. (motivat$5 adj5 (intervention or interv$3)).ti,ab.
40. psychopathol$4.ti,ab.
41. psychosocial$4.ti,ab.
42. distress$4.ti,ab.
43. (health adj5 education).ti,ab.
44. (heart adj5 manual).ti,ab.
45. autogenic$5.ti,ab.
46. or/17-45
47. 9 or 16
48. 46 and 47
49. (random$ or placebo$).ti,ab.
50. ((singl$3 or doubl$3 or tripl$3 or trebl$3) adj5 (blind$3 or mask$3)).ti,ab.
51. (clinic$3 adj trial$2).ti,ab.
52. 49 or 50 or 51
53. 48 and 52
54. limit 53 to yr=“2008 -Current”
Embase Ovid 1980 to 2013 week 5
1. exp heart disease/
2. (myocard$4 adj5 (ischaemi$2 or ischemi$2)).ti,ab.
3. ((ischaemi$2 or ischemi$2) adj5 heart).ti,ab.
4. exp coronary artery disease/
5. transluminal coronary angioplasty/
6. (coronary adj5 (disease$2 or bypass$2 or thrombo$5 or angioplasty$2)).ti,ab.
7. exp heart infarction/
8. (myocard$5 adj5 infarct$5).ti,ab.
9. (heart adj5 infarct$5).ti,ab.
10. heart muscle revascularization/
11. exp Angina Pectoris/
12. angina.ti,ab.
13. exp congestive heart failure/
14. (heart adj5 failure).ti,ab.
15. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
16. or/1-15
17. (heart adj5 disease$2).ti,ab.
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18. cardiac$2.ti,ab.
19. CABG.ti,ab.
20. PTCA.ti,ab.
21. (stent$4 and heart).ti,ab.
22. exp extracorporeal circulation/
23. or/17-22
24. 16 or 23
25. *Psychotherapy/
26. psychotherapy$2.ti,ab.
27. (psycholog$5 adj5 intervent$5).ti,ab.
28. relax$6.ti,ab.
29. relaxation training/
30. *counselling/
31. (counselling or counseling).ti,ab.
32. ((behavior$4 or behaviour$4) adj5 (modify or modificat$4 or therap$2 or change)).ti,ab.
33. stress management/
34. (stress adj5 management).ti,ab.
35. *Mediation/
36. meditat$5.ti,ab.
37. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
38. CBT.ti,ab.
39. hypnotherap$2.ti,ab.
40. (goal$2 adj5 setting).ti,ab.
41. (psycho-educat$5 or psychoeducat$5).ti,ab.
42. (motivat$5 adj5 intervent$6).ti,ab.
43. exp psychosocial care/ or exp psychosocial rehabilitation/
44. psychosocial.ti,ab.
45. exp health education/
46. (health adj5 education).ti,ab.
47. (heart adj5 manual).ti,ab.
48. autogenic training/
49. autogenic.ti,ab.
50. *Rehabilitation/
51. rehabilitation center/
52. rehabil$.ti,ab.
53. exp Sport/
54. exp Kinesiotherapy/
55. exp Exercise/
56. exp Physiotherapy/
57. (physical$4 adj5 (fit or fitness or train$5 or therap$5 or activit$5)).ti,ab.
58. (train$5 adj5 (strength$3 or aerobic or exercise$4)).ti,ab.
59. ((exercise$4 or fitness) adj5 (treatment or intervent$4 or programs$2 or therapy)).ti,ab.
60. (aerobic$4 adj5 exercise$4).ti,ab.
61. (kinesiotherapy or physiotherapy).ti,ab.
62. patient education/
63. (patient$2 adj5 educat$4).ti,ab.
64. ((((lifestyle or life) adj1 style) or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
65. exp self care/
66. (self adj5 (manage$5 or care or motivate$5)).ti,ab.
67. exp ambulatory care/
68. (psycho-educat$5 or psychoeducat$5).ti,ab.
69. (motivat$5 adj5 intervent$6).ti,ab.
70. psychosocial care/ or psychosocial rehabilitation/
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71. psychosocial.ti,ab.
72. exp health education/
73. (health adj5 education).ti,ab.
74. (heart adj5 manual).ti,ab.
75. autogenic training/
76. autogenic$5.ti,ab.
77. (psycho-educat$5 or psychoeducat$5).ti,ab.
78. (motivat$5 adj5 intervent$6).ti,ab.
79. psychosocial care/ or psychosocial rehabilitation/
80. psychosocial.ti,ab.
81. exp health education/
82. (health adj5 education).ti,ab.
83. (heart adj5 manual).ti,ab.
84. or/25-50
85. or/51-83
86. 84 or 85
87. (random$ or placebo$).ti,ab.
88. ((singl$4 or doubl$4 or tripl$4 or trebl$4) adj5 (blind$4 or mask$4)).ti,ab.
89. (controlled adj1 clinical adj1 trial).ti,ab.
90. randomized controlled trial/
91. or/87-90
92. 24 and 86
93. 91 and 92
94. (animal$ not human$).sh,hw.
95. 93 not 94
96. limit 95 to yr=“2008 -Current”
PsycINFO Ovid 1806 to January week 5 2013
1. exp heart disorders/
2. *Myocardial Infarctions/
3. exp Ischemia/
4. *Heart Surgery/
5. angioplasty.ti,ab.
6. (heart adj1 bypass).ti,ab.
7. coronary.ti,ab.
8. (ischemi$3 or ischaemi$3).ti,ab.
9. (myocard$5 adj5 infarct$5).ti,ab.
10. (heart adj5 (infarct$5 or failure or attack)).ti,ab.
11. angina.ti,ab.
12. (heart adj5 disease$2).ti,ab.
13. myocard$5.ti,ab.
14. cardiac$4.ti,ab.
15. CABG.ti,ab.
16. PTCA.ti,ab.
17. (HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”).ti,ab.
18. or/1-17
19. exp Physical Activity/
20. exp Sports/
21. *Physical Education/
22. exp Health Behavior/
23. *Physical Fitness/
24. (physical adj1 education).ti,ab.
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25. exertion$6.ti,ab.
26. rehabilitat$6.ti,ab.
27. (physical adj5 (fit$5 or train$5 or therap$5 or activit$4)).ti,ab.
28. (train$4 adj5 (strength$4 or aerobic or exercise$2)).ti,ab.
29. ((exercise$3 or fitness) adj5 (treatment or intervent$4 or program$4 or therap$2)).ti,ab.
30. patient with education.ti,ab.
31. exp Client Education/
32. exp Health Promotion/
33. ((lifestyle or life-style) adj5 (intervent$5 or program$2 or treatment$2)).ti,ab.
34. exp Outpatient Treatment/
35. or/19-34
36. exp Psychotherapy/
37. psychotherapy$2.ti,ab.
38. exp Treatment/
39. (psycholog$4 adj5 intervent$5).ti,ab.
40. exp Counseling/
41. exp Coping Behavior/
42. *Meditation/
43. *Autogenic Training/
44. exp Health Education/
45. relax$6.ti,ab.
46. (counselling or counseling).ti,ab.
47. ((behavior or behaviour) adj5 (modif$5 or therap$5 or rehabilit5 or change)).ti,ab.
48. (stress adj5 management).ti,ab.
49. meditat$5.ti,ab.
50. (manage$5 adj5 (anxiety or depress$5)).ti,ab.
51. ((cbt or cognitive$2) adj5 therap$3).ti,ab.
52. hypnotherap$3.ti,ab.
53. (psycho-educat$6 or psychoeducat$6).ti,ab.
54. (motivat$5 adj5 intervent$5).ti,ab.
55. (self adj5 manag$6).ti,ab.
56. autogenic$3.ti,ab.
57. (goal adj5 setting).ti,ab.
58. (health adj5 education).ti,ab.
59. (heart adj1 manual).ti,ab.
60. or/36-59
61. 18 and (35 or 60)
62. (random$5 or placebo$5).ti,ab.
63. ((single$4 or double$4 or triple$4) and (blind$4 or mask or sham$4 or dummy)).ti,ab.
64. RCT.ti,ab.
65. or/62-64
66. 61 and 65
67. limit 66 to yr=“2008 -Current”
CINAHL EBSCOhost, search date 5 February 2013
1. TI((myocard* N5 ischaemi*) or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*)) OR AB((myocard* N5
ischaemi*) or (myocard* N5 ischemi*) or (heart N5 ischaemi*) or (heart N5 ischemi*))
2. TI(coronary) or AB(coronary)
3. TI((myocard* N5 infarc*) or (heart N5 infarc*)) or AB((myocard* N5 infarc*) or (heart N5 infarc*))
4. TI(angina) OR AB(angina)
5. TI(heart N5 failure) or AB(heart N5 failure)
6. TI(heart N5 diseas*) or AB(heart N5 diseas*)
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7. TI(cardiac) or AB(cardiac)
8. TI(CABG) or AB(CABG)
9. TI(PTCA) or AB(PTCA)
10. TI(Stent* and (heart or cardiac*)) or AB(Stent* and (heart or cardiac*))
11. (MH “Myocardial Ischemia+”)
12. (MH “Myocardial Infarction+”)
13. (MH “Coronary Artery Bypass+”)
14. (MH “Coronary Disease+”)
15. TI(cardiac N5 patient*) or AB(cardiac N5 patient*)
16. TI(Cardiomyopathies) or AB(Cardiomyopathies)
17. (MH “Myocardial Revascularization+”)
18. (MH “Heart Diseases+”)
19. (MH “Cardiovascular Diseases+”)
20. (MH “Heart Failure+”)
21. (MH “Angina Pectoris+”)
22. TI(HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”) or AB(HFNEF or HFPEF or HFREF or “HF NEF”
or “HF PEF” or “HF REF”)
23. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18 OR S19 OR S20 OR S21 OR S22
24. (MM “Rehabilitation”)
25. (MM “Sports”)
26. (MM “Physical Activity”)
27. (MH “Muscle Strengthening+”)
28. (MH “Aerobic Exercises+”)
29. (MH “Physical Fitness+”)
30. (MH “Patient Education+”)
31. (MH “Therapeutic Exercise+”)
32. TI(rehabilitat*) or AB(rehabilitat*)
33. TI((physical* N5 fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*)) or
AB((physical* N5 fit) or (physical N5 fitness) or (physical N5 train*) or (physical N5 therap*) or (physical N5 activit*))
34. TI((train N5 strength) or (train N5 aerobic) or (train N5 exercis*)) or AB((train N5 strength) or (train N5 aerobic) or (train N5
exercis*))
35. TI((exercise N5 treatment) or (fitness N5 treatment) or (exercise N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*)
or (fitness N5 program) or (exercise N5 therapy) or (fitness N5 therapy)) or AB((exercise N5 treatment) or (fitness N5 treatment)
or (exercise N5 intervent*) or (fitness N5 intervent*) or (exercise N5 program*) or (fitness N5 program) or (exercise N5 therapy) or
(fitness N5 therapy))
36. TI(patient* N5 educat*) or AB(patient* N5 educat*)
37. TI ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or (life-style N5 program*) or (lifestyle N5
treatment) or (life-style N5 treatment)) OR AB ((lifestyle N5 intervent*) or (life-style N5 intervent*) or (lifestyle N5 program*) or
(life-style N5 program*) or (lifestyle N5 treatment) or (life-style N5 treatment))
38. (MH “Self Care+”)
39. TI((self N5 manage*) or (self N5 care) or (self N5 motivat*)) or AB((self N5 manage*) or (self N5 care) or (self N5 motivat*))
40. (MM “Ambulatory Care”)
41. TI(aerobic) or AB(aerobic)
42. TI(resistance W1 train*) or AB(resistance W1 train*)
43. TI(muscle W1 strength*) or AB(muscle W1 strength*)
44. TI(resistance W1 train*) or AB(resistance W1 train*)
45. TI(muscle W1 strength*) or AB(muscle W1 strength*)
46. (MH “Psychotherapy+”)
47. TI(psychotherap*) or AB(psychotherap*)
48. TI(psycholog* N5 intervent*) or AB(psycholog* N5 intervent*)
49. TI(relax) or AB(relax)
50. (MH “Relaxation Techniques+”)
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51. TI(counselling or counseling) or AB(counselling or counseling)
52. (MH “Counseling+”)
53. TI((behavio?r* N5 modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change)) or AB((behavio?
r* N5 modify) or (behavio?r* N5 modificat*) or (behavio?r* N5 therap*) or (behavio?r* N5 change))
54. (MM “Stress Management”)
55. TI(stress N5 manag*) or AB(stress N5 manag*)
56. TI(cognitive N5 therap*) or AB(cognitive N5 therap*)
57. (MM “Meditation”)
58. TI(meditat*) or AB(meditat*)
59. (MH “Anxiety+”)
60. TI((manage* N5 anxiety) or (manage* N5 depress*)) or AB((manage* N5 anxiety) or (manage* N5 depress*))
61. TI(CBT) or AB(CBT)
62. TI(hypnotherap*) or AB(hypnotherap*)
63. TI(goal* N5 setting) or AB(goal* N5 setting)
64. TI(psycho-educat* or psychoeducat*) or AB(psycho-educat* or psychoeducat*)
65. TI((motivat* N5 interv*) or (motivate* N5 intervent*)) or AB((motivat* N5 interv*) or (motivate* N5 intervent*))
66. TI(psychosocial*) or AB(psychosocial*)
67. (MH “Health Education+”)
68. TI(health N5 educat*) or AB(health N5 educat*)
69. TI(heart W1 manual) or AB(heart W1 manual)
70. TI(autogenic*) or AB(autogenic*)
71. S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38
OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45
72. S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60
OR S61 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70
73. S71 OR S72
74. S23 AND S73
75. PT CLINICAL TRIAL
76. (MH “Clinical Trials+”)
77. TI (random* or placebo*) or AB (random* or placebo*)
78. TI(singl* or double* or triple* or treble* and (blind* or mask*)) or AB(singl* or double* or triple* or treble* and (blind* or mask*))
79. TI(controlled w1 clinical w1 trials) or AB(controlled w1 clinical w1 trials)
80. S75 OR S76 OR S77 OR S78 OR S79
81. S74 AND S80 date limit=2008-current
Web of Science, search date 6 February 2013
1. TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
2. TS=((coronary* or heart*) SAME (by?pass or disease*))
3. TS=((heart) SAME (infarct* or isch?emia or failure or attack))
4. TS=(angina or cardiac* or PTCA or CABG)
5. TS=(HFNEF or HFPEF or HFREF or “HF NEF” or “HF PEF” or “HF REF”)
6. #1 OR #2 OR #3 OR #4 OR #5
7. TS=(rehab* or educat*)
8. #6 AND #7
9. TS=(random* or placebo*)
10. TS=((singl* or doubl* or tripl* or trebl*) SAME (blind* or mask*))
11. TS=(“clinic* trial*”)
12. #9 OR #10 OR #11
13. #8 AND #12
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2008-2013
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WH A T ’ S N E W
Date Event Description
1 June 2018 New citation required but conclusions have not changed Eleven new studies (29 publications) were included in
the update. The study population included adults with
evidence of HF - either HFrEF or HFpEF. We based our
search strategy on the January 2013 search strategy, which
was made to reflect more recent use of the terms ’HFpEF’
and ’HFrEF’. The search for this current review update
was updated from the 2013 search (January 2013 to 29
January 2018), with date limits applied to our latest search
to identify only those records that have been newly added
to the databases since the last search. Review conclusions
remain unchanged
31 May 2018 New search has been performed Weupdated this reviewwith trials identified by the update
search, which we ran on 29 January 2018
H I S T O R Y
Protocol first published: Issue 4, 2001
Review first published: Issue 3, 2004
Date Event Description
1 November 2013 New citation required but conclusions have not
changed
For this review update, we identified 14 additional tri-
als.Whilst conclusions of the review have not changed,
this update provides a broader body of evidence of the
benefits of exercise-based interventions, which includes
patients with HFpEF and delivery in a home-based set-
ting
14 February 2013 New search has been performed Searches were updated
18 May 2004 New citation required and conclusions have changed Substantive amendments were made
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We have updated this review compared to the protocol in terms of specification of outcomes. We have changed ’must report outcome’
to ’must have intended to assess outcomes of interest’; also, sudden death is no longer an outcome of interest.
Since the previous update in 2014, we have broadened the inclusion criteria from chronic systolic heart failure to general heart failure.
N O T E S
None.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise Therapy [mortality]; Chronic Disease; Exercise Tolerance; Health Status; Heart Failure [mortality; ∗rehabilitation]; Hospi-
talization [statistics & numerical data]; Quality of Life; Randomized Controlled Trials as Topic
MeSH check words
Adult; Aged; Humans; Middle Aged; Young Adult
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